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Summary and conclusions  
Introduction 
1. Bovine TB is an infectious disease that spreads between cattle that is unlike any 
other endemic disease afflicting the livestock industry in England.  The prevalence 
of the disease in parts of the country, coupled with the test and slaughter strategy 
that is the basis of disease control, makes the risk and consequences of infection 
one of the greatest factors affecting the livelihoods of numerous farmers.  In writing 
this report we are acutely aware of the burden this disease places on the welfare 
and well-being of farmers and their families.  We do think more can be done to 
control this disease, and hopefully eventually eliminate it, but we would be offering 
false hope if we pretended this will be other than a protracted campaign. 
2. The disease is also unusual in that it infects an iconic wild animal, the badger, and 
there is transmission to and from badgers and cattle.  Culling of badgers to reduce 
infection in cattle is seen as unconscionable by some sections of society and 
currently the Labour Party has pledged that culling will not be part of its bovine TB 
control strategy (and Wales also currently has a no-cull policy).  The deeply held 
beliefs of people who cannot countenance culling badgers deserve respect, as do 
the beliefs of people who argue that sacrificing badgers is justified to reduce the 
burden of this disease on livestock and farmers.  The decision whether or not to cull 
badgers must be informed by evidence which provides important information on 
likely outcomes.  However, final decisions have to take into account the 
irreconcilable views of different stakeholders and so inevitably require judgements 
to be made by ministers.  
3. Our interpretation of the evidence is that the presence of infected badgers does 
pose a threat to local cattle herds.  This interpretation reflects the broad consensus 
amongst epidemiologists who have studied the disease. Reducing this threat, by 
culling or non-lethal intervention, will thus help lower the incidence of the disease in 
cattle.  If a decision is made not to cull, and if non-lethal interventions prove less 
effective, then progress towards eliminating the disease will be slower and complete 
elimination may be even more difficult. 
4. A very unfortunate consequence of the controversy around badger culling and the 
politicisation of the debate has been a deflection of focus from what can be done by 
the individual farmer and by the livestock industry to help control the disease.  In 
particular, the poor take up of on-farm biosecurity measures and the extent of 
trading in often high-risk cattle is, we believe, severely hampering disease control 
measures.  All the industry bodies we spoke to recognised this as an issue and saw 
the need for industry to take more ownership of the problem.  Implementing better 
control measures on the livestock side will mean short- to medium-term costs to the 
industry to achieve the greater goal of bovine TB elimination.  The degree to which 
the industry as opposed to the state or the consumer bears these costs is a 
decision for ministers but it is wrong, we believe, to over-emphasise the role of 
wildlife and so avoid the need for the industry to take measures that have in the 
short-term negative financial consequences. 
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5. Bovine TB is a notifiable disease and exactly how it is monitored and controlled 
affects our ability to trade.  The complex statutory underpinning of surveillance and 
control, involving both national and European legislation, makes agile and adaptive 
management of the disease very difficult.  We believe this legal and administrative 
viscosity hampers better disease control.  We report at a time when the UK is 
negotiating to leave the EU but when the final settlement of our trading relationship 
and regulatory alignment with the EU is yet to be agreed.  The disadvantage of this 
timing is that detailed cost-benefit analysis of the consequences of the different 
control options we discuss is not possible.  The advantage is that with the inevitable 
restructuring of our agricultural governance arrangements there is the opportunity to 
explore better disease control interventions.  We urge that the opportunity to re-
fashion the regulation on bovine TB is not missed. 
6. The main body of the report, Chapters 3-9, explores a wide range of interventions 
that we believe should be considered in attempts to control bovine TB in England.  
We have attempted to broaden the discussion of interventions from a narrow focus 
on epidemiology, and tried dispassionately to weigh their advantages and 
disadvantages.  In many cases we do not recommend a specific course of actions.  
This is for a number of reasons including: (i) many decisions require ministerial 
judgement, for example those involving ethics or costs; (ii) further more detailed 
cost-benefit analysis and modelling is required than has been possible in this study; 
(iii) we do not know the final post-EU arrangements.  In this chapter we summarise 
our conclusions and highlight the factors that we believe should be at the front of 
decision makers’ minds when determining future policy. 
Governance 
7. We believe that there is a strong argument that current governance arrangements 
poorly serve bovine TB control.  They have resulted in too little industry ownership 
of the disease and a widespread implicit belief that bovine TB is government’s 
problem alone.  Within government and its agencies, multiple bodies share 
responsibility for different aspects of the disease, and the ability of the system to 
adapt rapidly to new epidemiological evidence or new technologies is inadequate. 
8. In New Zealand, bovine TB control efforts are led by the industry and this has 
produced very good results.  There is also a major wildlife reservoir species in New 
Zealand, but this is the introduced Australian brush-tailed possum; culling possums 
has agricultural and conservation benefits and is relatively uncontroversial.  We do 
not think adopting this governance model in England would be possible as giving 
industry as great a control over policy concerning the disease in wildlife would be 
unacceptable to many, while partial responsibility would be unattractive or 
unacceptable to industry. 
9. We see many advantages of retaining high-level policy making in Defra but 
devolving much of the disease control operations to a new body that would take 
over functions currently performed by APHA, Natural England and local authorities.  
Centralising functions in this way would be more efficient, avoid duplication and 
allow greater co-ordination and agility.  Separation from government would make it 
easier for the new body to work collaboratively with industry and other stakeholders, 
encouraging shared ownership of the problem.  We have discussed these issues 
with Dame Glenys Stacey who is currently leading a review for Defra of the broader 
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issue of farm regulation and inspection and are aware this proposal aligns with 
some of her likely recommendations.  
10. An important part of farmers taking more ownership of the disease is ensuring that 
they receive the best advice (for example on safe trading practices, on-farm 
controls and biosecurity) from trusted sources. Existing information available on the 
web (TB Hub) is very good, though obviously farmers must be motivated to find and 
make use of it.  We believe the role of private veterinarians in providing advice is 
particularly important and should be supported, taking into account the true costs of 
its provision for veterinary businesses.  Study of best practice in the Devolved 
Administrations and the Republic of Ireland (RoI) will be very helpful in designing 
support for farmers in England. 
11. Consultation with industry and other stakeholders is an important part of bovine TB 
control and of achieving shared ownership of the problem.  Nevertheless, we 
believe that the current frequency and granularity of consultation is cumbersome 
and counter-productive.  Concern over ‘consultation fatigue’ was expressed to us by 
many stakeholders.  We see advantages in consulting at a higher level on broad 
strategy and principles of adaptive management.  This will enable operational 
decisions to be made more swiftly and more flexibly as circumstances change and 
new evidence emerges.  We are aware that changes in the nature of consultation 
will involve some legislative amendments. 
Surveillance and diagnostics 
12. If a test is not sensitive enough it will miss too many infected animals, while if it is 
not specific enough it will produce too many false positives.  There is often a trade-
off between sensitivity and specificity.  The test we use in the United Kingdom (UK) 
and the RoI (the Single Intradermal Comparative Cervical Test, SICCT) has high 
specificity but lower sensitivity than that used in continental Europe (the Single 
Intradermal Cervical Test, SICT).  There is some evidence that the sensitivity of the 
SICCT under operational field conditions is lower than that estimated in formal 
trials.   
13. Policy makers need to balance the disadvantages of low specificity (more cattle 
sent to slaughter and herds placed under provisional restrictions) and low sensitivity 
(infections going unrecognised).  We see a strong argument for moving to a more 
sensitive test (probably the SICT) for surveillance in the High Risk Area (HRA) and 
Edge Area (EA) to enable the detection of infections in these regions as early as 
possible.  In the Low Risk Area (LRA) the numbers of new infections detected 
would not justify the increased number of false positives.  Such a change would be 
allowed given current EU rules.  Once outside the EU, there would be scope to use 
either the SICT or caudal fold test (CFT) for herd screening and to retest reactor 
animals with the interferon gamma test to reduce the number of false positives 
detected by the more sensitive screening test. 
14. Were this change to be made, the number of herd breakdowns would in the short 
term go up as more infections are revealed.  It is very important that policy makers 
and all stakeholders understand this epidemiological reality and do not misinterpret 
it as a policy failure. 
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15. Once infection is discovered in a herd it is important to identify all cattle infected 
with the bacterium. There are a number of circumstances where there is particular 
premium on removing infections from herds as quickly as possible.  These include 
herds with persistent and recurrent infections, herds in badger cull areas where it is 
important to avoid re-infecting wildlife, herds in the EA where preventing 
geographical spread into the LRA is a high priority, and emerging hotspots of 
infection within the LRA. Here, combining a skin test, the interferon gamma test and 
the IDEXX ELISA serological test, should be considered as each test detects some 
infected animals that the other tests miss. The costs of testing would increase, but 
the epidemiological benefits in these critical cases would be substantial.  
16. The current SICCT, SICT and interferon gamma tests rely on tuberculin – 
essentially a cocktail of proteins derived from the bacterium that is difficult to 
standardise.  We see a strong argument for investing in better tuberculin quality 
control.  In the medium term, and requiring efficacy and safety tests, the aim should 
be to replace tuberculin by defined antigens.  Such tests would also provide a DIVA 
(differentiating infected from vaccinated animals) function.  
17. There is intensive research on TB testing and diagnostics in both the human and 
veterinary science worlds.  A number of promising tests are in development.  Other 
innovations include the possible bulk-testing of milk for evidence of infection.  We 
see it as very important to make sure that an efficient pipeline is developed to 
assess the value of new innovations, to carry out field efficacy and safety tests, and 
where justified to deploy them rapidly.  We realise, of course, that the administrative 
burden of changing test protocols, as well as any consequences for trade, have to 
be taken into account. 
18. Currently, M. bovis, the bacterium responsible for bovine TB, is genotyped using 
information from specific regions of its genome.  Recent advances in molecular 
biology make it now feasible and cost-efficient to move to whole-genome 
sequencing which we believe should be used routinely.  This technique allows 
disease transmission pathways to be identified with greater accuracy (though 
cannot of course resolve all issues in identifying sources of infection). 
Vaccination and genetic resistance in cattle 
19. The BCG vaccine available for cattle provides some but not complete protection 
against bovine TB.  However, vaccinated cattle often test positive for current 
tuberculin-based tests for the disease and the widespread use of BCG in cattle 
would compromise surveillance (and affect trade in live cattle and dairy products). 
20. In our view, the goal should be for testing to move to DIVA tests (see ¶ 16).  Once 
these are available, then the possible advantages of different models of vaccination 
deployment should be re-examined.  This should involve a cost-benefit analysis that 
takes into account implications for international and UK trade and business.  Recent 
studies in humans and other primates have explored the potential of improving BCG 
vaccines and vaccination protocols.  Investigation of whether these and future 
advances carry over to cattle is worthwhile. 
21. Progress has been made in understanding the genetic basis of bovine TB 
resistance in cattle enabling genetic selection for higher resistance.  This sensible 
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approach that will in the long term make a modest but valuable contribution to 
disease control should, we believe, be supported. 
Risk-based trading 
22. Defra and the livestock industry are currently investing in the Livestock Information 
Service (LIS) which will provide information on the movements of all cattle in the UK 
linked to electronic identification tags.  LIS will have multiple functions, of which 
providing information that can be used in bovine TB control will be one of the most 
important.  We place a very high priority on supporting and implementing LIS, and 
strongly advise that considerations of how it can be used to combat this disease are 
taken into account at the design stage. 
23. It is now routine to mark horses and pets with microchips and we believe further 
investigation of the feasibility of this for cattle is warranted.  It would reduce the 
opportunities for fraud and improve traceability.  We understand the need to avoid 
microchips entering the human food chain. 
24. Relatively crude indices of the risk of infection of cattle have already been 
developed and LIS will enable more sophisticated measures.  There is, we believe, 
a very strong argument that these measures should mandatorily be available prior 
to purchase and at market ring-sides. 
25. The number of cattle movements in England is very high and will inevitably be a risk 
for disease spread.  We have not been able to do a full analysis of the regulatory 
and economic drivers of this level of trading with the time and resources available.  
We recommend such an analysis is carried out to discover whether there are 
perverse incentives for movement and if these can be changed as part of post-EU 
agricultural reforms.  The analysis should also test whether movements that 
increase the efficiency of the industry provide sufficient benefits to outweigh the 
negative externality of disease spread. 
26. Farmers are currently compensated for slaughtered cattle (or might in the future 
take out insurance against the risk).  We believe that there is a strong argument for 
disincentivising risky trading by reducing compensation (or insurance payments) to 
reflect trading behaviour.  Such adjustments would need to be relatively large to 
change behaviour. 
27. There is evidence that mandatory post-movement testing has reduced the 
movement of cattle from high- to low-risk areas.  Policy makers should consider 
extending this to at least the EA and to mandate the use of the most sensitive test.  
We consider that the increased costs of trading that will be borne by the industry is 
justified by the likely reduction in disease spread.  
Disease in wildlife 
28. The evidence shows that badgers do transmit bovine TB to cattle and contribute to 
the persistence of the disease.  Ministers have to decide whether the real but 
circumscribed benefits of culling to the farming industry outweigh the animal welfare 
and environmental concerns of other stakeholders.  This decision must be informed 
by scientific evidence but inescapably involves a judgement call by ministers. 
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29. There is evidence that culling badgers perturbs the animal’s social structure leading 
to increased risks of herd breakdowns in adjacent non-culled areas – the 
perturbation effect.  If a decision is made to cull, then carrying it out over sufficiently 
large geographic areas to reduce the relative effects of perturbation and utilising 
natural barriers to badger movement, as is done at the moment, is in our view 
correct.  Experience from the Randomised Badger Culling Trial suggests that the 
benefits of widespread culling repeated annually for four years persist for some 
years after lethal control stops, and hence we see periodic culling as a more 
promising strategy than continuous culling beyond four years. 
30. Moving from lethal to non-lethal control of the disease in badgers is highly desirable.  
Though research into other options should continue, we believe that the injectable 
BCG vaccine is the only viable option currently available.  At the moment there is 
limited information about the relative effectiveness of vaccination and culling on 
incidence of the disease in cattle, though the results from small-scale vaccine 
projects in England and large-scale deployment of vaccination in the RoI will help 
address this.  We believe it is very important to maintain flexibility in policy over 
control of the risk of transmission from badgers to be able to respond to the 
changing evidence base. 
31. If uncertainty about the relative effectiveness of vaccination and culling is not 
resolved by analysis of the outcomes of existing interventions (in England and 
elsewhere) then we believe Government should address this need.  Culling is 
currently being carried out, or being planned, in 32 areas, chiefly in the west of 
England.  On the assumption that this goes ahead and that periodic culling rather 
than continuous culling is adopted (¶ 29), we suggest that after four years of culling 
Government should consider a programme in which badgers are vaccinated in half 
of the areas and, after a two-year pause, intensive culling resumes in the other half.  
The outcomes should be monitored and adaptively managed so should it become 
clear that vaccination is providing comparable benefits to culling then all areas 
should adopt it, with the opposite happening if vaccination fails to provide 
protection. 
32. The evidence does not suggest that other wild or feral animals (for example deer, 
fox, wild boar) pose a substantial national threat to cattle but any opportunity to 
increase our knowledge of disease prevalence in these species should be taken. 
The disease in non-bovine managed animals 
33. Bovine TB occurs in other farmed animals, though is less of a problem than in 
cattle.  Defra has recently consulted on improvements in regulations concerning 
non-bovines (particularly South American camelids such as alpacas) and we 
support their implementation.   
Biosecurity 
34. The evidence base about which particular biosecurity measures work is not strong 
because of the difficulties of carrying out formal experiments for each of multiple 
different options.  Nevertheless, there are many relatively cheap things a farmer can 
do to separate cattle from badgers, cattle from other cattle on neighbouring 
holdings, and potentially infected from uninfected cattle.  These are ’no regret’ 
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biosecurity options whose take up is disappointingly low.  In our view, the issue 
here is not the availability of information but motivation to discover what can be 
done and to implement the measures.  Above we stress the importance of the 
industry taking greater ownership of the disease, and we hope this leads to greater 
uptake of biosecurity.  We also underline the importance of farmers’ trusted 
advisors, in particular private veterinarians, giving clear and unambiguous advice on 
biosecurity. 
35. A number of accreditation schemes mandate biosecurity measures while 
supermarkets also lay down rules for their suppliers.  Unifying all these rules 
relevant to bovine TB in a single guidance set would, we believe, be helpful for 
farmers and stimulate uptake.  Were the single bovine TB authority we discuss in 
chapter 9 to be created, this would be the natural body to coordinate. 
36. Farmers are at present partly compensated for losses due to cattle slaughtered for 
reasons of disease control.  We have examined the relative merits of compensation 
versus insurance and recommend further exploration of the latter.  Because of the 
issues of adverse selection, Government would need to be involved in setting up an 
insurance programme (as, for example, it has been in flooding insurance) and in 
information provision.  We envisage a compulsory insurance programme partially 
supported by Government (replacing compensation) with premiums and 
compensation designed to incentivise and reward behaviour that reduces the risk of 
disease. 
37. We note recent evidence that the potential for bovine TB to be dispersed by 
spreading slurry or manure on the land may have been under-appreciated. We 
believe obtaining more evidence on this transmission route, and then if appropriate 
mitigating it, is important.   
British farming after the CAP 
38. In September 2018 the government published the Agriculture Bill and a policy 
statement on The Future for Food, Farming and the Environment both of which 
outline a vision for British agriculture outside the Common Agriculture Policy (CAP).  
A clear direction of travel from indirect subsidy (Single Farm Payment) to “public 
money for public good” is indicated.  The next decade will see arguably the greatest 
change in British farming since the 1940s and ensuring these changes facilitate 
bovine TB control will be critical to successful elimination of the disease. 
39. Current incentives to hold agricultural land for investment has increased the amount 
of land rented out for grazing.  New rules introducing Temporary Land Associations 
mean that a farmer renting the land is not required to record cattle movements as 
long as they are less than 10 miles from his or her farm’s central location.  We have 
not been able to analyse fully the extent of this movement but are concerned about 
the role of short-distance movement in disease spread.  We hope that the 
introduction of the LIS will enable data to be collected on this movement easily 
without excessively burdening the farmer.  Policy makers should consider whether, 
even with our imperfect current knowledge, reducing local movements in the most 
critical places for spread (the EA) is justified.  Looking to the future, ensuring post-
CAP arrangements reduce incentives for local movements would be helpful, though 
we realise may impact upon the industry. 
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40. There has been recent discussion about the extent of short-term tenancies in British 
farming and the disincentive this introduces to investment to increase productivity.  
We note that these investments include those to reduce the risk of bovine TB and 
that disease control would also benefit from measures to encourage long-term 
investment. 
Research 
41. There are many areas, some outlined in this review, where research has played a 
valuable role in the battle against bovine TB. The specific need for more research, 
such as in novel diagnostics, vaccines, genetic resistance and around farmer 
behaviour, is identified in this report. Research in this field is funded by a variety of 
bodies and occupies the whole spectrum from largely fundamental to highly 
strategic.  This diversity is a strength.  Nevertheless, we believe there would be a 
benefit from setting up a forum that would better link research funders with the 
needs of customers of the more applied research.  This would ensure that the 
research had the highest possible impact and value for money. 
Concluding comments 
42. We conclude with two broad observations. TB is a complex and difficult disease to 
control, both in humans and in animals.  Research over more than a century has 
provided many insights into the disease and tools to help combat it, and future 
research will be equally informative.  In designing a strategy to control bovine TB in 
England and progress towards elimination it is important to be flexible and set up 
systems that ensure new insights from surveillance and research are efficiently 
incorporated into policy and implementation. 
43. Second, we most always remember that this is a disease control campaign with a 
clear objective and, unfortunately, requiring sacrifices to be successful.  Because of 
the complexities and multiple consequences of the disease – epidemiological, 
economic and social – it is inevitable that a large series of rules and regulations 
have had to be put in place.  This can foster a philosophy of living with the disease 
(and the regulations) rather than being part of a disease control campaign.  Today, 
bovine TB incidences in England, definitely in cattle and possibly in badgers, are at 
best roughly stable.  This cannot be allowed to continue.  There are no easy 
answers to reducing disease levels and what is required is new drive and a 
concerted and concentrated effort by all sectors involved.
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Chapter 1: Introduction 
Preamble 
1.1. Bovine tuberculosis (bovine TB) is an important disease of cattle which also attacks 
a broad range of farm and wild mammals.  The causative agent is a bacterium, 
Mycobacterium bovis (M. bovis), and developed infections result in deterioration in 
condition, milk yield, and meat quality. Bovine TB can infect humans and before 
milk pasteurisation became standard it was a significant global public health 
problem, including in the United Kingdom (UK).  Today, only a few human infections 
occur annually in the UK.  Infected cattle secrete bacilli which, though the precise 
modes of transmission are poorly characterised, infect other cattle. There is also 
two-way transmission between cattle and wild animals.  In the UK and RoI, the most 
important wildlife host is the badger1.  
1.2. Bovine TB is found throughout the world and, amongst high-income countries, it is a 
particular problem in the UK and RoI.  In the UK, the Devolved Administrations 
(DAs) have responsibility for policy on bovine TB.  The disease is particularly 
prevalent in the west of England, Wales and Northern Ireland while incidents in 
Scotland are rare and sporadic.  The UK administrations work to control the disease 
within a framework specified by the European Union (EU).  Deviations from this 
framework are at present illegal and would impact the UK’s ability to trade cattle 
with other countries in the EU2. 
1.3. Control of bovine TB in England is based around regular testing of cattle in the 
nation’s herds.  A herd that contains cattle that test positive (reactors) is said to 
experience a herd breakdown and if confirmed it has its Officially TB Free (OTF) 
status withdrawn.  The herd is then subject to movement restrictions (typically cattle 
can only be sent to slaughter) and is tested more frequently until reactors are no 
longer present.  Reactors are slaughtered and compensation is paid to the farmer.  
Testing frequency and details of other interventions are different in the High Risk 
Area (HRA), the Edge Area (EA), and the Low Risk Area (LRA). These areas are 
set out at Figure 1.1.  Government also intervenes to promote biosecurity (for 
example, discouraging the purchase of cattle with a risk of infection and reducing 
the probability of transmission from wildlife) and to support research on bovine TB 
epidemiology, surveillance and vaccination3. 
1.4. When badgers were discovered to be hosts of bovine TB in the UK following 
investigations on a farm in Gloucestershire in 1971 a programme of badger culling 
was initiated.  This became highly controversial with arguments that it was both 
ethically wrong and epidemiologically ineffective.  The Krebs Report (1997) 
recommended a large-scale field experiment, the Randomised Badger Culling Trial 
(RBCT) that ran from 1998-2005.  It showed an overall though relatively modest 
benefit of widespread culling on the incidence of herd breakdowns.  Badger culling 
began again in 2013 at two pilot sites and currently (2018) this has been licensed 
for 32 sites. 
                                            
1 Further background details of M. bovis epidemiology and pathology are given in Chapter 2. 
2 Further background details of bovine TB distribution and European governance are given in Chapter 2. 
3 The interventions described in this and the next paragraph are explored in detail in the core of the report. 
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1.5. Despite intensive efforts by government and industry the numbers of herd 
breakdowns in parts of England remains stubbornly high (Figure 1.2). Currently, 
government spends about £70 million a year on disease control in England with the 
cost to industry estimated to be a further £50 million. Government also funds a 
substantial research programme as discussed at Annex 5. Herd breakdowns have 
major financial and non-financial consequences for affected farms, including on 
farmer and farm worker health and well-being.  The programme of badger culling 
remains controversial and one major political party is committed to ending culling. 
This Review 
1.6. In February 2018 the Secretary of State at the Department for Environment, Food 
and Rural Affairs (Defra) announced a review of bovine TB strategy in England.  
The intention was to reflect on the progress made with implementation of the 
current (2014) bovine TB strategy and “to advise on changes to take the strategy to 
the next phase, in order to maintain momentum towards the government’s goal of 
achieving officially free status in England by 2038”.  The full Terms of Reference are 
given in Annex 3 and the members of the Review Panel and their declarations of 
interest in Annex 2.  The Panel began their work in late March 2018. 
1.7. With agreement of Defra the Review Panel interpreted their brief as follows: 
(i) The Review would be forward looking and revisit past successes and failures 
only in as much as it helped develop future interventions and strategies. 
(ii) The Review would take a broad view of bovine TB in England and reflect not 
only on the epidemiology of the disease but also the role of the structure of the 
beef and dairy industries and the way we manage rural landscapes on the 
incidence of the infection. 
1.8. The work of the Panel took place between March and September 2018 at a time 
when the UK is committed to leave the EU but the final details of the relationship 
between EU and UK agricultural rules and trade arrangements have not been 
settled.  We have thus not confined ourselves to consider interventions that are in 
accord with current EU rules though realise, of course, that the viability of some of 
the options we explore will be influenced by the final settlement. 
1.9. Many of the decisions that need to be made about bovine TB control have to take 
into account the sometimes conflicting views of different stakeholders and so 
inevitably require judgements to be made by ministers.  For example, there is no 
strictly scientific counter-argument to the claims made by people who consider 
badger culling to be intrinsically unethical; such issues have to be decided in a 
democracy by ministers in elected governments.  Similarly, the question about the 
degree to which the state should intervene financially to compensate farmers for 
bovine TB outbreaks is a question of political economy for which there is no 
technically ‘right’ answer.  Evidence from the natural and social sciences is very 
important for placing bounds on feasible strategies and helping policy makers 
choose amongst different options but cannot by itself determine a single best 
approach to disease control. 
1.10. With this in mind, the approach we have taken in this Review is to consider a series 
of different options for interventions in different domains that may affect disease 
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transmission.  For each option we attempt to weigh up the pros and cons of the 
different alternatives.  We discuss the weight of evidence supporting the efficacy 
and cost-effectiveness of different interventions, and try to articulate clearly where 
ministers have to exercise value judgements based on this information.  Our 
‘Summary and conclusions’ set out what we believe are some of the most promising 
approaches. 
1.11. As stated above, one of the goals of the Review is to widen the possible set of 
interventions considered by government (especially in light of the increased 
autonomy possible outside the EU).  Some of the options we explore are thus 
relatively novel.  We point out that in the six-month’s time span of the Review, and 
with the resources available to us, we cannot perform an in-depth analysis of the 
details of the implementation.  We ask readers to concentrate on the big picture and 
anticipate that careful cost-benefit analysis and a check to avoid perverse incentives 
would be conducted prior to any implementation. 
1.12. Bovine TB is a particularly difficult disease to study and control because of, 
amongst other reasons: (i) the specific pathology of the disease, (ii) the existence of 
a nocturnally active wildlife host that spends much time underground, (iii) the 
difficulty and expense of carrying out large-scale experiments, and (iv) the 
complexity of the dairy and beef industries in England and in the rest of the UK.  
Intensive research on the disease in farmed and wild animals, as well as on the 
closely related human TB pathogen (Mycobacterium tuberculosis), will certainly 
provide new insights in coming years.  Bovine TB strategy thus needs to be 
‘adaptive’ and able to respond to new knowledge and technology, as well as to 
changes in disease prevalence and spatial distribution. 
How the Review was conducted 
1.13. The Review was conducted by a Panel of five people (Annex 2) acting in a personal 
capacity and supported by a secretariat provided by Defra.  The UK’s Chief 
Veterinary Officer (CVO) attended meetings and offered commentary and advice.    
1.14. The Review issued a call for evidence on 24 April 2018 with a deadline of 31 May. 
We asked for information about evidence-based interventions for bovine TB control 
(including epidemiological, regulatory, and economic measures). Specifically, we 
invited submissions on: (i) research considering how to improve the deployment of 
existing bovine TB control interventions, (ii) potential new approaches and tools and 
technologies to deal with bovine TB, (iii) approaches taken to control bovine TB in 
other countries, and (iv) work on human TB that might be relevant to the Review. 
1.15. We received 39 responses from a wide range of stakeholders, including public 
sector organisations, wildlife groups, industry representative bodies, trade 
organisations, individuals, and research groups. Alongside the request for written 
submissions, we held a number of face-to-face meetings with a variety of different 
stakeholders. These sessions allowed us better to understand different perspectives 
about the disease and in some cases to examine in further detail key issues we 
identified from the written responses. A summary is provided in Annex 4. 
1.16. Whilst our Terms of Reference focused on bovine TB eradication strategy for 
England, we considered lessons from other countries and engaged with policy 
makers and veterinarians in the DAs and the RoI. We looked at experience with 
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human TB and the management of other diseases. We took evidence on the 
technical and operational logistics of different strategies for disease control. We also 
engaged with wider work underway in Defra to consider future agricultural policy 
and the farming regulatory and enforcement landscape, especially in the light of the 
UK’s exit from the EU. 
1.17. We are very grateful to all those who took the time to engage with us as part of this 
Review; their input has been extremely helpful. 
The organisation of the Review 
1.18. Chapter 2 provides some background material on the nature of the disease in cattle, 
the epidemiology of the disease in its multiple hosts, details of the different tests 
available to identify bovine TB in cattle, and the current legislative framework for 
disease control in England.  We make no attempt to provide a comprehensive 
assessment of these topics (though provide an entry to the literature) but consider a 
number of critical issues underlying our reasoning in discussing the pros and cons 
of different interventions.  
1.19. Chapters 3 to 9 discuss possible interventions to help control the disease. For ease 
of presentation we divide them into interventions around: (3) surveillance and 
diagnostics; (4) the disease in cattle – vaccination and resistance; (5) cattle 
movements and risk-based trading; (6) the disease in wildlife; (7) non-bovine 
farmed animals; (8) biosecurity, compensation and insurance; and (9) governance.   
1.20. In our ‘Summary and conclusions’ we highlight the factors that we believe should be 
at the front of decision makers’ minds when determining future policy. 
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Figure 1.1: Risk map for Great Britain (Edge Area boundaries pre-2018) 
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Figure 1.2: Changes in incidence and distribution of bovine TB in Great Britain 1986–
2012. (a) Changes in incidence, which varies seasonally. Bovine TB testing was 
interrupted during the foot and mouth epidemic. (b) Increase in the geographical area 
affected by bovine TB, ‘hot’ colours indicating higher densities of farms where disease has 
been confirmed (official TB-free status withdrawal). Herd density is measured as the 






Figure 1.3: Herd density of bovine TB in England, 2017 (Herd density is measured as the 




                                            
4 Edge Area boundaries were adjusted in 2018, this map reflects the 2017 position. 
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Figure 1.4: Herd level incidence of bovine TB in England, 2017.  Herd incidence is the 
average incidence in the 100 closest herds to each herd location which ‘smooths’ the 
effect of political boundaries in England, 20175 
 
 
                                            
5 Edge Area boundaries were adjusted in 2018, this map reflects the 2017 position. 
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Chapter 2: Background 
Introduction 
2.1. This Review does not include a detailed history of attempts to control bovine TB in 
the UK which are well summarised in a series of earlier reports.  There is also a 
large technical literature in both the natural and social sciences relevant to bovine 
TB control. 
2.2. In this chapter we first provide an overview of the Government’s current plans for 
achieving officially bovine Tuberculosis Free (OTF) status for England as set out in 
Defra’s 2014 Strategy and subsequent updates.  More detailed discussion of most 
individual elements can be found in subsequent chapters exploring current and 
future interventions. 
2.3. We then explore the background of three topics in more detail: epidemiology, 
diagnostics and testing, and the legislative framework for bovine TB.  We do this for 
two reasons. First, we believe an up-to-date non-technical summary of these topics 
will be helpful for ministers and policy makers taking decisions about future 
interventions.  Second, they provide context to the rationale behind our discussions 
of different intervention options. 
Overview of current bovine TB strategy in England 
2.4. Defra published its Strategy for achieving OTF status for England on 3 April 2014 
following extensive public consultation. The Animal Health and Welfare Board for 
England (AHWBE) and the Bovine TB Eradication Advisory Group for England 
(TBEAG) contributed substantially to its development.  
2.5. The Strategy acknowledged bovine TB as the most pressing animal health problem 
in the UK with increasing numbers of affected herds. Tackling bovine TB in England 
is estimated to cost the taxpayer around £70 million a year, with costs to farmers 
running to a further £50 million. Enabling an economically sustainable livestock 
industry and reducing the taxpayer bill could be achieved by dealing effectively with 
the disease, maintaining trade, and achieving OTF status for England incrementally 
by 2038. The Strategy envisaged non-governmental organisations, farmers, 
veterinarians, and government working together to free England of TB. 
2.6. The Strategy set out a broad range of interventions to fight the disease, including 
those already available and those in development, such as a cattle vaccine and 
improved diagnostic tests. It put forward an approach based on stringent cattle 
control measures, combined with tackling the primary wildlife reservoir through 
culling of badgers in bovine TB hot spots, with schemes for vaccination of badgers 
around the edge of those badly affected areas to stop the disease from spreading. 
The Strategy proposed a stronger focus on biosecurity measures and further work 
with the farming industry to consider the potential for risk-based trading. It set a 
range of targets to help with measuring progress towards OTF status.  
2.7. The Strategy recognised the need to apply different tools in different herds 
depending on local circumstances and disease risk, and defined, for the first time, 
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three different risk areas in England. It aimed to preserve the LRA in the north and 
east of England, stop and reverse the spread of bovine TB at the ‘frontier’ of the 
disease (the buffer zone known as the EA), and reduce the level of infection in the 
HRA, spanning the south-west and west Midlands.  
2.8. To date, the principal elements deployed in the Strategy have been cattle 
movement controls, the detection and removal of infected cattle from herds, and the 
badger cull. A range of new controls have been introduced since 2014, including: 
stricter testing protocols for TB breakdown herds (including wider use of the 
interferon gamma blood test), 31 badger cull zones in the HRA and EA, mandatory 
testing of cattle moved to herds in the LRA from higher risk areas (post-movement 
testing), and support for a voluntary herd accreditation scheme. Ministers have said 
that they want to ensure other tools and interventions, such as cattle vaccination or 
further developing genetic resistance in the national cattle herd, are ready to be 
deployed in the next phase of the Strategy to accelerate progress towards the 
target of achieving OTF status by 2038.   
Epidemiology 
2.9. Epidemiology is the study of the frequency and distribution of diseases in 
populations and the reasons why certain individuals become unhealthy whilst others 
do not.  For infectious diseases, mathematical models are typically used to 
understand their spread through populations and how their transmission may be 
controlled.   
2.10. A very important result from epidemiological theory, of major consequence to the 
control of all infectious diseases, is that there is a quantity, the ‘basic reproduction 
number’, universally termed R0 (and pronounced R nought), that determines 
whether a disease will increase or decline in frequency when introduced into a 
previously uninfected (naïve) population.  In the simplest of cases this quantity is 
the average number of secondary infections arising from a single introduced 
infection.  If this quantity is greater than one, the disease will spread, while if it is 
less than one it will decline.  Understanding the different aspects of the host and 
pathogen biology that determine R0 is immensely important in designing control 
programmes; for example, vaccination strategies.  Estimation of R0 in specific 
circumstances is typically complex and may need to account for variation between 
groups or individuals and factors that vary (perhaps randomly) in time or space, but 
the fundamental insight of a threshold that separates the circumstances under 
which a disease spreads or declines holds true. 
2.11. A disease with R0 only a little greater than one is, other things being equal, easier to 
control than a disease where the number is much higher.  Analysis of disease 
transmission can reveal which part of the transmission system can be targeted most 
effectively to reduce disease spread.  Calculations involving R0 can also be used to 
study the prevalence of a disease that becomes endemic (i.e. persists in a region at 
a more or less stable level rather than present only in outbreaks), the rate at which 
it spreads through space, the fraction of the population that needs to be vaccinated 
for the disease to decline, and many other processes.  
2.12. For bovine TB in the UK, R0 is a complicated function of: (i) the frequency of 
transmission between different hosts (cattle-cattle, badger-badger, and cattle-
badger in both directions, with other species potentially transmitting as well), (ii) the 
20 
densities of the different hosts, (iii) the frequency and magnitude of animal 
movements (both natural and human-facilitated), (iv) the structure of cattle herds 
and badger social groups, (v) the distribution and survival of bacteria in the 
environment, and (vi) other factors. 
2.13. Several studies have sought to estimate R0 for bovine TB infections in the joint 
cattle-badger system in the UK6.  Not enough is known about the quantitative 
epidemiology of the disease to construct a highly detailed (quasi-realistic) multi-
species model and instead more idealised models were designed to represent the 
key processes.  These studies indicate that R0 is greater than one but not 
substantially so (an initial infection causing greater than one but fewer than two 
further infections on average). This is encouraging as it suggests that a combination 
of interventions, possibly each of relatively small effect, may combine together to 
drive R0 below one. This positive message must be tempered with caution due to 
the preliminary and approximate nature of the underlying idealised models. Further 
studies to robustly estimate R0 would be very helpful. 
2.14. An important question is whether bovine TB in badgers is sustainable by itself 
without further infections from cattle (in other words would R0 be greater than one in 
a population of badgers). If R0 were less than one then were the disease controlled 
in cattle it would die out in badgers. If this were not the case then it would persist 
and unless measures in wildlife were taken cattle would continue to be at risk.  
There is not a consensus amongst epidemiologists about whether R0 within badger 
populations is above or below this threshold, though more agreement that it is not 
substantially below one so the disease would, at best, die out slowly.   
2.15. General epidemiological considerations offer some guidance about interpreting new 
information for bovine TB control.  First, improvements in disease control combine 
non-linearly to affect R0. Thus an x% reduction in, say, one transmission pathway is 
unlikely to lead simply to an x% reduction in herd breakdowns – it could be either 
more or less. A corollary of this is that a proportionally small reduction in one 
transmission pathway can be more significant than a large reduction in a different 
pathway; it is important to understand how each contributes to the epidemiology.  
Second, if R0 is above but relatively close to one then a combination of 
interventions, possibly each of relatively small effect, may combine together to push 
the disease below the threshold at which it declines towards extinction.  A corollary 
of this is that it is not necessarily essential to intervene in every possible way to 
control the disease.  Nevertheless, choosing not to intervene in one way implies 
that other interventions have to take more of the burden of control and the rate at 
which disease declines is likely to be slower.  Ongoing and future research into 
bovine TB epidemiology will help make this guidance more concrete. 
Diagnostics and surveillance 
2.16. Testing cattle and other livestock for the disease is challenging because of the 
nature of the pathogen and the interaction with its host.  We summarise below 
some of the background biology relevant to discussion of surveillance and 
diagnostics. Test performance depends on the characteristics of the test used, its 
                                            
6 Cox et al. 2005 https://doi.org/10.1073/pnas.0509003102, Brooks-Pollock & Wood 2015 
https://doi.org/10.1098/rspb.2015.0374. 
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correct application, and on the prevalence of the disease in the region or herd being 
tested. 
2.17. The performance of a test is based on its ‘sensitivity’ and ‘specificity’.  The 
sensitivity of a test describes its ability to detect all cases of the disease; a 
sensitivity of 90% means that 9 out of 10 animals with the disease are correctly 
identified but that 1 in 10 are missed (false negatives).  The specificity describes the 
accuracy of the test in ruling out disease; a specificity of 99% means that 99 out of 
100 animals that are not infected will test negative but that 1 out of 100 of them will 
be incorrectly diagnosed (false positives).  Tests differ in both sensitivity and 
specificity and there is often a trade-off between the two measures of performance. 
2.18. The cut-off point, or threshold, of a diagnostic test determines its sensitivity and 
specificity and can be modified to suit the background of the prevailing 
epidemiological circumstances. Parallel testing (combining several tests and 
regarding any positive test result as a positive animal) increases sensitivity, while 
serial testing (combining several tests and regarding only those animals that test 
positive by all methods as positive) increases specificity. 
2.19. The ‘positive predictive value’ (PPV) of a diagnostic test is defined as the probability 
that an animal testing positive is truly infected. Conversely, the ‘negative predictive 
value’ (NPV) is the probability that an animal with a negative test result is truly free 
from infection. Both of these measures depend on the proportion of the population 
that is truly infected (the prevalence of infection) as well as the sensitivity and 
specificity of the test. 
2.20. For a given diagnostic test, the higher the prevalence of infection in a population, 
the higher the PPV and the lower the NPV. In other words, the same diagnostic test 
for M. bovis infection in cattle will not have the same predictive value when used in 
different infection risk or prevalence areas. For example, in a population of 2,000 
with 50% prevalence (i.e. 1,000 infected and 1,000 uninfected individuals) a test 
with 90% sensitivity and 99% specificity would produce 900 true positives and 10 
false positives for a PPV of 900/910 (98.9%), as well as 100 false negatives and 
990 true negatives for an NPV of 990/1090 (90.8%). Similar calculations for a 
population with 33% prevalence (500 infected and 1,000 uninfected individuals) 
yield a PPV of 97.8% and an NPV of 95.1%. Figure 2.1 shows how PPV and NPV 
vary as a function of prevalence. 
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Figure 2.1: The PPV and NPV as a function of prevalence (from 0 to 25%) assuming a 
sensitivity of 80% and a specificity of 99.98%.  
 
2.21. Due to the effect of stage of infection on test sensitivity, and the differing prevalence 
of disease in different parts of the country, ‘average’ predictive values for tests are 
not useful estimates. Values in different risk areas are important for planning how 
test results should be interpreted. 
2.22. Our best estimates of the animal-level sensitivity and specificity of the main tests for 
which there are UK data are summarised in simplified form in Table 2.1. There are 
important caveats in all cases. 
Table 2.1: Estimated sensitivity (Se) and specificity (Sp) in cattle of the ante mortem 
diagnostic tests officially approved for use in cattle in the UK. Single Intradermal 
Comparative Cervical Tuberculin (SICCT), Interferon Gamma (IFNγ) tests and IDEXX 
ELISA (Enzyme-Linked Immunosorbent Assay) 
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Sp Ewer and Vordmeier, 2003 
(cited in R. de la Rua-Domenech et 
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98% [95% CI 
97.5-98.4%] 
Se and SP values according to 
information supplied by the 
manufacturer in its OIE registration 
dossier. Not yet an EU-approved 
test for TB in cattle 
 
2.23. All current skin tests make use of a cocktail of proteins (termed tuberculin or a 
Purified Protein Derivative, PPD) obtained from cultures of M. bovis (hence PPD-B).  
If an animal has been previously exposed to this bacterium then it will react to the 
injection of tuberculin into the deep layer of the skin by producing a local swelling.  
The precise components of tuberculin that cause this localised allergic reaction are 
unknown. Though the comparative potency of different batches of tuberculin are 
tested (on guinea pigs or cattle) against an international standard before their 
release to the field, there is some residual variation between batches of the product 
that may affect test results.  A Purified Protein Derivate, PPD-A, is prepared in a 
similar way to PPD-B but uses M. avium rather than M. bovis. 
2.24. The SICCT test involves a comparison of the immune reaction to M. bovis and M. 
avium derived tuberculins injected side-by-side into the skin of the animal’s neck.  
An animal is classed as a reactor and removed if the response to PPD-B three days 
later, i.e. a swelling or lump that can be measured using callipers, is greater than 
the response to PPD-A by more than 4mm (standard interpretation) or 2mm (severe 
interpretation).  Borderline cases with weak reactions are classified as ‘inconclusive 
reactors’. Since the SICCT test has limited sensitivity, once a herd has been 
declared infected (a TB breakdown) multiple skin tests must be performed at 
prescribed time intervals of at least 60 days to increase the probability of detecting 
all infected animals that remain in the herd. Other strategies employed by Animal 
and Plant Health Agency (APHA) veterinarians to increase the animal-level 
sensitivity of testing in TB breakdown herds include: (i) switching from the standard 
to a severe interpretation of the skin test, (ii) supplementing the SICCT test with the 
IFNγ blood test, and (iii) removing as ‘direct contacts’ any negative-testing and 
inconclusive reactor animals that are considered to be at a particularly high risk of 
exposure to infection. 
2.25. The SICT is the primary test for routine screening of both herds and individual cattle 
for most of continental Europe; it has a higher sensitivity than the SICCT test. 
However, sensitisation of cattle to the SICT by exposure to environmental 
                                            
9 https://doi.org/10.1016/j.rvsc.2005.11.005  
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mycobacteria, which can cause cross reactions to the SICT test and lead to false 
positive results, was reported to be high in the UK and RoI10.  As a result, in 1972, 
on the accession of the UK, RoI and Denmark to the European Economic 
Community (now the EU), it was agreed that the SICCT test (first used in the UK in 
1947) could continue to be used in these countries, initially for a transitional period 
but, from 1980, as an approved EU test. Testing using the SICT is nevertheless 
required of animals over 42 days old in OTF herds that are destined for export to 
EU member states. 
2.26. The IFNγ test involves taking a blood sample from an animal and stimulating it in 
the laboratory with bovine and avian tuberculin PPDs that are used for skin testing.  
The existence of an immune response is assessed by measuring the release of 
interferon gamma (a cytokine, a signalling protein involved in the development of an 
immune response).  Blood from an M. bovis-infected animal will release more 
interferon gamma in response to bovine tuberculin than to avian tuberculin. This 
test has higher sensitivity but lower specificity than the SICCT and can identify 
animals at an earlier stage of infection.  It is only approved for use as a supplement 
to the SICCT test in breakdown herds, with blood samples taken and tested by 
APHA. 
2.27. A slightly different format of the IFNγ test has also been available for some time for 
use in the UK in specific situations. It differs in including an additional peptide 
cocktail of M. bovis-specific antigens and is less sensitive but more specific than the 
standard IFNγ test.  It is used by APHA in specific circumstances to re-test skin test 
reactor cattle; for example, in LRA herds with persistent breakdowns.  
2.28. Both formats of the IFNγ test have also been available since 2016 for private use by 
cattle farmers, with prior permission from APHA. For example, this might enable 
farmers to market their cattle on the basis of high bovine TB health status.  
2.29. The Caudal Fold Tuberculin (CFT) test is similar to the SICT except that the 
tuberculin is injected into the flap at the base of the tail rather than the neck.  It is 
used for herd screening in the USA, Canada and New Zealand with test-positive 
animals retested using either the SICCT or IFNγ. Until 2010 in the USA, all cattle 
from reactor herds identified using the CFT test were slaughtered, but because of 
larger herd sizes in the USA compared to Europe, and the consequent costs of this 
policy to industry and the taxpayer, the SICCT is now used to identify infected 
animals in CFT positive herds without whole-herd slaughter. This format of the skin 
test is currently not approved for use in the EU. There is currently no data on the 
performance characteristics of the CFT in the UK but there are practical advantages 
to the test in that it is easier to perform in a cattle crush and there is less risk of 
injury to the person performing the test.  
2.30. All skin and laboratory tests that involve tuberculin recognise an animal as infected 
because it has developed an immune response to the pathogen.  Animals at early 
stages of infection, before this response has become established, will thus not be 
detected.  Retesting, after a gap of at least 60 days, can help identify these animals, 
though some of those infected may still be unresponsive. 
                                            
10 Allen et al (2018) https://doi.org/10.3389/fvets.2018.00109  
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2.31. Serological tests detect the presence in blood serum of antibodies produced by the 
animal against M. bovis (the immunological tests discussed so far rely on the 
presence of immune cell-mediated responses).  They are cheaper and quicker than 
the current tests although their sensitivity may be lower.  The sensitivity of 
serological tests can be boosted by the prior injection of tuberculin between 10-30 
days earlier which boosts antibody production in infected animals but not in 
uninfected ones.  At present the IDEXX ELISA11 test is the only OIE (World 
Organisation for Animal Health) registered serological test available for the 
diagnosis of M. bovis infection in cattle though other tests are under development.  
Limited use of the IDEXX ELISA test in the UK has detected an additional 1-3% of 
infected animals that were skin test and IFNγ negative in (Official TB Free 
Withdrawn) OTFW herds.   
2.32. The tests discussed so far are based on monitoring the animal’s response to 
infection and not the pathogen itself. PCR (polymerase chain reaction) tests detect 
minute amounts of M. bovis DNA and thus reveal the presence of living or recently 
living bacteria.  PCR tests can be very specific if they are based on unique DNA 
sequences in M. bovis.  PCR tests can be used to identify bacteria in blood, though 
the numbers of bacterial cells here are typically small and hence sensitivity is low.  
PCR tests or growing the bacteria using laboratory culture methods are the only 
means of detecting bacteria in faeces and in the environment.  Culturing M. bovis is 
quite challenging because, amongst other aspects of its biology, it grows slowly 
compared with other bacteria and there may be low numbers of bacteria in a 
sample. 
2.33. The Actiphage test is a newly developed but not yet validated method of detecting 
very low densities of M. bovis.  It involves incubating a blood or milk sample with a 
specific virus that infects bacteria (bacteriophage) and detecting whether the virus 
finds a host cell and replicates by PCR. Like the PCR test it detects M. bovis 
directly but unlike this test it only signals the presence of live and viable bacterial 
cells.  The diagnostic performance of this novel test in both infected and TB-free 
herds needs further research and evaluation in field trials.   
2.34. The Dual Path Platform (DPP) immunological blood test can be used for diagnosis 
of TB infection in badgers. The DPP can be conducted (with different protocols) on 
whole blood samples (in the field) or on serum samples (under laboratory 
conditions). The test is used in the ‘Test and vaccinate or remove’ (TVR) study in 
Northern Ireland and in the delivery of badger trap and test operations on chronic 
TB breakdown farms in Wales. The DPP has been estimated to have a sensitivity 
with serum of 55.3% (95% CI: 38.3 to 71.4) and a specificity of 97.5% (95% CI: 86.6 
to 99.9). With whole blood the sensitivity is 52.5% (95% CI: 36.1 to 68.5) and 
specificity is 97.5% (95% CI: 86.6 to 99.9). The DPP test was signed off as an 
APHA validated test in February 201812. 
                                            






2.35. Responsibilities for bovine TB eradication are fully devolved to administrations in 
England, Wales, Scotland and Northern Ireland. 
2.36. The EU provides the existing legal framework for bovine TB eradication 
programmes, comprising legislation on: (i) trade in bovine animals, (ii) EU co-
financing of eradication programmes, (iii) animal products for human consumption 
(meat and milk), (iv) official diagnostic tests and controls, in particular of the 
manufacture of tuberculin and the performance and interpretation of the skin tests, 
and (v) bovine animal identification and registration. The main EU regulation on 
bovine TB is Council Directive 64/432/EEC, which deals with animal health 
problems affecting trade inside the EU in bovine animals and swine.  
2.37. A new EU Animal Health Law will take effect from 2021, introducing a single, 
comprehensive legislative framework for the EU livestock sector, including bovine 
TB. The UK government continues to work at EU level on how the new regulation 
might be implemented. This will also depend on the final post-EU arrangements. 
2.38. Domestic Statutory Instruments give effect to the EU rules in England and provide 
more specific details of compensation payments for cattle compulsorily slaughtered 
for TB control reasons, testing, movement controls, and enforcement. Further 
details of domestic and EU legislation relevant to the control of bovine TB are 
provided at Appendix 1. 
2.39. There have been a number of legal challenges to bovine TB policy in England in 
recent years. Primarily, these have contested decisions about the implementation of 
wildlife controls under the Protection of Badgers Act 1992. These challenges, and 
their main outcomes, are summarised at Appendix 2. 
2.40. The enforcement of bovine TB regulation, including the roles and responsibilities of 
Natural England, APHA, and local authorities is discussed in Chapter 9. 
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Appendix 1: Summary of legislation  
The European Union (EU) provides the legal framework for bovine TB control covering: (i) trade in bovine animals, (ii) EU co-financing of 
eradication programmes, (iii) animals products for human consumption (meat and milk), (iv) official controls, in particular of the 
tuberculosis EU reference laboratory, and (v) bovine animals identification and registration. Domestic Statutory Instruments (SI) give 
effect to the EU rules in England and provide more specific detail (e.g. compensation rates, testing, movement controls, and enforcement 
etc.). 
The EU Animal Health Law will take effect from 2021, introducing a single, comprehensive legislative framework for the EU livestock 




Council of Europe - Convention on the Conservation 
of European Wildlife and Natural Habitats (The Bern 
Convention) 1979 
Conservation of wild fauna and their habitats. Defines the European badger as a 
protected species. The UK is a member of the Council of Europe (since 1949) and 
signatory to the Convention (1979) which will continue to apply in the UK post EU 
exit.  
Council Directive 64/432/EEC Rules for intra-EU trade in bovine animals and swine for breeding, production or 
slaughter.  
Council Directive 77/391/EEC Requires Member States to develop plans for the eradication of bovine TB and 
other diseases in cattle.  
Council Directive 78/52/EEC Establishes criteria for EU financial contributions to national TB control 
programmes. Provides that farmers should be “appropriately compensated” for the 
loss of diseased animals. 
Regulation EU No 652/2014 Provides for the award of grants to EU Member States affected by bovine TB, 
subject to conditions.  
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Legislation Summary 
Domestic - The Animal Health Act 1981 c.22 Enables Ministers to make orders to prevent the spread of disease: cleansing and 
disinfection, biosecurity, animal movements, and imports and exports etc. 
Establishes a framework for government expenditure to control animal diseases 
and entitlements to compensation. 
Domestic - The Tuberculosis (England) Order, SI 
2014/2383, as amended by S.I. 2016/347 
Sets out the main TB cattle controls in England. Amended in 2014 and 2016 with 
additional requirements for TB testing. 
Domestic - The Protection of Badgers Act 1992 c.51 Establishes that it is an offence to (or attempt to) kill, injure, or take a badger, or 
interfere with a badger sett, unless under licence. Sets out exceptions and 
conditions for granting a licence. Sets out enforcement and penalties for non-
compliance.  
Domestic - The Veterinary Surgery (Testing for 
Tuberculosis in Bovines) Order 2005 SI 2005/2015 
Permits non-veterinarians to carry out tuberculin testing of cattle. 
Domestic - The Veterinary Surgery (Vaccination of 
Badgers Against Tuberculosis) Order 2010, SI 
2010/580 
Permits non-veterinarians to vaccinate badgers by injection against tuberculosis, 
subject to certain specified conditions. 
Domestic - Cattle Compensation (England) Order, 
SI 2012/1379, as amended by S.1. 2018/754 
Sets out detailed arrangements for the payment of compensation to dairy and beef 
farmers where an animal has to be slaughtered under section 32(1) of the Animal 
Health Act 1981 for bovine TB. Amended by more recent legislation. 
Domestic - The Tuberculosis (Deer and Camelid) 
(England) Order, SI 2014/2337 




The Tuberculosis (Deer and Camelid) Slaughter 
and Compensation (England) Order 2014, SI 
2014/2338 
Provides for statutory compensation for the owners of deer or camelids when an 




Appendix 2: Legal challenges to bovine TB policy in England 
 
The majority of legal challenges (and attempts to bring about a Judicial Review) relating to bovine TB policy in England have been about 
badger control.  
 




The Badger Trust: challenging the 2011 badger control policy in terms of statutory 
interpretation of powers to cull badgers, powers to issue guidance, and failure to update 
the impact assessment on all policy options originally consulted upon. 
The challenge was dismissed. An 
appeal judgement also found in 
favour of the Secretary of State.  
Apr 
2012 
The Badger Trust: whether the proposed culls met the test of “preventing the spread of 
disease” set out the Protection of Badgers Act, whether the Secretary of State had legal 
powers to issue guidance to Natural England (NE), and asserting that the cost impact 
assessment was flawed.   
The challenge was dismissed. An 
appeal judgement also found in 
favour of the Secretary of State. 
2014 The Badger Trust: challenged the decision to allow badger culling in Somerset and 
Gloucester, arguing there was legitimate expectation of further use of an independent 
expert panel whilst the culls were still ‘pilots’.  
The challenge was dismissed. An 
appeal judgement also found in 
favour of the Secretary of State. 
July 
2018 
Mr Langton: challenged the decision to publish guidance on licensing badger culls to 
prevent the spread of bovine TB, and the subsequent decision to grant two supplementary 
badger disease control licenses, arguing both were unlawful. 






Attempted proceedings/Judicial Reviews relating to Badger Culling in England 
Date Claimant / Grounds Outcome / To Note 
Nov 
2013 
Save Me Trust: Urgent challenge to extension of Gloucester cull period on grounds of 
‘unreasonable decision’. 
The court said the need for urgency 
was "not easy to see" so did not give 
the challenge urgent consideration. 
2014 Human Society International v SSEFRA:  seeking judicial review for lack of consultation 
and assessment.  
Permission for a Judicial Review 
was refused. 
2015 Save Me Trust v Natural England: challenging the decision to grant three badger cull 
licences in western Gloucestershire, western Somerset, and Dorset, arguing there was 
inadequate consultation and no reasonable grounds for culling. 




Save Me Trust: argued that authorisation of the cull was unlawful - it was not done 
under the Animal Health Act which provides for certain safeguards.  




Mr Thomas Langton: consultation on badger culling in the Low Risk Area was unlawful 
and the 2018 guidance falls outside the powers of the Protection of Badgers Act. 
Defra must file their Summary 
Grounds by 27 September 2018. 




Anti-badger cull website (www.badger-killers.co.uk (“BK.co.uk”) published the personal/work contact details of Defra Ministers 
and others linked to the proposed badger cull (with implicit incitement to harass them).TSOL obtained an emergency injunction 
which applies indefinitely and prohibits “Persons Unknown” (and others) from “publishing or disclosing or communicating (or 
doing or instructing or encouraging or causing or permitting any other person to publish or disclose or communicate) …by 
whatever means, the personal or work contact details of any person connected with the organisation of or implementation of 
the badger culls pursuant to the Secretary of State’s policy dated 14 December 2011.” 
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Chapter 3: Surveillance and diagnostics in cattle 
Introduction 
3.1. Bovine TB is an endemic notifiable livestock disease and a statutory surveillance 
and testing programme is in place in the UK in accordance with European and 
international legislation. This approach is based on the use of a skin test, 
supplemented in specific cases by the interferon gamma (IFNγ) blood test, to detect 
infected animals which are then slaughtered. This is combined with carcass 
inspection of all animals in slaughterhouses. 
3.2. This chapter explores whether the current diagnostic and testing regime, underlying 
surveillance and removing the disease from infected herds, might be improved 
given advancing knowledge and greater regulatory autonomy after leaving the EU. 
Rationale 
3.3. An ideal test for a disease recognises every true case of infection and never 
misdiagnoses a healthy individual.  Such tests do not exist for bovine (or human) 
TB and though this is an area of active research, surveillance and testing regimes 
have had to be designed using less-than-perfect tests, something that will continue 
for the foreseeable future.   
3.4. Testing cattle and other livestock for the disease is challenging because of the 
nature of the pathogen and the interaction with its host.  We summarise some of the 
background biology relevant to discussion of surveillance and diagnostics in 
Chapter 2.  Test performance depends on the characteristics of the test used, its 
correct application and on the prevalence of the disease in the region or herd being 
tested. 
3.5. Existing surveillance regimes underestimate the prevalence of the disease in cattle 
in England and this hinders control13. This conclusion is based on experimental 
studies using novel tests that are finding more infections than are revealed by the 
standard accredited tests, and a realisation that the performance of these tests 
under field conditions may be lower than expected based on their benchmark 
performance measured under standardised conditions. 
3.6. All cattle that react positively to statutory skin or laboratory tests are slaughtered 
and examined visually for bovine TB lesions. Samples are collected from these 
animals and efforts are made to culture M. bovis from diseased organs or tissues 
likely to contain the bacterium. Diseased organs may also be examined under the 
microscope for signs of bovine TB. If M. bovis is cultured, then information from 
DNA genotyping is obtained to help establish the origin of the infection.  
3.7. All tests for bovine TB in the UK are done under strict government control. Farmers 
and their veterinarians are prohibited from testing their animals unless under 
government authorisation.  The reason for this is concern that infected or riskier 
                                            
13 Conlan et al. 2012 https://doi.org/10.1371/journal.pcbi.1002730  
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animals discovered by unauthorised testing may be traded to avoid the restrictions 
associated with a new breakdown being identified. 
3.8. All cattle routinely slaughtered (1.26 million each year in England14) are examined 
visually for signs of bovine TB; typically, these are lesions found in the lungs and its 
associated lymph nodes, or lymph nodes around the head and neck. Where lesions 
are found, samples are taken and analysed as for test-positive animals. Of all herd 
breakdowns in the LRA, 40-50% are discovered in this way, though the sensitivity of 
this form of detection is thought to be relatively low (~50%)15.   
Current policy 
3.9. In 2013, England was divided into three risk management areas that differ in terms 
of the prevalence and epidemiology of bovine TB: the HRA, the EA and the LRA, 
see Figure 1.1.  From January 2018, following a public consultation, a number of 
changes took effect aimed at re-defining EA boundaries by incorporating as whole 
counties those that previously straddled the HRA and EA parts of England and 
increasing the frequency of TB surveillance for herds in the EA16. 
3.10. In the LRA, breeding animals in the majority of herds are tested every four years. 
Approximately 10% of herds in the LRA are tested annually because of their trading 
patterns (for example, purchases from the HRA), proximity to a breakdown with 
lesion or culture positive cattle (radial tests), or for public health reasons. Cattle in 
intensive indoor beef fattening units are not routinely TB tested.  In the HRA, all 
cattle over 6 weeks old are tested annually (this will change to six monthly from 
2020) while in the EA all cattle are tested six monthly or annually (depending on the 
levels of bovine TB).  The SICCT test (¶ 2.24) is used throughout17.  
3.11. If one or more animals test positive (reactors) or are inconclusive, the status of the 
herd as Officially TB Free (OTF) is suspended (OTFS) and movements other than 
to slaughter or approved premises for rearing, fattening or finishing are prohibited.  
Reactors are slaughtered and occasionally other animals in the herd which are 
considered to be at high risk of bovine TB infection (direct contact animals) are also 
slaughtered. Inconclusive reactors are retested after 60 days. In rare cases, all the 
cattle in the herd may be slaughtered if the infection is severe or extensive. Farmers 
receive compensation for any animals slaughtered because of bovine TB. Testing is 
repeated at 60-day intervals until the herd is eligible to regain its OTF status.  
3.12. If a subsequent test reveals other reactors, or if infection is found in slaughtered 
animals, then the status of the herd becomes Officially TB Free Withdrawn (OTFW).  
                                            
14 APHA Bovine tuberculosis in England in 2017 (September 2018). 
https://www.gov.uk/government/publications/bovine-tb-epidemiology-and-surveillance-in-great-
britain-2017  
15 McKinley et al. Risk factors and variations in detection of new bovine tuberculosis breakdowns via 
slaughterhouse surveillance in Great Britain. https://doi.org/10.1371/journal.pone.0198760 
16 http://www.tbhub.co.uk/tb-policy/england/expansion-of-the-edge-area-in-england-and-new-cattle-testing-
arrangements/  
17 An overview of the current testing regimes can be found in APHA’s ‘Bovine tuberculosis in Great Britain in 




The severe interpretation (¶ 2.24) of the SICCT test is used for these follow-up 
tests. The herd is then tested at 60-day intervals until no reactors are detected in 
two successive tests and OTF status can be restored.   The IFNγ test is used to 
supplement the SICCT test in all OTFW breakdowns in the EA and LRA, and in 
certain circumstances in the HRA where there is a high rate of cattle infection. From 
April 2017, the IFNγ test may be used alongside the skin test, to help resolve OTFW 
breakdowns with lesion and/or culture positive animals in the HRA, where any of 
the following three criteria are met:  
(i) APHA concludes that the most likely bovine TB transmission route for the 
affected herd was contact with infected cattle and measures are in place to 
prevent further spread of the disease from this source. 
(ii) The infected herd is located in one of the areas where at least two annual 
rounds of effective licensed badger population control have been completed. 
(iii) There is clear evidence that repeat skin testing of the herd has failed to resolve 
a TB breakdown. 
3.13. Infections in herds may also be detected other than through regular surveillance: for 
example, through private tests undertaken prior to movement of cattle out of herds 
located in the HRA and EA (discussed in Chapter 5 on risk-based trading); through 
targeted surveillance testing of herds contiguous to OTFW breakdown herds in the 
HRA and EA; radial tests in the LRA; or ad hoc tests following the detection of 
animals with suspicious TB lesions at routine slaughter. Once a reactor is identified 
then the OTFS and OTFW testing procedures described above come into play. 
3.14. In line with EU legislation, only the bovine reaction of the SICCT test (see ¶ 2.24) is 
considered when interpreting the test results in animals intended for export to other 
EU countries. This rule recognises the reduced sensitivity of the SICCT test 
compared with that of the SICT test used on mainland Europe.  This interpretation 
is referred to as the 'Intra-Community trade' interpretation, and is in line with 
Community legislation18.  
3.15. At present, the only testing allowed for bovine TB is ‘statutory testing’, meaning a 
skin test or any other diagnostic test approved by the Secretary of State19. 
Surveillance and breakdown testing is funded by government. Additional private 
testing carried out by private veterinarians is allowed at farmers’ expense (mainly 
pre- and post-movement skin testing, and pre-export skin testing) under a general 
authorisation. Compulsory post-movement testing in the LRA is generally paid for 
by the person who brings cattle into the LRA from higher TB risk areas. However, a 
government-funded whole-herd TB surveillance test can be used as a pre- or post-
movement test if its timing makes it possible. Additional, unofficial private TB testing 
is possible but requires prior permission from APHA. The results of all additional 
tests must immediately be sent to APHA. 
                                            
18 Council Directive 64/432/EEC. 
19 The Tuberculosis (England) Order 2014 (Statutory Instrument 2383/2014). 
http://www.legislation.gov.uk/uksi/2014/2383/contents/made  
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3.16. The complete slaughter of herds is used very sparingly in the LRA where standard 
skin tests and IFNγ tests fail to achieve a rapid resolution of a serious herd 
breakdown and APHA decides that infection is severe or extensive.  Slaughter of 
whole herds is generally not considered a cost-effective strategy in the HRA and the 
EA where reinfection of replacement herds may occur from wildlife or from cattle 
bought from premises in the HRA or the EA. 
3.17. In England and Wales, bovine TB testing is carried out by seven Regional 
Veterinary Delivery Partners (VDPs), commissioned by APHA. Each VDP is 
contracted to carry out bovine TB testing and disease outbreak response in cattle 
and non-bovine farmed animals across a defined geographical area. The VDPs 
chiefly use existing veterinary businesses to deliver services. APHA notifies VDPs 
of tasks and service requirements and the VDP is then responsible for ensuring that 
the work is completed either by subcontractors or their own official veterinarian (OV) 
staff.  
3.18. Testing regimes in the DAs are similar, with minor exceptions. In Wales, herds in 
the Intensive Action Area (IAA) in south-west Wales are tested twice yearly as part 
of additional cattle controls in place in this high-risk area. Herds in the rest of Wales 
are tested annually. Scotland, which as a nation has OTF status, operates as if it 
were a LRA except that over half of herds are identified as ‘low risk’ and as such 
are exempt from four yearly routine herd testing and monitored through 
slaughterhouse surveillance only20. In Northern Ireland, all herds are tested 
annually, as a minimum requirement, but some are tested more frequently if they 
are considered at increased risk. 
3.19. The RoI operates an annual testing programme for bovine TB using the SICCT test. 
All animals in the country are tested for bovine TB at least once a year (with the 
exception of calves under the age of 6 weeks born on the holding). The Irish 
programme also includes tests of herds contiguous to TB breakdowns. Ante and 
post mortem surveillance is carried out at slaughterhouses and detects a high 
percentage of all breakdowns. 
Options for the future 
3.20. Outside of the EU, the UK could decide not to carry out statutory testing with 
individual businesses paying for testing where required for export or if thought cost 
effective.  Meat inspection and pasteurisation of milk would continue to protect 
public health. We have not considered this strategy further because we believe 
there is a significant threat of a major increase in the incidence and the prevalence 
of the disease in cattle.  For example, there is clear evidence from the suspension 
of testing during the 2001 outbreak of Foot and Mouth Disease21 that without the 
current surveillance systems there would be a rapid increase in bovine TB in 
England.  This could pose additional risks to farmers and veterinarians and also 
                                            
20 https://www.gov.scot/Topics/farmingrural/Agriculture/animal-
welfare/Diseases/disease/tuberculosis/guidance  
21 APHA Bovine tuberculosis in England in 2016: Epidemiological analysis of the 2016 data and historical 
trends (September 2017) https://www.gov.uk/government/publications/bovine-tb-epidemiology-and-
surveillance-in-great-britain-2016  
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spill over into other animals, including domestic pets with the risk of new routes of 
infection to humans. 
Improving current testing and surveillance 
3.21. We consider here the option of maintaining the current schedule of surveillance and 
testing while taking measures to improve its effectiveness.  
3.22. Conducting a SICCT test involves comparing two immune responses (lumps) using 
callipers (¶ 2.24) and is open to a degree of subjective interpretation.  Currently 
testers must successfully complete a formal training module every two years and 
carry out at least ten hours of relevant continuing professional development within 
the two-year cycle. Once the Livestock Information Service (see ¶ 5.29) is in 
operation and electronic data capture the norm, SICCT measurements using 
wireless-connected callipers, which automatically standardise the pressure used in 
measuring skin thickness, could be considered to reduce subjectivity. 
3.23. Currently, APHA field audits are used to spot-check the testing performance of the 
OVs using a risk-based approach informed by test results, late test submissions, 
and local intelligence.  It is possible to estimate statistically the number of positive 
tests that different veterinary practices are expected to find based on factors such 
as farm history and geographical region, a capacity likely to be enhanced by the 
Livestock Information Service and other initiatives discussed in this report. 
Systematic analysis of performance data to obtain information on testers that are 
finding unexpectedly more or fewer reactors could be used to target the inspection 
of testers, as has been successfully implemented in the RoI. 
3.24. The use of ‘lay-testers’ for bovine TB is already allowed for tests carried out by 
APHA subject to quality control and training.  Currently, EU rules do not allow lay-
testers to be used by private practices.  Specialised lay-testers are less expensive 
to employ than licensed veterinary surgeons and given the narrow margins on 
private sector contracts for statutory testing the use of dedicated specialists could 
provide improved service.  Certification of lay-testers would remain with APHA and 
they would be subject to existing quality control and training measures. 
3.25. We note that a very large proportion of Defra, APHA and private veterinarians 
employed to test for bovine TB are from continental Europe.  Severe disruption of 
this labour force would pose a serious problem for disease control and we 
understand this is already on Defra’s register of risks associated with leaving the 
EU. 
3.26. The tuberculin used in the SICCT test is a complex mixture of proteins and 
notoriously hard to quality control.  There is an OIE initiative to produce a new 
international standard for PPD-B (¶ 2.23) which has the potential to play an 
important role for future standardisation of tuberculin potency. Tuberculin quality 
could be assured or improved by supporting this initiative and through greater use 
of inspection visits at production sites, and potency assays. 
3.27. The frequency with which a herd is tested depends on the risk area (HRA, EA LRA) 
within which it is located.  There are no published criteria and mechanisms that 
allow these areas to be redefined as the disease geographically spreads or 
declines. The last changes to EA boundaries took effect from January 2018, 
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following a public consultation exercise launched in August 201622. Faster 
redefinition of risk areas based on criteria agreed in advance (without consultation 
every time) could greatly facilitate the adaptive management of the disease. 
3.28. We discuss in Chapter 5 the development of farm-level risk scores for use in risk-
based trading.  The same scores could be used to determine testing frequency, 
especially in the LRA (an extension of current practice that takes into account 
trading history).  
Improving surveillance and detection of M. bovis infected herds 
3.29. A surveillance regime must balance the trade-off between diagnostic sensitivity and 
specificity (¶ 2.17).  There is the option to use a more sensitive test (or combination 
of tests) that would detect more infected herds and animals within infected herds at 
the cost of some false positives.  Understanding the costs and benefits of such a 
change is not straightforward because the detection of additional infected herds, or 
earlier detection thereof, would reduce onward cattle-to-cattle transmission and 
movement of infected cattle into other herds. The use of these tests would have the 
greatest value in the EA, the HRA and in emerging hotspots.  In the LRA the 
benefits would be outweighed by the number of false positives. 
3.30. Two options for a more sensitive surveillance test are: 
(i) The single intradermal cervical tuberculin test (SICT test, ¶ 2.25) is thought to be 
more sensitive than the SICCT test, and its lower specificity could be mitigated 
by using the IFNγ test to confirm infection in positive reactor animals (i.e. as a 
serial test). Such a strategy would require the same number of farm visits but 
entail additional laboratory expenses. 
(ii) The caudal fold tuberculin test (CFT test, ¶ 2.29) is more sensitive that the 
SICCT test and could be used as the primary surveillance test after the UK 
leaves the EU.  It also has the advantage that it is quicker and safer for the 
veterinarian to perform. Before such a test could be used, field trials under 
English conditions would be needed to define test interpretation criteria.   
3.31. The SICCT, SICT and CFT tests are known to underperform in animals suffering 
simultaneous infections.  For example, another mycobacterium, M. avium 
subspecies paratuberculosis, the causative organism of Johne’s disease, is known 
to complicate the interpretation of the tuberculin test. Replacing SICCT with another 
test (for example the ‘high specificity IFNγ test’ which uses specific M. bovis 
antigens, ¶ 2.26) in herds with known or suspected other infections would increase 
the detection rate of the disease though at an additional financial cost and 
administrative burden.  Clear criteria of what constituted a simultaneous 
(intercurrent) infection would need to be developed. 
3.32. At present, with few exceptions, the frequency of OTF herd testing in England is 
determined purely by whether a farm is in the HRA, the EA or the LRA.  In Chapter 
5 we explore the development of indices for the risk of infection of different herds, 
                                            
22  Defra consultation on enhanced bovine TB surveillance and controls in the High Risk and Edge Areas of 
England (August 2016)  https://consult.defra.gov.uk/bovine-tb/enhancements-to-hra-edge/  
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and these indices could be used to determine testing frequency. Scotland already 
implements risk-based testing which takes into account whether a herd sends many 
animals to slaughter (where they are examined for infection) and their history of 
risk-based trading. 
3.33. Pre- and post-movement testing could use the most sensitive test to reduce the risk 
of spreading M. bovis infection from one herd to another, particularly when cattle 
are being moved from the HRA to the LRA.  This could be either the SICT (as for 
trade outside of the UK), or the IFNγ test. The latter is the more expensive test and 
would require additional laboratory capacity. 
3.34. Recent research has shown that it is possible to use serological tests to detect the 
presence of antibodies to bovine TB in bulk milk23.  Test sensitivity was low in these 
studies but if this could be increased and the test was scalable at reasonable cost, it 
could be used to identify infected dairy herds on a continuous basis and would 
complement existing surveillance testing. 
3.35. About 40-50% of herd breakdowns in the LRA are detected through slaughterhouse 
surveillance.  This could be enhanced by raising awareness of its importance with 
slaughterhouse workers, financial incentives for good practice and more frequent 
inspection.  Quality assurance could be based on assessing reporting rates against 
levels predicted from risk areas and slaughterhouse throughput24.  
Increasing the efforts to remove infections from herds 
3.36. Tools are available to increase the probability that an infection is removed from a 
herd that has been declared OTFW.  This would benefit the farmer because the risk 
of a subsequent breakdown due to undiagnosed infections in the herd would be 
reduced.  It would also have the industry-wide benefit of reducing disease spread.  
Against this, the extra testing would entail costs for the state or the business, and 
the OTFW status of the herd may be extended not only because more infected 
cattle are identified but because more false positives occur and are sent to 
slaughter. 
3.37. There are several options to use tests with greater sensitivity than the SICCT:- 
(i) The single intradermal cervical tuberculin test (SICT test, ¶ 2.25) has higher 
sensitivity but lower specificity. 
(ii) The caudal fold tuberculin test (CFT test, ¶ 2.29), is also thought to have higher 
sensitivity but lower specificity than the SICCT test. 
(iii) The IFNγ test (¶ 2.26) has higher sensitivity but lower specificity compared to the 
SICCT test and could be used in all herd breakdowns rather than the more 
targeted ways in which it is employed at present.  This test also has the 
advantage that it detects animals at an earlier stage of the disease and so its 
use will identify and remove animals at an earlier stage of disease progression 
thereby reducing the chance of onward transmission.  
                                            
23 Waters et al. 2011 https://doi.org/10.1128/CVI.05343-11  
24 McKinley et al. 2018 https://doi.org/10.1371/journal.pone.0198760  
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(iv) Combining the skin test, the IFNγ test and the IDEXX ELISA serological test (¶ 
2.31) to maximise sensitivity, as each test detects some infected animals than 
the other tests miss. The costs of testing would increase, but this approach 
might be particularly useful to clear persistent and recurrent herds, herds in the 
HRA post-cull, the EA and emerging hotspots in the LRA.  
(v) There are a variety of new tests under development and active research in this 
area for both human and bovine TB.  Facilitating the validation of promising tests 
and designing testing regulations so that they can utilise new technology swiftly 
as soon as they have been validated and accredited is important.  
3.38. Animals that test inconclusive to the SICCT test are tested again after 60 days 
when about 10% are confirmed as reactors25. Epidemiological studies of ‘resolved’ 
IRs in a high bovine TB prevalence country like the RoI have demonstrated that 
such animals have significantly higher odds of becoming reactors at a subsequent 
test in the same or another herd26,27. Sending all inconclusive cattle to slaughter 
would reduce the chance of infection spreading in the herd and to wildlife but would 
increase compensation costs at least in the short term. 
3.39. A more stringent criterion for herds to be declared OTF would be to require two 
tests, 60 days apart, for OTFS to be removed and three or four tests for OFTW to 
end.  The increased chance of herds being truly free from bovine TB would need to 
be weighed against the additional costs for the farmer and government.  In the final 
stages of Australia’s eradication programme four or five successive negative whole-
herd tests were required for disease-control measures to be removed. 
3.40. Farmers are not generally allowed at present to conduct additional tests during a 
herd breakdown, even at their own expense (¶ 3.7).  Some farmers would like to 
employ additional tests (ELISA, Actiphage or PCR, Chapter 2) to accelerate the 
removal of infected individuals and to better manage within-herd transmission.  
Because these tests have lower specificity, their use would be discouraged if all 
positive animals were sent to slaughter.  The use of alternative tests could be 
allowed during breakdowns (with reactors statutorily notified but not necessarily 
slaughtered) with the herd remaining OTFW until it passed the normal two tests.  To 
participate in this programme farmers would need to apply for and achieve ‘earned 
recognition’ status. 
3.41. There is evidence to suggest that faecal shedding by cattle plays an important role 
in the transmission of M. bovis28 and the development of PCR assays (¶ 2.32) to 
detect animals that are shedding bacteria in their faeces are showing promise 
though more information is needed on their sensitivity and specificity.   If these tests 
were scalable at reasonable cost, they could be used to complement existing 
surveillance testing.  
                                            
25 https://www.gov.uk/government/publications/bovine-tb-epidemiology-and-surveillance-in-great-britain-2017   
26 Clegg, T. A. et al. (2011) https://doi.org/10.1016/j.prevetmed.2011.02.015  
27 Clegg, T. A. et al. (2011) https://doi.org/10.1016/j.prevetmed.2011.07.014  
28  McCallan, McNair and Skuce (February 2014). A review of the potential role of cattle slurry in the spread 
of bovine tuberculosis. 
 https://www.daera-ni.gov.uk/sites/default/files/publications/dard/tb-slurry-lit-review.pdf  
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3.42. Sometimes infection cannot be cleared from a herd and all animals are culled and 
compensation paid. This option could be used more frequently to deal with 
intractable breakdowns, although with very major consequences for the farms 
involved.  Examples of such a case might be breakdowns involving multiple 
reactors in the LRA caused by high-risk trading, or long-term persistently infected 
herds. 
3.43. After infection is diagnosed in individual cattle, they are kept on farm for a period of 
up to ten working days before going to slaughter.  Reducing this maximum period 
and mandating their isolation from the rest of the herd would help prevent disease 
spread, though at costs for both government and the farms involved. To be 
effective, facilities must be available adequately to isolate cattle and to ensure this 
would require inspection (see also Chapter 8).  
3.44. There is evidence that in rare cases farmers actively break the law in order to 
increase compensation paid to them during breakdowns, either by manufacturing 
positive SICCT tests or by changing ear tags so that poorly performing cows are 
slaughtered and good milkers are retained (though the introduction of DNA ear tags 
has helped to mitigate this). The latter but not the former will tend to increase 
disease spread.  In ¶ 5.47 we discuss micro-chipping cows, an intervention that 
would also be helpful in preventing these types of fraudulent activity. 
Special issues of new foci of infection 
3.45. Herd breakdowns occur sporadically in the LRA and occasionally these turn into 
foci of infections with a number of neighbouring farms infected and evidence of 
transmission to wildlife.  An example of this is the focus in East Cumbria which 
began in cattle in 2014 with infections recorded in badgers from 2017 (and which 
genetic analysis showed was linked). 
3.46. Irrespective of decisions made to enhance removal of infections from herds 
throughout the LRA, the imposition of enhanced measures around developing foci 
should be considered (see also ¶ 6.36. for control in wildlife).  
3.47. For this to work, it must be possible to identify foci and impose a stricter regime 
quickly.  Thus consultation on this strategy should be done in advance and on the 
principle of the approach, not for each focus identified which would cause delay. 
3.48. Whole-herd slaughter is currently used sparingly in the LRA and there is a clear 
argument against its use in other areas (¶ 3.16).  However, it could be used more 
frequently in the LRA; for example, when there is clear evidence of multiple 
infections in a herd associated with risky or reckless purchasing behaviours.   
Testing and epidemiological intelligence 
3.49. Genetic analysis (genotyping) of M. bovis has traditionally relied on analysis of 
restricted regions of variable DNA allowing the identification ‘spoligotypes’ (a 
category of genetic variants) and VNTR (variable number of tandem repeat) types. 
Using a combination of these methods, genotypic analysis can sometimes identify 
the source of a new focus of infection (for example, genotyping showed that a 
recent outbreak in East Cumbria probably originated from cattle bought from 
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Northern Ireland).  The cost of sequencing the whole genome of M. bovis is 
decreasing and this allows much more insightful epidemiological investigations for a 
similar cost.  Whole-genome sequencing could be employed routinely to aid 
epidemiological investigation and control. The greatest benefits would be gained by 
sequencing a series of isolates from farm breakdowns that persist over several 
testing cycles, and for multiple isolates to be sequenced in larger breakdowns. 
Research & development priorities 
3.50. The absence of a cattle test with both high specificity and sensitivity is probably the 
single greatest barrier to effective disease control.  The last few years have seen 
new tests proposed which are currently in the early stages of commercialisation.  
There is also a fruitful read across from work on human TB diagnostics.  Research 
and development to characterise the performance of novel tests and explore new 
options is, we believe, of high priority. Discussions and exploration of novel tests is 
also hampered by the lack of high-quality data on the true performance of currently 
available tests in cattle in the UK and filling this evidence gap is, we believe, also a 
high priority. Such data would facilitate the quantification of the likely costs and 
benefits of the different testing regimes we explore.   
3.51. The establishment of a repository (biobank) of bovine material would greatly assist 
research and development of new tests.  For example, where whole herds are 
slaughtered and each animal has been multiply tested (SICCT, IFNγ, post mortem 
inspection and culturing), the retention of material (such as blood sera, peripheral 
blood mononuclear cells and faeces) would provide a standard sample set to 
validate future diagnostic tests. 
3.52. Further from application are novel approaches to bovine TB detection based on 
bacterial metabolites and other biomarkers present in cattle blood, breath or faeces.  
More fundamental research in this high-risk/high-reward area (of the type 
appropriately funded by Research Councils) is, we believe, justified. 
3.53. As discussed in Chapter 4, vaccination using the standard BCG vaccine precludes 
the normal use of the SICCT test.  This has led to the search for other antigens that 
reveal the presence of an immune response to M. bovis but not BCG (so called 
DIVA – differentiating infected from vaccinated animals – tests).  Recent advances 
in high-throughput molecular biology screening techniques have facilitated this 
search with promising candidates for skin (like SICCT) and blood (IFNγ) tests.  
Further research in this area is recommended. 
3.54. Development and validation of new diagnostic tests require access to materials and 
samples from infected farms. Such access is currently restricted by notifiable 
disease legislation which risks hindering bovine TB control and the development of 
new commercial products for the international market.  Altering the legislation so 
that it eased the provision of research material while maintaining appropriate levels 
of biosecurity would be helpful.  
3.55. A far better understanding of the excretion and modes of transmission of M. bovis 
between cattle and other species, including the importance of environmental 
contamination via slurry is needed as a priority. Testing biobanks as described 
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above and sample sets from infected farms to address this evidence gap is a further 
priority. 
Chapter 4: The disease in cattle: Vaccination and resistance 
Introduction 
4.1. The spread of bovine TB can be reduced by increasing the resistance of cattle to 
infection by M. bovis.  Two, not mutually exclusive, ways to do this are through 
vaccination or by breeding for increased resistance to infection.  We discuss 
vaccination in wildlife in Chapter 6. 
4.2. Vaccination is an important means of preventing infectious diseases that cannot be 
eradicated in other ways, and in principle this is true of bovine TB in cattle. A 
vaccine similar to that used for human TB was first trialled in the 1920s  and, though 
it provided some limited protection, it was viewed as a less effective control 
measure than test and slaughter which became the main control strategy in the 
1950s.  Because the test used could not distinguish between vaccinated and 
infected animals, vaccination was discontinued and subsequently made illegal 
under UK and EU legislation. 
4.3. There is evidence that cattle vary genetically in their susceptibility to bovine TB and, 
once infected, there may be genetic variation in their propensity to spread the 
infection to other animals.  It is thus possible to select for better disease 
susceptibility and transmission traits as part of cattle breeding programmes. 
Rationale for vaccination and breeding for resistance 
Vaccination 
4.4. The bovine TB vaccine used to date is the Bacillus Calmette-Guérin (BCG) vaccine, 
the same as that used against human TB.  It is prepared from weakened and no 
longer virulent strains of M. bovis.  The precise characteristics of a batch of vaccine 
can be influenced by the strain from which it was derived and how it is processed.  
Though developed at the beginning of the 20th century, early studies of BCG 
vaccination provide only limited information about its effectiveness because of 
variation in vaccine type, dose and delivery, as well as shortcomings in 
experimental design. 
4.5. More systematic studies over the past 25 years have shown that calves are best 
vaccinated at 2-4 weeks and then revaccinated every 1-2 years to maintain 
immunity (earlier revaccination can be counterproductive).  Optimum dose and 
comparative BCG strain characteristics have been established. 
4.6. Field studies of effectiveness in Ethiopia29 and Mexico30 (where local disease 
prevalences are high) have shown vaccinated cattle are between 30-60% less likely 
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to contract the disease.  If a vaccinated animal becomes infected then disease 
progression is reduced (fewer and less severe lesions).  Experiments in New 
Zealand where some animals were vaccinated in herds containing reactor-positive 
cattle (and in the presence of infected wild possums) have shown that the degree to 
which vaccination reduces infection is in the range of 67-77% depending on how 
the vaccination was carried out and the age at which the animal was slaughtered 
and the disease assessed31.  
4.7. If an animal is already infected by M. bovis then subsequent vaccination does not 
alter the course of the disease.   
4.8. There is active research on improved BCG vaccines (for both human and animals) 
and on how to use existing vaccines; for example, on the benefits of intravenous 
versus subcutaneous injection.  Bovine TB control strategies should be flexible 
enough to make use of these new advances, should they occur. 
4.9. A major issue is that BCG vaccination is incompatible with a policy of test and 
slaughter.  Up to 80% of calves that receive the BCG vaccine react to the SICCT 
(see ¶ 2.24) test 6 months later.  Reactivity decreases to 10-20% after 9 months 
and may disappear completely after 18 months32.  If the CFT test is used (see ¶ 
2.29) 24% react positively 6 months after vaccination though similar levels of false 
positive reactions between vaccinated and unvaccinated animals are observed after 
12-18 months33. 
4.10. A DIVA (differentiating infected from vaccinated animals) test would allow infected 
animals to be distinguished from those that have been vaccinated.  A DIVA test is 
available based on the IFNγ test using antigens that are not present in BCG34. This 
is also used to diagnose TB in humans. The same antigens are now being used to 
develop a DIVA skin test35.  Hence, this is an area of active research and there is a 
reasonable likelihood of further progress in the medium term.  In our view progress 
on a DIVA test is more likely than the development of a markedly better vaccine. 
4.11. A manufacturer for both BCG and a DIVA test will also need to be identified and 
supplies secured before roll out of vaccination is possible.  The licensing process, 
including testing the safety and efficacy of the vaccine under field conditions, also 
needs to occur.  
Resistance 
4.12. Single bulls sire many cows and the probability that their daughters become 
infected by bovine TB (recorded in APHA databases) can be used to estimate their 
value in passing on resistance traits.  Genetic analysis can then identify genetic 
markers associated with resistance that can predict the performance of individuals. 
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4.13. Research by the Roslin Institute (Edinburgh) and Scotland’s Rural College (SRUC) 
has used data on the bovine TB infection status of over 650,000 Holstein cows to 
identify additive genetic variation in bovine TB resistance.  They found resistance to 
have a heritability of about 9% which is sufficient for the trait to be incorporated in 
selection programmes for all dairy cattle breeds alongside other production-oriented 
breeding criteria.  Work is currently underway to establish a similar index in beef 
breeds. 
4.14. Improving resistance is a long-term project and not a substitute for interventions 
that produce quicker results.  There is a possibility that M. bovis itself evolves to 
counter selected resistance traits.  There is no evidence that improved resistance is 
negatively correlated with other desirable traits (such as resistance to other 
diseases or production indices) but this should be considered and monitored. 
4.15. Current genetic indices are constructed using data on whether animals react 
positively to the SICCT test during herd breakdowns. There is a risk that the index 
may in part reflect the ability to avoid reacting to the skin test, rather than genuine 
resistance to infection.  Further research on the biological mechanism underlying 
resistance and the role of genes identified by the genetic analysis will be important 
in excluding this possibility. 
4.16. Investigating genetic variation in bovine TB infectivity could help in identifying 
opportunities to accelerate the reduction of breakdown risk and severity.  This 
would be more challenging than studying resistance as the trait (the propensity to 
infect other animals) is much harder to measure.  
Current policy 
Vaccination 
4.17. Neither BCG nor any other vaccine is licensed for use in cattle in the UK or the EU.  
APHA has applied for the licence from the regulator, the Veterinary Medicines 
Directorate (VMD), necessary for BCG to be used if cattle vaccination were to be 
permitted. APHA is now addressing specific requirements needed for this approval, 
including developing protocols for field trials. Since 1998, Government has invested 
about £40 million into the development of a cattle vaccine for bovine TB and DIVA 
tests. 
4.18. Permission to vaccinate within the EU requires European legislation to be 
amended.  In 2012, the British Government formally approached the European 
Commission asking for a time schedule for a vaccination strategy to be approved 
and then implemented through legislation. In its response in January 2013, the 
European Commission set out a tentative timeline for bovine TB vaccination of 
cattle in the UK and EU, showing the series of steps that would be needed; 
including, scientific and veterinary debate on the conditions for use of vaccine, and 
marketing authorisation procedures. The Commission indicated the necessity of 
field trials to assess efficacy and safety under European production conditions, and 
recommendations on the design of suitable field trials were prepared by the 
European Food Safety Authority36.  However, to obtain sufficient statistical power 
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using this approach would likely require, given the prevalence of bovine TB in 
England, large-scale field trials which might involve 500 farms over 2 years37.  This 
may be unfeasible and equivalent information might be obtained more easily using 
vaccination and challenge experimentation with approximately 200 individual 
animals. 
Resistance 
4.19. AHDB Dairy launched ‘TB Advantage’ in January 2016.  This is an index of the 
degree of resistance to bovine TB that any particular bull is likely to pass on.  The 
index runs from -3 to +3 and if a bull has a score of x then x% fewer of his 
daughters are predicted on average to become infected during a breakdown.  The 
score is based on the observed performance of established bulls that have 
sufficient daughters in the national herd exposed to bovine TB.  In addition, for 
Holstein cattle, genetic analysis (¶ 4.12), allows a score to be given to young bulls 
or cows that have been genotyped (the index in this case is a little less reliable).  
Resistance is weakly positively correlated with other traits that farmers use in 
breeding and hence resistance may have been under recent indirect selection.  
4.20. In March 2018, AHDB Dairy announced that they will be partnering with SRUC to 
embark on two new projects, one in dairy and the other in beef, aimed at further 
advancing a national database of genetic evaluations and a new genomic prediction 
tool.  This would enable more farmers to identify natural resistance traits and make 
informed decisions about which cattle they choose to breed, depending on their 
resistance to bovine TB. The diversity and number of different beef breeds (and 
their relatively small population size) makes progress in beef genetics the more 
challenging. 
Options for the future 
Maintain current vaccination policy 
4.21. We interpret the maintenance of current policy as working to obtain approval for 
BCG vaccination within the rules of the EU, even after the UK leaves the EU.  There 
is considerable uncertainty about the precise testing hurdles that will need to be 
overcome and the time this will take, and indeed whether either addressing them, or 
producing a vaccination and testing programme that is cost-effective for farmers to 
use, is actually possible.  Success and speed of progress will also depend on the 
level of investment in this development work. 
Maintain current breeding for resistance policy 
4.22. The uptake of TB Advantage is a good example of an industry-led initiative 
embraced by farmers.  Extending the genetic analyses to other breeds is likely to be 
valuable. Dairy farmers are strongly focused on genetic selection for yield and milk 
quality as part of the regular process of selecting bulls for artificial insemination. The 
inclusion of data on TB Advantage on bull reports may encourage farmers to 
consider other measures that can be taken to protect their cattle against bovine TB, 
alongside the choice of bull. 
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4.23. Uptake of TB Advantage could in principle be incentivised by including its use in 
indices used in risk-based trading, insurance or compensation (see Chapters 5 and 
8).  However, breeding for disease resistance has most value in the long-term so its 
recent use by a farm may not make a very large difference to a statistically derived 
index.  Crediting herds for using TB Advantage through supermarket or other 
accreditation schemes that take into account industry-wide benefits is likely to be a 
better approach. 
Deployment of a BCG vaccine 
4.24. After the UK leaves the EU, the existing BCG vaccine could be licensed before a 
DIVA test is validated and licensed. Some preparatory experiments and field trials 
would be required to address safety and other issues in order to obtain a marketing 
authorisation licence from VMD.  
4.25. The BCG vaccine could be deployed in a variety of ways, and exactly how best to 
do so would require detailed feasibility studies including epidemiological and 
economic modelling.  One option would be to deploy BCG in higher risk areas (the 
HRA with or without the EA) and cease current SICCT testing to avoid the costs of 
increased testing required when vaccinating.  Alternatively, animals could be tested 
just prior to vaccination and then retested again just before revaccination (when the 
masking effect of BCG would have largely waned, although false positives would 
still likely occur in larger herds).  Thus, testing continues but at a lower frequency 
than currently in high risk areas with the likelihood of a greater number of false 
positive reactors.  The relationship between vaccination and movement rules would 
need to be defined. It would not be advisable to allow untested vaccinated animals 
to be moved to lower risk areas.   
4.26. Full details of vaccination would be recorded on the Livestock Information Service 
(LIS) database (see Chapter 5).  Work would be required to determine how the 
current and past vaccination status of an individual animal or herd would affect risk 
scores used in risk-based trading or for other reasons.   
4.27. Given our current knowledge base there are clear risks in reducing testing and 
surveillance in favour of vaccination.  Close monitoring of disease prevalence, in 
particular through stepped up post mortem checks to determine the efficacy of 
vaccination, would be needed. 
4.28. The introduction of vaccination would likely impact trade.  Trading partners would 
almost certainly put restrictions on the export of vaccinated animals and possibly on 
dairy products. If current surveillance programmes were modified, they may not be 
judged effective enough to allow products to be traded safely internationally. 
Engagement with the OIE and the regulatory authorities of potential trading partners 
would be important from the design stage. 
4.29. Until the costs of vaccination and its effects on trade and business practices are 
understood, it is not possible to analyse the economics of vaccination.  A careful 
analysis of its costs and benefits would of course be very important before 
implementing vaccination and can also guide the value of further investment in this 
intervention.  However, given the probable costs involved, it seems unlikely that 
farmers would elect to vaccinate and hence a vaccination strategy would need to be 
compulsory or heavily incentivised.  Incentives might include more positive scores 
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on animal or herd risk indices, or the reduction or removal of compensation for 
unvaccinated animals. 
Deployment of a BCG vaccine with DIVA test 
4.30. Outside of the EU, the existing BCG vaccine could be licensed and a DIVA test 
used in surveillance.  There are several DIVA test options that could be used 
immediately; for example, one based on the IFNγ test.  Alternatively, given this is an 
area of particular active research, concentrated investment could be made in 
optimising a DIVA skin test for deployment in a few years.  Any DIVA skin test 
would need to go through safety and efficacy assessment supervised by VMD 
under the regulatory arrangements in place after the UK leaves the EU. 
4.31. The benefits of vaccination in combination with a DIVA test are greatly influenced 
by the DIVA test characteristics and costs; a small change in specificity will 
markedly affect the reduction in breakdown and reactor numbers. This makes 
further validation work on the DIVA skin test a priority in order to better understand 
the potential benefits of deploying cattle BCG vaccine. The increased or additional 
testing likely required in vaccinated cattle may incur substantial costs and could be 
a major determinant of any economic benefit of vaccination.  
4.32. As with deployment of the BCG vaccine alone, this option could be implemented in 
different ways and detailed feasibility studies would be required prior to 
implementation.  Similarly, engagement with the OIE and trading partners would be 
important. 
Targeted vaccine deployment. 
4.33. Instead of blanket vaccination throughout higher risk zones, a strategy of 
vaccination, or vaccination combined with a DIVA test, could be targeted at critical 
areas of infection.  For example, farms in the EA could be vaccinated, or ring 
vaccination deployed around clusters of infected farms. 
4.34. The same issues of validation, licensing and effects on trade discussed above 
would also apply to targeted vaccination.  Because fewer farms are affected, the 
effects of any restrictions on trade in animals or animal products would be reduced 
and less costly to compensate.  However, the effects on trade and business for the 
farmer are likely to be substantial requiring a mandatory programme which in the 
absence of a stronger evidence base for its value would be unpopular.  
Engagement with trading partners in advance to understand their response to this 
intervention would obviously be important. 
Research & development priorities 
Vaccination 
4.35. The major research priority in the broad field of vaccination is the validation and 
licensing of a DIVA skin test that can reliably and economically identify vaccinated 
cattle that have become infected. This has the additional and independent benefit of 
potentially producing a test that is better than the century-old tuberculin-based skin 
testing approach still used internationally.   
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4.36. A better vaccine than BCG has proved hard to identify for humans (though some 
encouraging progress has been made recently) and may be equally hard to find in 
cattle, making investment in developing better cattle vaccines somewhat 
speculative. Instead, it may be more profitable to pursue approaches associated 
with improved BCG efficacy, including the feasibility of intravenous vaccination 
which has showed improved protection over subcutaneous vaccination against 
strains of human TB (M. tuberculosis) in non-human primates.  Should better 
vaccines be developed for human TB, then the efficacy of these vaccines in cattle 
should be determined. 
4.37. We have an imperfect understanding of the economics of vaccine deployment, 
farmer attitudes and acceptance of cattle vaccination, and the response of 
consumers to products derived from vaccinated animals.  Research in the social 
sciences will be valuable in addressing these gaps. 
Resistance 
4.38. Continued genetic analysis of resistance in multiple cattle breeds to enhance the 
value of the TB Advantage score will be valuable, enhanced if data can be shared 
with RoI and Northern Ireland and likely assisted by the LIS.  Research to ensure 
that true resistance and not test avoidance is being identified and selected for is 
important. 
4.39. Researchers in China have recently used genome editing tools to alter a gene in 
cattle involved in fighting infection, producing some early evidence that the resulting 
transgenic cattle may have increased resistance to M. bovis infection38.  Carrying 
out gene editing in cattle will almost certainly become easier in the next few years 
and, as we learn more about the genetic basis of resistance in cattle (and humans), 
the opportunities for using this technique to improve resistance will increase.  Gene-
edited organisms are currently considered genetically modified organisms (GMOs) 
in Europe but (depending on the precise alteration) not in the USA or Japan. 
4.40. None of the national epidemiological bovine TB models currently incorporate 
genetics.  New models that include genetics will be valuable to predict changes in 
bovine TB prevalence in England over time resulting from genetic improvement 
alone and in combination with other control strategies. 
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Chapter 5: Cattle Movements and risk-based trading 
Introduction 
5.1. Movement of infected cattle onto previously uninfected premises is a significant 
source of spread of bovine TB.  This risk is partially mitigated by pre-movement 
testing of cattle (compulsory since March 2006 throughout the EA and HRA for 
cattle over six weeks old), though this does not identify all infected individuals. 
Since April 2016, post-movement testing is compulsory in the LRA for cattle moved 
from other areas of England and from Wales. 
5.2. There were just under 5.5 million cattle on agricultural holdings in England in 
December 2016.  Excluding cattle sent to slaughter (directly or via approved 
finishing units), which would not spread the disease, a little over 1.7 million cattle 
were moved within and between different risk areas in England in 2016.  
Movements between non-contiguous parts of a single farm business, which may be 
some distance apart, are not included in this figure (see also Chapter 8).  This 
number of movements has remained broadly similar over time and includes 
substantial numbers moving from higher to lower risk areas (Figure 5.1).  Even if a 
small fraction of the animals that are in transit is infected, the very large number of 
movements suggests this could be a potentially important source of new infections. 
Figure 5.1: Cattle movements in England in 2016 
 
5.3. Cattle movements occur for a number of reasons.  Farms often specialise in 
different stages of the production process: calf rearing, growing, finishing for beef, 
and milk production.  This specialisation and consequent improved industry 
efficiency requires movement between farms with some cattle moving through 
multiple farms over their lifetime.  Modern farming increasingly monitors the 
performance of individual dairy cows with low producers being sent to slaughter and 
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replacements being bought in (18-35% of dairy cattle are typically culled from herds 
each year)39.  Contracts to supply milk may specify fixed supply amounts 
incentivising farmers to replace quickly animals that are poorly performing or have 
died. 
5.4. The trading patterns of cattle are dynamic, showing seasonal variation with complex 
relationships between regions and farm enterprises. Approximately 45% of cattle 
are traded by direct purchase between farms with the rest bought through 
markets40.  Live auctions bring together hundreds of cattle from a wide regional 
catchment. The geographic direction of cattle movements is generally from the west 
of England to the east. One reason for this is that crops for cattle feed are better 
grown in the east and it is cheaper to transport cattle to the feed once rather than 
continuously to move large volumes of feed to the animals. 
5.5. Around 20-30,000 live animals are imported each year from the RoI and other parts 
of northern Europe; mainly female animals going to dairy herds as replacement 
stock.  
5.6. An unknown but likely small proportion of movements will be of known or suspected 
infected animals, moved to avoid detection. Since 2011, cattle testing positive for 
bovine TB are DNA tagged to help discourage fraud. The Animal Health and 
Veterinary Laboratories Agency (AHVLA) found a significant reduction in the 
numbers of double replacement ear tags being ordered after DNA tagging was 
introduced suggesting the existence of previous illegal activity. 
Rationale for risk-based trading 
5.7. In principle, farmers will want to avoid purchasing cattle that are at risk of 
introducing bovine TB into their dairy or beef herds – that is, they will practice risk-
based trading.  Simplistically, the farmer will weigh the future financial costs of a 
breakdown in determining whether or not to purchase an animal with a particular 
risk profile and if so at price, and this will mean that higher risk cattle are cheaper.  
There is, however, a possibility that the low price will lead to irrational purchases.  In 
general, the actual behaviour of farmers can be more complicated than a simple 
rational model predicts and can be affected by attitudes of resignation amongst 
some farmers regarding their likelihood of avoiding the disease (fatalism)41.   
5.8. There are several reasons why the market may fail to maximise both private and 
public benefit through current trading practices.  For example, the purchaser may 
have imperfect information about the risk status of an animal at a livestock market.  
There is of course an incentive for the seller to provide evidence that an animal is at 
low risk of carrying an infection but no incentive to disclose any information of the 
opposite.  In general, the seller has more knowledge about the animal than the 
purchaser which leads to an information asymmetry.  The provision of more 
accurate information, particularly at point of sale, would enable risk-based trading.  
There is an extensive economic literature about the theory of markets in the 
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presence of information asymmetry and when low-risk sellers should abandon 
markets for private sale arrangements. 
5.9. In addition, not all the costs of a herd breakdown are borne by the individual farmer.  
First, the farmer is partly compensated for losses.  Second, any herd breakdown 
hinders efforts to control the disease with costs to all farmers while the introduction 
of the disease to a new area may affect many farms beyond the one involved with 
the purchase.  Restrictions on trading, though they may economically hurt the 
individual farmer, have wider industry and national benefits.  On the supply side 
these restrictions can include rules forbidding animals from infected or high-risk 
herds being sent for sale; on the demand side they can include reductions in 
compensation for reactors that occur on premises that have bought high-risk cattle. 
Though the latter does not resolve the problem that a farmer’s purchasing decisions 
will only include the costs to their own enterprise (in economics jargon it does not 
make them internalise the externality), it does increase the costs of risky behaviour 
to their own business and hence should result in improved practices. 
5.10. There is some evidence that a small minority of farmers deliberately send to market 
animals that they fear may prove positive at the next routine bovine TB test, or 
swap ear tags to hide infection status.  Irrespective of whether this is more than a 
rare event, the belief that it may occur undermines trust in risk-based trading.  
Measures to prevent fraudulent trading thus have both a direct and indirect benefit. 
5.11. Different types of information can be made available to the farmer at purchase (at 
ring-side or through a database).  Perhaps the most straightforward are: (i) the 
number of years the herd from which the particular animal is derived has been OTF, 
or (ii) whether in England the herd is in the HRA, the EA, or the LRA.  More 
sophisticated scores are possible based on more detailed information about the 
herd’s risk factors.  Information on every individual bovine animal in the country is 
held on the Cattle Tracing System (CTS) database maintained by the British Cattle 
Movement Service (BCMS) and it would also be feasible to derive a risk-score for 
individual animals that would incorporate their complete history of movement and 
testing.  Information to allow risk-based trading might be provided voluntarily or 
mandated by the state. 
5.12. Modelling the effect of risk-based trading is difficult and requires a variety of 
different assumptions to be made.  A recent study estimated that a voluntary 
scheme might reduce the number of infected animals traded by 23% (90% CI 22% - 
25%) and a statutory scheme by 37% (90% CI 35% - 39%)42. While changing the 
assumptions will affect the exact estimates we suspect the qualitative conclusions 
from this study are likely to be correct. 
5.13. There is broad industry support for risk-based trading, though also some concerns.  
First, the provision of information at the herd or animal level to allow risk-based 
trading is an administrative burden for the farmer.  Second, some of the risk of 
infection can be captured by geographic location, the basis of the HRA, EA and 
LRA classification.  Interventions that explicitly or implicitly limited trade between 
high and low risk areas might lead to two wholly or partially disconnected markets 
with lower prices in the HRA.  A cow on a farm in the HRA that had never had a 
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breakdown would be worth less than an equivalent animal in the LRA (which might 
have come from a farm that conducted high-risk trades), something that has been 
described as unfair.  A survey of farmers found more support for risk-based trading 
in the LRA compared to the EA and HRA (which reflects comparative benefits) and 
for compulsory over voluntary approaches43.  The lack of support for risk-based 
trading in the HRA also reflects a belief amongst many farmers that cattle 
movement is not a significant risk compared to infection from wildlife. 
5.14. In May 2013, the industry-led Bovine TB Risk-Based Trading Group recommended 
the introduction of an (initially) voluntary risk-based trading system supported by a 
comprehensive, accessible animal-level database providing access to a range of 
TB risk factors such as movement history, testing history, background prevalence of 
disease, as well an overall risk rating.  It argued for a range of provisions to be 
introduced more quickly in advance of the database being completed.  Defra’s 2014 
bovine TB Strategy emphasised the importance of risk-based trading and since 
then a number of measures have been introduced or subject to consultation.  
5.15. Risk-based trading has been implemented in several countries: 
(i) A statutory scheme ran in Australia from 1970 to 1997. This classified disease 
risk at the regional level and at the herd level. Regulations specified which herds 
in each area were free to move to which regions. 
(ii) In New Zealand all cattle herds are classified to reflect their TB status. There are 
three categories: clear, infected or suspended. For example, a herd with a status 
C6 has been clear of bovine TB for six years, whereas a herd with I9 has been 
infected for nine years. Suspended status means that the disease is suspected. 
A herd’s bovine TB status can also change to suspended due to receiving stock 
from an infected herd.  Bovine TB status is employed extensively by New 
Zealand farmers, though its use and interpretation are influenced by local 
conditions and the degree to which farmers feel empowered to affect their risks 
of infection44. 
(iii) In the USA, individual states are assigned an accreditation level based on 
disease prevalence. This determines the testing and other requirements needed 
to move cattle to another state. Cattle from a state that is accredited as bovine 
TB free may be moved to another state without restriction; animals from states 
that are not accredited as bovine TB free must come from accredited herds, or 
complete specified testing requirements in order to be permitted to move. 
Owners can achieve accredited bovine TB free status for their herds by following 
prescribed testing procedures and strict record keeping. 
(iv) In the RoI information is available at livestock markets via the Animal 
Identification and Movement (AIM) database. Prospective buyers are able to see 
the date of the last bovine TB test for an animal on the display board over the 
ring at the time of sale. The provision of such data is mandatory.   
                                            
43 Farmers’ attitudes to a risk based trading scheme for cattle in England, ADAS UK Ltd. (2012)  
44 Enticott 2016 https://doi.org/10.1016/j.jrurstud.2016.04.008  
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Current policy 
5.16. Since 2006, pre-movement tests have been required for all cattle (over six weeks 
old) on premises subject to annual or more frequent testing unless the herd or 
movement type meets certain specified exemptions.  These include movements 
direct to slaughter, an Approved Finishing Unit (AFU) or a pre-movement test 
Exempt Finishing Unit (EFU).  The test is paid for by the farmer (though results from 
regular state-sponsored tests can be used). 
5.17. Since 2016, post-movement tests have been required for cattle moving onto 
premises in the LRA from areas subject to annual or more frequent testing, paid for 
by the purchasing farmer. 
5.18. An initiative to inform farmers about the importance of risk-based trading was 
introduced in 2015.  It stresses the importance of enquiring about the herd-
breakdown status of the premises from which animals are purchased, and provides 
advice about keeping purchased cattle separate and ideally arranging for them to 
be post-movement tested for bovine TB even when not statutorily required. 
 
5.19. Since 2015 an online interactive tool (ibTB) has been available that provides 
information on the geographic location of all herd breakdowns in England and 
Wales (Figure 5.2).  Data are available from 2014 and the database can be 
searched by postcode or County Parish Holding (CPH) number.  However, ibTB 
appears to be of limited use at auctions unless the sale is catalogued in advance 
(and includes the CPH or postcode which seldom happens) to allow purchasers the 
opportunity to research vendor bovine TB status45. ibTB receives about 100 hits a 
day but the fraction of these that are farmers using it for risk management is not 
known46.   
 
                                            
45 APHA (2015) https://www.gov.uk/government/publications/bovine-tb-epidemiology-reports-2015  
46 http://www.assembly.wales/research%20documents/18-003/18-003-web-english.pdf   
54 
Figure 5.2: An illustrative graphic from the online interactive tool ibTB. 
5.20. A study of the introduction of ibTB found that it scored highly on different measures 
of usability.  Until recently bovine TB status was confidential, hence the study noted 
some concerns among the farming community about the accuracy and accessibility 
of the data.  There was also some uncertainty amongst private veterinarians about 
their changing roles in relation to providing advice on bovine TB control to their 
farmer clients as information that had previously been private became more 
available47. 
5.21. Currently, there is no formal requirement for vendors to provide information about 
their animals’ bovine TB status and the level of demand for this from purchasers 
appear to be limited.  Information such as the date of the latest herd bovine TB test 
comes in the form of a farmer declaration and the veracity of these statements are 
not assured. Grants were made available in 2014-15 to auction markets to cover 
half the cost of electronic display equipment to display bovine TB information 
ringside during cattle sales. About 25% of markets took them up. Our discussions 
with the industry suggest this reflects a concern of auctioneers that the provision of 
data on bovine TB status is unlikely to be successful without a more robust source 
of up-to-date information and greater demand for herd health data from buyers and 
sellers of cattle. 
5.22. The Cattle Health Certification Standards (CHeCS) organisation launched a bovine 
TB herd accreditation scheme in 2016.  Participating farms obtain enhanced 
biosecurity advice and perform additional post-movement tests beyond regulatory 
requirements.  They receive a score reflecting the amount of time since their last 
herd breakdown.  This can be particularly valuable for herds in the HRA and EA that 
have never had an infection.  However, take up of the scheme has been low with 
around 60 accredited herds in England to date (mainly high-value pedigree herds). 
5.23. From 1 November 2018, government will pay compensation at 50% of the average 
market price for any animal brought into a herd with a bovine TB breakdown which 
then fails a test whilst that breakdown is still ongoing. This already happens in 
Wales and is intended to encourage herd owners to take further steps to improve 
their disease control. Herds which are CheCS accredited at the time of the 
breakdown will continue to receive 100% compensation for all compulsorily 
slaughtered cattle. 
5.24. There are further measures under consideration in England: 
(i) APHA have developed a herd scoring system based on known and measurable 
risk factors that could be used in risk-based trading48.  About one third of all 
breakdowns can be predicted by the factors included in the model.  
(ii) Development of a Livestock Information Service (LIS) as discussed at ¶ 5.29. 
5.25. There are some differences between England and the DAs. Wales operates a 
voluntary ‘informed purchasing’ scheme, which encourages farmers to share 
                                            
47 Bovine TB in Wales: governance and risk, Gareth Enticott (2018) 
http://www.assembly.wales/research%20documents/18-003/18-003-web-english.pdf   
48 Adkin et al. 2016 http://dx.doi.org/10.1016/j.prevetmed.2015.11.020  
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information about the bovine TB status of their animals when selling. Northern 
Ireland has recently consulted on a proposal that the farming industry should lead 
the adoption of an informed purchasing approach for farmers bringing in stock to 
their farms. This would involve support to promote information openness and 
transparency at livestock markets (for example, on the health status of cattle) and 
increased awareness raising. Scotland has a requirement for pre- and post-
movement testing of cattle coming from annually or more frequently tested herds in 
England and from Wales. 
Options for the future 
Maintaining the status quo 
5.26. Given the evidence that moving cattle can spread bovine TB, existing pre- and post-
movement testing almost certainly prevents some new infections.  However, the 
limited sensitivity of the tests used means that not all infections will be identified and 
purchase of stock, especially from high-risk herds, always carries a risk of 
introducing infection. 
5.27. Existing voluntary schemes such as CHeCS herd accreditation and the use of the 
ibTB database are poorly taken up by the industry.  Though they may benefit 
individual farm businesses they are unlikely to be having a major effect on the 
incidence and spread of disease in England.  Risk-based trading has not culturally 
been embraced by large sections of the farming community, in significant part 
because of lack of confidence in the value of the information available, and also 
because of an under-appreciation of the risks of purchasing infected cattle49. 
5.28. It is possible that existing measures could be made more effective; for example, by 
better marketing and a greater understanding of incentivising farmer behaviour.  
However, we believe more than at present can be done to discourage risky trading. 
Improving the information available at purchase 
5.29. In spring 2018, Defra announced a major investment to develop the LIS.  The 
service, to be in place from 2019, will use electronic identification tags to identify 
and record the movements of all cattle, sheep, pigs and goats in the UK.  The 
initiative arises from a joint government-industry working group and has broad 
sector support.  At the time of writing, the details of how the LIS will be constructed 
and operate are not fully available.  However, it is clear that it is potentially an 
enormously important resource to help all aspects of bovine TB control including 
risk-based trading. 
5.30. LIS is planned to perform multiple functions of which assisting bovine TB control is 
but one.  It is stating the obvious to emphasise that in the design phase it is critically 
important that the needs of bovine TB control are understood, and that this system 
should be constructed so that it is intuitive and simple for farmers, veterinarians and 
other stakeholders to use.  The continuing involvement of the National Farmers 
Union (NFU), the Livestock Auctioneers Association (LAA) and other bodies is 
important. 
5.31. The LIS database should carry the complete location history of each animal as well 
as other individual-specific information relevant to bovine TB risk such as its 
                                            
49 Farmers’ attitudes to a risk based trading scheme for cattle in England, ADAS UK Ltd. (2012) 
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individual testing history and that of other animals in the herds it has been part of.  
These raw data are of limited use to farmers considering purchasing cattle and 
must be transformed into a useable index or score.  Indices such as those already 
developed by APHA can be employed immediately but research is needed to utilise 
the richer data that will be available through LIS. This should begin immediately so 
that it can inform the design of LIS.   
5.32. Though some risk factors can be estimated from information on individual animals, 
others are a function of farm location (for example, density of wildlife reservoirs).  It 
is important that LIS either includes or can interface with this type of data.  
Research is needed to see whether estimates of these types of risk factor can be 
estimated using proxy data (for example, remotely-sensed habitat data might be 
used to estimate badger densities) and can contribute to the index or score. 
5.33. There could be a mandatory requirement that the risk assessment index or score is 
presented to a potential purchaser before purchase, ideally in both the sales 
catalogue and on large screens at ring side.  Technology would allow ear tags to be 
scanned and the information automatically uploaded from LIS.  A concerted 
information campaign by the industry and government would be needed to raise 
awareness and understanding in the farming community.  Insights from the 
behavioural sciences will be valuable in designing the best ways to communicate 
information to purchasers in the cognitively complex environment of the auction 
ring.  The LAA supports the principle of improving the level of information available 
to farmers at market provided it is timely, accurate, and reliable. 
5.34. As part of the LIS programme all cattle will be electronically tagged.  We envisage 
that in time all farmers will have hand-held scanners that can read an individual 
animal’s identity and in real time communicate with LIS to provide a potential seller 
or purchaser with an estimate of risk.  Insights from behavioural psychology are 
likely to be helpful in designing the precise interface that elicits the optimum 
response from the farmer.   
5.35. There are a number of potential drawbacks of using LIS for risk-based trading: 
(i) Implementation and development of LIS carries significant costs, though these 
are partially mitigated by the multiple functions it can perform.  However, getting 
LIS to work for bovine TB control will require bespoke investment as described 
above. 
(ii) Despite broad support from industry there will be some farmers who will find LIS 
intrusive and burdensome.  The increasing professionalism of UK farming 
suggests this will decrease over time but it will be necessary to demonstrate the 
benefits of LIS to ensure maximum buy-in. 
(iii) Government has in the past found it difficult to implement large-scale IT projects.  
Hopefully this will not be the case here but prudence suggests not relying on the 
existence of LIS to the exclusion of existing information sources until its delivery 
is assured.  Some of the measures above could be implemented using existing 
APHA scoring of herd risk profiles in the absence of LIS though in our view this 
would be a substantially poorer outcome. 
(iv) Introducing more information about the risk of infection of individual cattle 
reduces the demand for the riskiest animals and hence lowers their sale price.  
This fall in price might undermine moves to reduce risky trading if it encouraged 
their purchase by farmers with a greater appetite for risk. It is important to 
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consider risk-based trading within the broader context of compensation or 
insurance for herd breakdowns to avoid perverse outcomes. 
Financially incentivising risk-based trading 
5.36. Risk-based trading could be incentivised by reducing the compensation paid for 
high-risk cattle, or cattle from high-risk herds that are purchased and subsequently 
are tested bovine TB positive.  Positive behaviours (absence of risky trading) could 
be rewarded by enhanced CHeCS scores.  The general issue of adjusting 
compensation to risky behaviour is discussed in Chapter 8. 
5.37. Such measures are likely to be unpopular with the industry because they potentially 
penalise farmers.  An argument is that farmers already practice risk-based trading 
and to penalise them further is unjust.  There are two counter-arguments.  First, 
farmers may prefer an immediate gain (reduced price cattle) over future loss (the 
risk of a breakdown) – i.e. show ‘time discounting’. Reduced compensation may 
help correct this bias.   Second, the social benefit of reduced disease incidence and 
spread may not be internalised in the individual farmer’s decision.  Reduced 
compensation may thus bring industry-wide benefits. 
Strengthening regulations on movement 
5.38. Movement from the HRA or from high-risk premises to the LRA might be forbidden 
by regulation.  A risk cut-off for movement was considered a key element of the 
successful Australian bovine TB control strategy though in a very different 
environmental and industry context. 
5.39. Even in the HRA there are many farms that have never had a herd breakdown.  
Preventing them from trading completely might be viewed by the industry as 
draconian and a lessening of incentives to avoid infection.  Trade from herds with 
OTF status withdrawn or suspended is restricted (e.g. to AFUs or to slaughter) and 
increasing the extent of this restriction would be viewed as making the burden of a 
breakdown greater. 
Extending post-movement testing 
5.40. Government could consider the extension of post-movement testing to the EA in 
response to increased numbers of herd breakdowns. Enhanced post-movement 
testing is already part of the CHeCS accreditation scheme requirement.  Advice is 
available to farmers on isolating brought in cattle to ensure that they are not 
incubating any disease; in particular when buying in cattle from a herd of higher TB 
risk status. Evidence from Scotland shows that the introduction of pre- and post-
movement testing has had a strong deterrent effect on the cattle import trade, albeit 
in an area of low bovine TB incidence50. 
5.41. Reducing the geographical spread of bovine TB is of high priority and likely to justify 
the introduction of post-movement testing in the EA despite the costs to the farms 
concerned.  Initial analyses of the introduction of the current post-movement testing 
regime have suggested it has reduced the numbers of cattle moving from the HRA 
and the EA into the LRA.  
5.42. Post-movement testing will be recorded on LIS and could contribute to the risk 
score of herds from which animals are sent to market. 
                                            
50 Gates et al. 2013 https://doi.org/10.1016/j.prevetmed.2012.07.016  
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Enhanced pre- and post-movement tests 
5.43. In Chapter 3 we explored the costs and benefits of moving from the SICCT test to 
other tests, in particular to the SICT or IFNγ tests, which have better sensitivity 
though in the latter case are more expensive to conduct.  These tests could be used 
for pre- and post-movement testing.  
5.44. Using the more sensitive test could be valuable in preventing the most potentially 
damaging types of movement; for example, from high- to low-risk areas.  This would 
obviously entail costs to individual farmers (we envisage the seller paying for pre-
movement and the buyer for post-movement tests) but by internalising the disease 
costs of risky movements it may increase overall industry efficiency.  The use of 
highly sensitive tests would be recorded on LIS and might contribute to reducing a 
premises’ risk score and hence increase the value of their cattle so mitigating some 
costs. 
Reducing fraudulent movements 
5.45. There are a small number of cases of farmers deliberately sending to market 
animals they know or suspect of being infected with bovine TB, sometimes after 
illegally swapping ear tags.  There is also some concern that individual cattle 
dealers may be failing to comply with TB testing and animal identification rules. 
Whether such practices are widespread is unknown, and probably largely 
unknowable, but the suspicion that it occurs can undermine farmer confidence in 
risk-based trading. 
5.46. Tissue samples that can be used for DNA genotyping are now taken of cattle that 
test positive for bovine TB.  The introduction of this coincided with a drop in 
requests for replacement ear tags suggesting it had disincentivised fraudulent 
behaviour. Tissue samples could be taken of all cattle at the time of ear tagging for 
subsequent DNA genotyping if fraud was suspected or as a spot check (genotyping 
would not routinely be carried out).  The costs of the storage of large numbers of 
samples would need to be established and a cost-benefit analysis conducted before 
further consideration of this suggestion.  
5.47. Alternatively, Defra could consider replacing or supplementing ear tags with 
injectable transponders.  A scheme to microchip all horses by 2020 has recently 
been announced and the technology is cheap and technically proven.  EU 
regulations will permit electronic identifiers to replace conventional ear tags from 
July 2019.  Research will be required to ensure that the microchip cannot enter 
tissues consumed by people or pets (or provision made in the food processing 
chain to detect microchips in meat). 
5.48. Representatives of the industry told us that the farming community were often 
aware of rare individuals conducting recklessly risky trading behaviour, and that 
there was a need for a ‘whistle-blower phone line’ for people to report such 
behaviour.  We believe this is a good suggestion.  
Research priorities 
5.49. We strongly emphasise the importance of the LIS in providing the data backbone 
for improvements in incentivising risk-based trading and many other aspects of 
bovine TB control.  We place the highest research and development priority on 
ensuring from the design stage that the system works to deliver these benefits for 
disease control.  It is imperative that APHA disease specialists are involved from 
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the beginning, and that the system is fully interoperable with other relevant bovine 
TB data sources. 
5.50. The full complexities of the trading history of a farm business or even the lifetime 
travels of an individual animal are of limited use to farmers making purchasing 
decisions, especially in the environment of a livestock market.  The development of 
indices describing the risks of purchasing from a particular farm, or the likelihood 
that an individual animal carries the infection are important, and should be based on 
the most robust statistical analysis of risk possible. 
5.51. Research in the social sciences into how farmers make economic choices regarding 
cattle purchasing, and how decisions that promote disease control can be 
incentivised, would be valuable. 
5.52. As described in the introduction the amount of cattle movement in the UK is very 
high.  Much of this is due to rational economic reasons. Nevertheless, movements 
do tend to foster disease spread (not only bovine TB but also other pathogens) and 
further study to understand movement patterns and to check none are being driven 
by perverse incentives is warranted.  
Chapter 6: The disease in wildlife 
Introduction 
6.1. The causative agent of bovine TB, Mycobacterium bovis, can infect a broad range 
of hosts including many species of wildlife.  In the 1970s it was discovered that in 
the UK and the RoI infections were present in wild badgers (Meles meles).  To 
prevent badgers acting as reservoirs of the disease different control measures were 
introduced, first gassing of badger setts (1975-1982) and then between 1982 and 
1997 different forms of direct culling of badgers on and around infected farms. 
6.2. The killing of wild badgers has been extremely controversial from the start.  A 
number of civil society organisations with substantial public support have argued 
that killing badgers under any circumstances is wrong in principle, and that it does 
not reduce disease in cattle in practice. Through well-organised campaigns, 
including action to disrupt culling, badger control has become a highly-charged and 
politicised issue.  Bovine TB now has a public salience unlike any other endemic 
livestock disease. 
6.3. A major review of bovine TB control in 1997, chaired by John (now Lord) Krebs, 
recommended a large-scale, replicated experiment to determine whether badger 
culling reduced the incidence of the disease in cattle51.  The RBCT ran from 1998-
2005 and showed that proactive culling of badgers reduced confirmed (OTFW) herd 
breakdowns inside culling areas but increased them among herds within a 2 km belt 
outside these areas52.  Reactive culling appeared to increase the number of 
confirmed (OTFW) breakdowns though its precise interpretation is still debated. 
                                            
51 Bovine Tuberculosis in Cattle and Badgers, Professor John R Krebs FRS and the Independent Scientific 
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6.4. The Labour Government in power when the RBCT reported decided not to 
implement badger culling.  The Coalition Government elected in 2010 instituted 
industry-led culls of badgers in two areas of the West Country in 2013.  Today 
(2018) culling has been licensed on 32 sites constituting 39% of the High Risk HRA 
and 2% of the EA. This includes one licence recently granted in Cumbria to 
eradicate a pocket of infection in both cattle and badgers in the LRA. 
6.5. A non-lethal alternative to controlling bovine TB is vaccination.  A number of 
projects involving catching and injecting badgers with BCG vaccine are underway in 
England, Wales and the island of Ireland.  Biosecurity measures aimed at reducing 
badger and cattle interactions are relatively low cost and strongly encouraged by 
Defra though there is a poor evidence base for the effectiveness of individual 
interventions.  
Rationale for action on wildlife 
6.6. Given a pathogen is present in farmed livestock and wildlife there are three possible 
epidemiological scenarios (see also ¶¶ 2.9 – 2.15).  First, the wildlife species may 
be a ‘spillover’ host, only infected because of the disease in livestock and not 
contributing to further infections of livestock.  Control of the disease in wildlife is in 
this case irrelevant to farming.  Second, there may be transmission between 
livestock and wildlife but the disease is not self-sustaining in the wildlife species 
alone.  Control measures directed at wildlife are in this case helpful but not 
essential to eliminating the disease in the long term.  The third scenario is as the 
second, except that the infection is self-sustaining in wildlife.  In this case the 
disease cannot be eliminated in livestock without control measures directed at the 
wildlife species (in the absence of a perfect cattle vaccine or other equivalent 
measure to completely stop transmission from wildlife).   
6.7. There is a scientific consensus that badgers can transmit bovine TB to cattle.  The 
RBCT is the most important replicated and controlled study to date and it showed 
that proactive (widespread, repeated) badger culling led to a reduction in confirmed 
(OFTW) herd breakdowns inside culling areas compared to unculled areas (Fig. 
6.1).  The results of the RBCT are broadly consistent with findings from smaller and 
less well controlled experiments in the UK and RoI.  Recent case studies using 
whole-genome sequencing of M. bovis in new outbreak foci have demonstrated 
transmission from cattle to badgers.  There is no scientific consensus about 
whether the disease is self-sustaining in badgers.  Furthermore, given the difficulty 
of researching this question, we do not believe it will be answered definitively in the 
foreseeable future. 
6.8. The RBCT also showed an increase in confirmed (OFTW) herd breakdowns in 
areas surrounding the proactively culled areas (taking the culled and surrounding 
areas together there was still an overall net benefit but this is less than indicated by 
reductions in herd breakdowns within the culled areas alone).  This increased risk is 
hypothesised to result from perturbation: culling disrupts the badgers’ social 
structure, causing individuals to range more widely.  Multiple studies have 
demonstrated behavioural perturbation but the RBCT is the only evidence that 
perturbation has an epidemiological effect on disease in both cattle and badgers.  
To reduce the impact of perturbation, the current industry-led culls in the HRA are 
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mandated to cover a minimum geographic area (100 km2) and (as in the RBCT) to 
utilise natural boundaries (coastline, rivers) as much as possible.53 
6.9. Badgers can be vaccinated against bovine TB using an injectable BCG vaccine 
approved in 2010.  There is also ongoing research on the potential for oral 
vaccination using baits but this has not progressed to a stage where there is a 
product ready to be tested for licensing. Vaccination provides some but not perfect 
protection against infection but does not cure an existing infection, and we do not 
know the duration of immunity.  Because of this and the need to inoculate new 
cubs, repeated annual vaccination campaigns are thought necessary. It has been 
shown that vaccinating adult badgers can reduce the risk of infection among 
unvaccinated cubs in the sett.  Vaccination protects the individual animal (direct 
protection) but by reducing the rate of transmission it can also reduce the risk of 
badger-to-badger transmission to unvaccinated badgers (indirect protection). There 
have been no large-scale trials of the impact of badger vaccination on disease risk 
in cattle comparable to the RBCT. 
6.10. Were a field test available that would allow rapid, accurate diagnosis of infection in 
badgers, a policy of culling infected and vaccinating uninfected animals would be 
possible.  This strategy has been explored in Wales using the DPP (see Chapter 2) 
antibody test54.  Of five badgers that tested positive and were culled, more sensitive 
laboratory tests showed at most one was infected (and subsequent analysis of 35 
blood samples suggested two potential false negatives).  Results are not yet 
available for a five-year ‘test and vaccinate or remove project’ (2014-2018) in 
Northern Ireland with approximately 300 badgers trapped each year55. 
6.11. Badger numbers could also be reduced (though with a substantial time delay) by 
controlling their fertility.  For example, the possibility of immunocontraception has 
been considered but not tested at scale. This would involve the use of a vaccine to 
generate an immune response to some key component of the reproductive system 
for captured female badgers. The development of ‘single-shot’ injectable vaccines 
has improved the potential for practical application in the field. 
6.12. Estimating badger density is challenging due to their nocturnal behaviour and 
because they spend a lot of time underground. There are an estimated 485,000 
(95% CI 391,000-581,000) badgers in England and Wales and some suggestion 
that numbers have increased in recent years.56 Techniques available for estimating 
local badger numbers are labour intensive (relying on the frequency of recapturing 
marked or genetically identified animals) or indirect and relatively inaccurate 
(counting setts and multiplying by a simple badgers-per-sett scaler).  They require 
quite demanding assumptions to be made about badger movement and behaviour, 
and they produce estimates with broad confidence intervals making monitoring of 
badger density reduction programmes difficult. 
                                            
53 The minimum size was originally 150km2 but was lowered to 100km2.  The rationale for this change is 
given in paragraphs 3.13-3.15 of Defra’s 2015 consultation on guidance to Natural England on 
licences to control the risk of bovine tuberculosis from badgers: https://consult.defra.gov.uk/bovine-
tb/licences-to-control-tb-from-badgers/  
54 https://gov.wales/docs/drah/publications/180712-delivery-of-badger-trap-and-test-operations-2017-report-
en.pdf - Animal & Plant Health Agency (APHA) report on the delivery of badger trap and test 
operations on chronic TB breakdown farms in Wales in 2017 (TBOG0135) 
55 https://www.daera-ni.gov.uk/articles/test-and-vaccinate-or-remove-tvr-wildlife-intervention-research  
56 Judge et al. 2017 https://doi.org/10.1038/s41598-017-00378-3  
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6.13. The Protection of Badgers Act 1992 makes it illegal without licence to kill or injure a 
badger, and to disturb or damage a sett.  Licences to cull or vaccinate in England 
are issued by Natural England.   
6.14. TB has been recorded in other wildlife species in the UK.  Of these, the most 
important is probably deer, but foxes and boar have been found to pose risks 
elsewhere in Europe, with a single feral boar found to be positive in the UK57. We 
currently have limited information about any risk of these infections to cattle. 
However, data from nearly 1,000 foxes demonstrated that they had much lower 
prevalence than badgers58. Furthermore, given the large reductions in risk achieved 
by proactive badger culling within culling areas in the RBCT, and that we know 
infection is transmitted between cattle, any contribution from other wildlife must be 
limited, at least on a regional scale. 
6.15. Amongst high-income countries, there is a correlation between the persistence of 
bovine TB as a livestock disease and the presence of wild and feral animal 
reservoirs.  Successful campaigns against bovine TB in Australia and Michigan, 
USA targeted infections in feral water buffalo and white-tailed deer respectively.  In 
New Zealand, the introduced brush-tailed possum (Trichosurus 62ulpecula), itself a 
pest, is an important reservoir and the object of an active eradication campaign.   
Current policy 
6.16. Culling in England is currently carried out by industry-led groups, licensed by 
Natural England. The criteria to obtain a licence to cull are: (i) compliance of 
farmers with TB statutory controls, (ii) “reasonable” biosecurity, (iii) an area of at 
least 100 km2, (iv) high TB risk (HRA or EA), (v) limited (no more than ~10%) land 
inaccessible for culling, (vi) “reasonable” measures to protect non-participants, and 
(vii) sufficient funding to undertake four years of culling.59 Defra advises Natural 
England on the minimum and maximum cull numbers for each cull with the aims of 
removing at least 70% of the badger population while ensuring a viable population 
remains.  
6.17. In 2013, two sites were licensed in Gloucestershire and Somerset. One further area 
(Dorset) was licensed in 2015, seven additional areas in 2016, eleven additional 
areas in 201760 and eleven additional areas in 201861.  Annex 6 summarises the 
number and distribution of current and approved cull sites, and the number of 
badgers culled each year.  There is currently a limit (ten) on the maximum number 
of new areas that can be licensed per year though Defra has announced (July 
                                            
57 Martin-Atance et al. 2005 https://doi.org/10.7589/0090-3558-41.2.435 (Spain).  
Michelet et al. 2018 https://doi.org/10.3201/eid2406.180094 (France).  
Amato et al. 2017 https://doi.org/10.1111/tbed.12776 (Italy).  
Madeira et al. 2017 https://doi.org/10.1111/tbed.12439 (Portugal).  
Perez de Val et al. 2017 https://doi.org/10.1111/tbed.12368 (Spain).  
Foyle et al.  2010 http://dx.doi.org/10.1136/vr.c2681 (UK) 
58 Bovine Tuberculosis in Cattle and Badgers, The Independent Scientific Review Group 1997 Table 2.2 
59 https://www.gov.uk/government/publications/guidance-to-natural-england-preventing-spread-of-bovine-tb – 
Defra, Guidance to Natural England Licences to kill or take badgers for the purpose of preventing the 
spread of bovine TV under section 10(2)(a) of the Protection of Badgers Act 1992. Criteria to obtain 
a licence for supplementary badger disease control or for a licence for badger control in the Low 
Risk Area are defined separately.  
60 https://www.gov.uk/government/publications/bovine-tb-authorisation-for-badger-control-in-2017  
61 https://www.gov.uk/government/publications/bovine-tb-authorisation-for-badger-control-in-2018  
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2018) that this limit will be kept under review62.  Authorisation has been granted in 
2018 for supplementary culling operations in Gloucestershire and Somerset63.  
6.18. The total cost of current culling operations is estimated to be £0.6 million per area 
over four years (see Table 6.2 below for a further breakdown).64   
 
Table 6.1: Breakdown of costs of badger culling per area (over 4 years) 
Natural 
England 
Processing licence applications and 
monitoring compliance with licence conditions 
£116k  
APHA Training, mentoring and advice £140k  
Defra Equipment (e.g. communications and 
positioning) 
£20k  
Police Maintaining public order and safety £210k  




6.19. Analysis of herd breakdowns in the two years following the start of the initial 
industry-led culls showed a 58% (95% CI 49-66%) reduction in herd breakdowns in 
the Gloucestershire cull area and a 21% (95% CI 13-28%) in Somerset65.  In 
Somerset, a significant 38% (95% CI 9-75%) increase in herd breakdowns was 
found in the 2 km buffer area surrounding the cull site but not in Gloucestershire 
(9% reduction, 95% CI 23% reduction – 7% increase).  These results are 
qualitatively consistent with those of the RBCT. Annual TB monitoring data and 
results for each badger control licensed area and their buffer areas up to the end of 
2017 have recently been published which appear consistent with the earlier results 
(full analysis is underway and will be published later in the year)66.  
6.20. In May 2018, Defra announced that culling will be allowed in the LRA in the rare 
event that disease in badgers is linked with infected herds67. The objective is to 
stamp out infection quickly and prevent further spread within wildlife and cattle. One 
such licence has been granted for culling in 2018 over an area of 190 km2 in 
Cumbria.  
                                            
62 An additional area was licensed in 2017 and 2018 as permitted in the licensing guidance to Natural 
England.  
63 Supplementary culling enables farmer-led licensed badger control in England to continue, to preserve the 
disease control benefits expected in areas where successful culls have been completed over at least 
four years. 
64 https://www.gov.uk/government/publications/bovine-tb-badger-control-policy-value-for-money-
analysis/badger-control-policy-value-for-money-analysis-2018    
65 Brunton et al. 2017 https://doi.org/10.1002/ece3.3254  
66 https://www.gov.uk/government/publications/bovine-tb-incidence-of-tb-in-cattle-in-licenced-badger-control-
areas-in-2013-to-2017   
67https://www.gov.uk/government/publications/guidance-to-natural-england-preventing-spread-of-bovine-tb  
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6.21. Culling has been the subject of several judicial reviews. These have largely centred 
round the interpretation of statutory powers, the procedural correctness of 
consultations and the accuracy of cost-benefit analyses underpinning decisions 
related to the culling operations. Further details are included in Chapter 2, Appendix 
2. 
6.22. The Badger Edge Vaccination Scheme (BEVS) was set up to promote vaccination 
in the EA where the possibility that badgers may be contributing towards the spatial 
spread of the disease is of particular concern.  The initial scheme in 2014, which 
supported six volunteer groups, was suspended the following year because of 
global BCG vaccine supply problems.  The scheme was relaunched in 2017 (BEVS 
2) when vaccination in three areas was licensed and is now underway. A small 
number of privately funded vaccination groups have been licensed and operate 
independently of the BEVS. 
6.23. There is currently no systematic surveillance of bovine TB in wildlife.  Some 
surveying occurs during the investigation of new foci, in particular in the LRA, and 
as part of specific research projects. 
6.24. In the RoI, herd breakdowns with three or more reactor cattle are investigated by a 
state veterinarian and if infection by badgers is suspected, and badger activity and 
the presence of setts found, a trapping programme is initiated. Badgers within a 2 
km radius of the affected farm are trapped and culled, with the aim of reducing 
badger densities to 0.5 badgers km2 (average pre-cull densities in farmland are 2-3 
badgers km2).  
6.25. Beginning in 2009, the RoI carried out large field trials of a BCG vaccine in badgers 
given orally in a lipid formulation. They showed that vaccination confers protection 
to badgers and reduced incidence rates in badger populations exposed to the 
disease68.  These results were consistent with those observed in England using 
intramuscular injection of a BCG vaccine (BadgerBCG)69.  In 2018, a policy was 
announced of replacing culling by BCG vaccination by injection in areas where 
badger densities had been reduced.  This is starting in the field-trial areas and will 
be extended to other parts of the country.  Culling may still be used in cases of 
serious and persistent breakdowns. 
6.26. In 2014, Northern Ireland began a five-year research project to describe the effects 
of implementing a ‘Test and Vaccinate or Remove’ intervention on badgers, in an 
area of high badger and cattle density and with high levels of bovine TB in cattle. In 
addition, it will quantify costs and field logistics of implementation. A single 
intervention area in County Down (about 100 km2 in size) will be compared with a 
number of similarly sized ‘control areas’. The field activities will conclude in late 
2018, with the project anticipated to report in late 2019. In Wales, there is an 
ongoing project to explore the feasibility of catching badgers and then culling or 
vaccinating depending on the results of a bovine TB test performed in the field (see 
¶ 6.10).   
                                            
68 Gormley et al. 2017 https://doi.org/10.1371/journal.pone.0168851  
69 Chambers et al. 2011 https://doi.org/10.1098/rspb.2010.1953 Carter et al. 2012 
https://doi.org/10.1371/journal.pone.0049833  
65 
Options for the future 
Continuing with current policy. 
6.27. We interpret current policy as encouraging industry-led culling campaigns in the 
HRA and EA, potentially relaxing the limit on the number of new culling areas 
allowed per year.  Ultimately all parts of the HRA and EA where the required 
majority of landowners were willing to take responsibility for culling would, over 
time, be included.  
6.28. Evidence from the RBCT and initial analyses of the industry-led culls indicate that 
current policy would reduce the number of herd breakdowns, compared to not 
culling.  Whether culling in addition to current cattle controls can reverse the 
increasing trend in bovine TB in England is not known, but it does represent an 
important option to help in controlling the disease. 
6.29. It is likely that the farming industry would be more willing to accept other 
interventions that could negatively affect dairy and beef profitability if they believed 
that the threat of transmission from badgers was being robustly addressed. 
6.30. The implications of scaling up badger culling operations over time would be an 
increase in the costs set out in Table 6.2. Costs might not increase in direct 
proportion to the number of areas. It is a shared goal of Defra and the Home Office 
that policing duties should eventually become a normal activity and so not incur 
additional costs, though this does assume that the frequency of protests and direct 
action (including illegal activity) will decline. Costs to government and industry are 
likely to decrease, as lessons are learnt and efficiencies or improvements are 
identified and implemented. 
6.31. Were culling to be extended to the majority of the HRA and EA then the number of 
badgers culled per year would rise substantially from today’s numbers. If there were 
40 cull areas in operation (based on 10 new areas per year and 4 years of culling in 
the first instance), then we might expect roughly 40,600 badgers to be culled each 
year70 (roughly 8% of the estimated badger population in England, see ¶ 6.12).  For 
comparison, 10,979 badgers were culled over the course of the RBCT between 
1998 and 2005 (including both proactive and reactive culling). This ongoing level of 
lethal control would not be acceptable to some (possibly large) sections of the 
public, and the costs of policing could be substantial. 
6.32. Current policy is to reduce badger density by at least 70% but estimating badger 
densities is difficult and inaccurate (¶ 6.12). It is unclear the degree to which region-
wide badger culling would affect the viability of the species in these areas and what 
the large-scale ecological effects would be.   
6.33. Reducing badger numbers will have consequences for other species in the local 
area.  Culling in the RBCT (which was limited to 100 km2 areas) was associated 
with increased numbers of foxes and hedgehogs71.  Badgers are omnivores (with a 
particular preference for earthworms) and inhabit highly modified farmland 
ecosystems.  Reducing their densities will have complex direct and indirect 
ecological effects with some species increasing and others decreasing in 
abundance. 
                                            
70 Extrapolating from the average of 1014 badgers culled per area in 2017 in areas 3-21; areas 1 and 2 were 
excluded from this calculation as undergoing supplementary culling, see Table 6.3 
71 Trewby et al, 2008 https://doi.org/10.1098/rsbl.2007.0516 
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6.34. The requirement that farmers come together and co-finance culling campaigns can 
cause tension when some farmers feel pressurised to agree to culling, and those 
that do not are viewed as free-riding.  Culling is not possible in some areas where 
major landowners (for example the National Trust) have policies not to permit it. 
One possibility would be for badger vaccination to be conducted within cull areas on 
farms or areas where culling is not accepted.  
6.35. The potential for perturbation to increase the risks of herd breakdowns in adjoining 
areas is a particular issue in the EA because of the importance of preventing the 
spread of bovine TB into the adjoining LRA.  The presence of physical barriers, 
limiting or preventing badger movement into adjacent areas, is an example of an 
argument in favour of allowing culling in a particular part of the EA. 
6.36. Herd breakdowns, typically caused by the importation of infected cattle, occur 
periodically in the LRA72.  Stopping the disease from becoming established in these 
areas and spreading further is a priority and Defra has already announced it will 
allow industry-led culling campaigns in these circumstances. The geographic extent 
of the cull should be large enough to reduce the possibility of further spread of 
infection through any perturbation effect (see ¶ 6.8). 
Stopping culling (without the introduction of other wildlife control measures) 
6.37. Stopping culling would cease the killing of a wild animal and address the concerns 
of a sizeable constituency that believes it is unacceptable.  
6.38. It would achieve substantial savings in terms of licensing and surveying.  
Depending on the future extent and nature of action to disrupt culling it would save 
on policing costs. Culling expenses would be saved, benefitting the industry locally.   
6.39. Stopping culling (without the introduction of other measures) would mean that an 
important source of transmission to cattle would not be addressed.  To achieve a 
comparable reduction in incidence in cattle more stringent interventions to reduce 
transmission between cattle would be required than if culling were allowed, which 
would negatively affect industry. If bovine TB can persist in badger populations 
(which is not known, ¶ 6.7) then the risk of transmission from wildlife would remain 
unless a fully protective cattle vaccine were to become available. 
6.40. There are no proven biosecurity measures to protect herds and give farmers 
confidence their herds are protected.  The willingness of the dairy and beef industry 
to cooperate with other disease control measures might be reduced if a proven 
source of infection is not tackled. 
Stopping culling and replacing by vaccination 
6.41. As in the last option, stopping culling would cease the killing of a wild animal and 
address the concerns of a sizeable constituency that believes it is unacceptable. 
6.42. Vaccination does not remove infectious badgers from the countryside and so does 
not immediately affect the risk to cattle.  However, over time vaccination will reduce 
the number of badgers that contract the disease. We would expect that this would 
yield some reduction in the risk of badger-to-cattle transmission though this effect 
has not been measured. Even if bovine TB can persist in badger populations then 
                                            
72 https://www.gov.uk/government/publications/bovine-tb-epidemiology-and-surveillance-in-great-britain-2016  
(page 109) 
67 
vaccination has the potential to reduce transmission so that in the absence of 
transmission from cattle the disease in time dies out, though this is not certain.   
6.43. Laboratory studies with captive badgers have shown that BCG vaccination by 
injection reduces TB lesions caused by M. bovis infection73.  Field studies involving 
BCG vaccination of over 800 wild badgers resulted in an approximately 74% 
reduction in the proportion of badgers testing positive to the antibody blood test for 
infection in badgers74. However, as the blood test is not an absolute indicator of 
bovine TB infection, these results cannot be taken as a reliable measure of vaccine 
efficacy.  The field study also showed an indirect protective effect of BCG 
vaccination on unvaccinated cubs born into vaccinated social groups if more than a 
third of the adults within the social group were vaccinated75. 
6.44. Vaccinating badgers with injectable BCG requires them to be trapped and handled 
by trained personnel.  Costs in the BEVS have been reduced through voluntary 
labour but it is unlikely that this could scale up to a national programme. As badgers 
must be vaccinated annually (including both revaccination of individuals and 
vaccination of newly trapped individuals) on-going costs are likely to be substantial 
(one estimate puts this at £2,250 per km2 per year)76. Consideration could be given 
to reducing costs using alternative capture methods, subject to careful 
consideration of the welfare (and potentially health and safety) impacts of these 
methods compared to those of currently used badger traps77. 
6.45. It is not clear what level of industry buy-in could be achieved without evidence of the 
impact of badger vaccination on the incidence of bovine TB in cattle.  Testing the 
impact of vaccines is thus of great importance.  There is an argument that if 
vaccination replaces culling motivated by reasons other than efficient disease 
control, then the state should shoulder more of the expense.  
6.46. It is not certain whether a viable and cost-effective oral vaccine (using baits) could 
be developed.  Were it possible, the costs of trapping and handling badgers might 
be avoided.  However, distributing baits to ensure sufficient badgers are vaccinated 
may be difficult and require large number of baits containing high doses of BCG. It 
would be important to ascertain whether cattle that consumed oral vaccine would 
test bovine TB positive. 
Stopping culling and replacing by fertility control 
6.47. This option shares with vaccination the advantage of avoiding killing a wild animal, 
as well as the disadvantages of not removing infected animals immediately and the 
expense of a continuing campaign of badger capture and handling.   
6.48. Reliable fertility control for badgers is not currently available although research 
continues to test potential options. A study in 2015 explored the use of an injectable 
immunocontraceptive vaccine, GonaCon, to generate infertility in badgers. This led 
                                            
73 Lesellier et al. 2011 https://doi.org/10.1016/j.vaccine.2011.03.028  
74 Chambers et al. 2011 https://doi.org/10.1098/rspb.2010.1953  
75 Carter et al. 2012 https://doi.org/10.1371/journal.pone.0049833  
76 Defra Impact Assessment 2011: Measures to address bovine TB in badgers 
https://www.gov.uk/government/publications/measures-to-address-bovine-tuberculosis-in-badgers-
impact-assessment  
77 Defra report (2005) - Review of effectiveness, environmental impact, humaneness and feasibility of lethal 
methods for badger control” discusses badger restraint methods. 
http://webarchive.nationalarchives.gov.uk/20081108133322/http://www.defra.gov.uk/animalh/tb/isg/p
df/final_report.pdf     
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to an immediate fall in cub production, but the effects of the vaccine declined in the 
second and third breeding seasons78. Further testing in the field to explore its 
potential as a tool for badger control, to understand the potential interaction 
between the efficacy of BCG and GonaCon, and to incorporate a vaccine into a 
self-administered bait have been identified as next steps to assess this 
intervention’s viability.  
6.49. Naturally occurring reproductive suppression in badgers limits the number of 
females that breed, but more than 75% of adult females carry blastocysts (very 
early stage embryos) each year and can potentially breed.  It is likely that a high 
proportion of females would need to be caught and treated before population 
numbers began to decline, increasing costs and logistic requirements. 
6.50. It is not clear how low the population needs to be before transmission to cattle is 
affected (as in culling). Given the increased ranging of badgers observed in areas 
subjected to culling, the effectiveness of fertility control could vary depending on the 
culling history of the local area. 
Periodic intensive culling  
6.51. Current badger culling licences last for four years though supplementary culling 
beyond this period has been approved in two areas (¶ 6.17).  Continuous culling 
obviously results in more badgers being culled but there are also arguments for 
periodic culling with a pause between campaigns. 
6.52. There is evidence from the RBCT that the greatest benefits from repeated, 
widespread culling occur in the first two years after culling is stopped (Figure 6.1).  
This suggests that a periodic culling regime might have the same disease reduction 
effects at lower costs.  Such a regime would involve culling for four years, not 
culling for two, and then resuming culling again. Badger populations would increase 
during the break in culling so when it resumes it would need to be more intensive 
than the maintenance culling assumed in the supplementary cull licences.  It is thus 
not clear how many fewer badgers would be killed with periodic culling, compared 
to four years of culling plus supplementary culling. 
6.53. These arguments are based on analysis of the RBCT, and though this is the best 
experimental study of the consequences of culling, it is not certain that the detailed 
pattern of herd breakdowns it found can be extrapolated to culling carried out in a 
different way. It is not possible to say what would have happened in proactively 
culled RBCT areas had they all been culled continuously for seven years. However, 
it is clear from the data that substantial post-cull benefits were achieved during 
years in which no culling costs were incurred.  
6.54. A two-year pause in culling after the initial four years would lead to savings in 
operational costs for the industry-led consortia running the culls.  Setting up these 
consortia involves logistical and financial challenges, in particular around obtaining 
legal and financial commitments from local farmers.  If periodic culling were 
implemented, it would be important to ensure that this did not result in extra 
regulatory and compliance burdens on the consortia that might reduce rates of 
participation and incur extra costs. 
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Figure 6.1 – Key results from the Randomised Badger Culling Trial, as summarised in 
Godfray et al. 2016 (https://doi.org/10.1098/rspb.2013.1634 ) 
 
Using culling to reduce badger densities and then replacing with vaccination 
(and/or possibly fertility control). 
6.55. Substantially reducing badger densities by culling over a large area means that the 
risk of transmission to cattle is reduced at the cost of continuing lethal wildlife 
control.  Once the lower density is reached, annual vaccination could reduce the 
likelihood of the badger population from becoming a similar threat again to cattle, 
even if the populations rebound.  Fertility controls could also potentially be 
introduced to prevent or reduce the extent of population rebound (with the 
challenges described in ¶ 6.47 et seq.). 
6.56. The advantages and disadvantages of culling, vaccination and fertility control 
applied singly also apply to this combined strategy (and its added complexity may 
be a further disadvantage).  The combination of using lethal control in the short term 
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while explicitly phasing out culling may be seen to be a compromise between 
groups arguing for and against culling (though still unacceptable to those who view 
culling as an absolute wrong).  
6.57. Were rapid and more accurate tests of badger infections in the field to become 
available, a variant on this strategy would be to test and cull any infected badger 
rather than vaccinate. This is currently being implemented with imperfect diagnostic 
tests on a small scale in Wales and in a 5-year trial in Northern Ireland (see ¶¶ 
6.26).  More evidence is required to assess the feasibility of this strategy. 
Comparing the benefits of periodic intensive culling and intensive culling followed 
by vaccination 
6.58. The absence of an estimate of the impact of badger vaccination on the incidence of 
bovine TB in cattle herds is a key information gap that hinders evidence-based 
policy-making.  For example, vaccination provides one of the few possible exit 
strategies from the policy of large repeated culls, yet we cannot say today whether it 
is feasible.  Modelling studies can provide some insights into this question, but 
cannot provide definitive answers because of our uncertainty about the underlying 
epidemiology.  We see it as very important to obtain new evidence on vaccination, 
though without compromising current control efforts. 
6.59. There are currently 31 large areas that have undergone at least one year of 
intensive industry-led culling.  Only two of these (Areas 1 and 2; Annex 6) have 
received supplementary culling following the initial four years of culling. There is an 
opportunity now to consider further the future of areas subjected to repeated 
intensive badger culls and to obtain evidence on the effectiveness of badger 
vaccination. 
6.60. In ¶¶ 6.51 – 6.54 we explain why we see periodic intensive culling as a more 
promising strategy than continuous culling beyond four years. If this argument is 
accepted, then we suggest that after the initial four-year intensive cull half the cull 
areas are allocated to vaccination and the other half to periodic culling.  The areas 
would be allocated randomly to the two treatments.  Vaccination would begin 
immediately and continue annually while culling would resume after the two-year 
pause. 
6.61. Herd-breakdown rates would be monitored in the two treatments to compare the 
effectiveness of culling versus vaccination.  Prior to the start of the trial ‘break 
points’ would be defined that would end the experiment (a procedure common in 
medical trials).  Thus, if the data showed vaccination was failing to provide sufficient 
protection by a predefined time it would be abandoned and culling resumed; 
conversely, if it provided comparable protection to culling then all areas would 
switch to vaccination. 
6.62. We envisage that, like the current industry-led 4-year culling programmes and the 
two examples of supplementary culling, the resumed culling would be funded and 
organised by local farmers. However, we think Government will need to fund the 
post-culling vaccination in these areas until sufficient evidence has been accrued 
robustly to inform a decision on the superiority of either approach. While this is an 
additional funding burden for the state, it should be viewed as an investment to 
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provide an expanded evidence base to inform future policy.  Ministers will need to 
decide on whether this investment is justified. 
Farm-led culling 
6.63. In Chapter 9 we explore the possibility of farmers being asked to take more 
responsibility for disease control on their premises and restricting the role of 
government to statutory testing and empowering farmers to act.  As part of this 
reassignment of responsibilities farmers could conceivably be allowed to apply for 
individual licences to control badgers on their premises (subject to appropriate 
welfare standards).   
6.64. Because decisions to cull badgers would be made by farmers with a detailed 
knowledge of the local cattle population and its risks, the control would be more 
targeted and cheaper.  The total number of badgers killed would likely be lower than 
in area-wide culling, although this would depend on the number of farms 
undertaking culls. 
6.65. It is known that culling causes disruption of badger social structure and data from 
the RBCT suggests that this can lead to increased herd breakdowns in the areas 
surrounding a large-scale cull (¶ 6.8).  There is thus a risk that farm-led culling 
might cause the dispersal of infected badgers and herd breakdowns on 
neighbouring properties and so it would only be possible if farmers could not be 
held responsible for local herd breakdowns.  There has been no specific experiment 
to test the effect of farm-led culling but analysis of data collected in high-risk areas 
as part of the RBCT provides no support to the idea that small-scale culling might 
reduce risk to local cattle, suggesting instead an increased risk.   
Research priorities 
6.66. It is not clear what drives the ongoing spread of bovine TB into the EA.  
Epidemiological analysis, informed by genetic analysis of M. bovis samples from 
infected cattle and from infected badgers detected in surveillance studies, is a 
research priority to understand this.  The work will benefit from the application of 
recent advances in whole-genome sequencing and analysis (and its reduction in 
costs).    
6.67. Better understanding of the prevalence of infection in badger populations in different 
areas could inform prioritisation of areas to receive interventions to limit badger-to-
cattle transmission.  It could also provide insight into differences observed in the 
impacts of badger culling on local TB incidence in cattle, such as seen between 
Somerset and Gloucestershire79.  
6.68. Continuing research on optimising injectable BGC vaccines in badgers is important.  
Analysis of the outcomes of badger vaccination programmes in the RoI and 
Northern Ireland, and the incorporation of lessons learnt into English bovine TB 
strategy, is a very high priority. Though the feasibility of oral vaccination using baits 
is less clear, research supporting new approaches and into methods of avoiding 
cattle eating oral vaccines should be considered. 
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6.69. Initial work on an immunocontraceptive for badgers in 2016 established an initial 
proof of principle80. Further investment may be justified as new approaches are put 
forward. 
6.70. Ecological studies of the consequences of reducing badger densities (by culling or 
fertility control) on other species (for example foxes81) should be undertaken given 
the key roles played by badgers in their local ecosystems. 
6.71. The social attitudes to culling in the farming community should be understood.  In 
particular, does control of badgers (whether through culling, vaccination or fertility 
control) incentivise better biosecurity or the reverse?  Within the RBCT, farmers all 
knew whether they were in a culling area or not so the effects observed would have 
included any impact of culling on the local farmers’ behaviour. Were farmers in 
culling areas to relax biosecurity, thinking the risk is already reduced, then the full 
potential of culling to control disease would not have been observed. The same 
applies to all badger-related control measures. 
Chapter 7: Non-bovine farmed animals 
Introduction 
7.1. Non-bovine farmed species, including deer, goats, South American camelids 
(SACs: alpacas and llamas), pigs and sheep, are susceptible to M. bovis infection 
to varying degrees. The reported incidence of the disease in these species is very 
low (¶ 7.20), and the risk of them passing on the disease to humans, cattle and 
wildlife is generally considered to be low. 
7.2. There is no statutory bovine TB surveillance programme in place for these species, 
but there is a duty to notify to APHA the suspicion of bovine TB in carcases or 
identification of M. bovis in samples taken from carcases or live animals. There is a 
statutory duty on keepers and veterinarians to notify suspicion of bovine TB in live 
deer. 
7.3. For deer, goats, pigs and sheep, the risk of human infection is through close contact 
with infected animals or their carcases (respiratory and cutaneous transmission) 
and, in the case of dairy goats and sheep, consumption of unpasteurized milk 
(digestive transmission).  For SACs, the risk of human infection is from close 
contact (mainly through spitting). Human cases of M. bovis infection contracted 
from non-bovine farmed animals are very rare.    
7.4. Because there is no statutory surveillance programme for these species, there is 
uncertainty around the true prevalence of infection. The Advisory Committee on 
Dangerous Pathogens M. bovis Working Group82 has advised that should M. bovis 
cases in non-bovine species at slaughterhouse increase in frequency, then the risks 
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should be reviewed.  There has been no consistent increase in the frequency of M. 
bovis infection detected in these species at slaughterhouse between 2011-2017 
(see Table 7.1).  
Table 7.1: Animal specimens that were culture positive for M. Bovis 
 Species 2011 2012 2013 2014 2015 2016 2017 
South American Camelids 17 45 36 34 39 20 30 
Sheep 35 20 3 1 7 2 4 
Goats 0 2 7 29 0 27 7 
Pigs 44 20 35 18 23 31 24 
Deer 23 17 27 24 34 29 29 
Other  22 12 30 26 42 30 11 
 
7.5. Domestic pets can be infected with M. bovis, but again cases are thought to be 
rare. The risk of infection to these species comes from ingestion; for example, 
drinking unpasteurised infected cow’s milk, eating carcases of infected animals, and 
direct or indirect contact with infected farm animals or wildlife (badgers or, in rare 
cases, deer).  
Rationale for action on other farm-managed species 
7.6. Recent veterinary risk assessments83 conclude that non-bovine farmed animals in 
the UK are largely ‘spillover’ hosts: individuals are at risk of becoming infected from 
the major carriers of M. bovis, mainly in areas of the country where M. bovis 
infection is known to be endemic.  Non-bovine species vary in the extent to which 
the disease is able to persist in their populations. Given the right conditions, they 
can also infect other animals and herds of the same species (e.g. via movements of 
undetected infected animals between holdings). However, the current consensus is 
that bovine TB in non-bovine farmed animals and pets would gradually disappear if 
the infection could be brought under control in cattle and badgers.  
7.7. There is uncertainty about the true prevalence of M. bovis infection in non-bovine 
farmed animals because data come chiefly from slaughterhouse inspection and 
post mortem examinations in veterinary laboratories which, as in cattle, have a 
relatively low sensitivity compared with live testing. However, the presence of 
potential non-bovine hosts on (or near) cattle farms affected by bovine TB 
breakdowns is of concern for disease control.  
7.8. Except where noted below, the SICCT test (¶ 2.24) is used to test for bovine TB in 
other farmed animals though currently it is only internationally recognised for use in 
                                            
83 https://consult.defra.gov.uk/bovine-tb/tb-in-non-bovine-farmed-animals-call-for-views/ 
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deer, goats and SACs. In species where skin testing is difficult, such as pigs and 
farmed deer, the results of slaughterhouse post mortem examinations may be taken 
into consideration when decisions are made on whether to lift restrictions from 
infected herds.   
7.9. SACs tend to be kept on dedicated farms and purchased at specialist and direct 
farm-to-farm sales. Most incidents of bovine TB in SACs in England (see Table 7.2) 
occur in the HRA and the EA. Cases of bovine TB transmission within and between 
SAC herds have been recorded, but not to other animals (except, very rarely, to 
humans in close and frequent contact).  There is no mandatory requirement to 
identify, register or report SAC movements in GB.  Some infected animals display 
extensive and severe pathology and can be highly infectious.   
7.10. Pre-movement testing (SICCT or SICT, ¶¶ 2.24 & 2.25) is required when trading 
SACs between EU member states and most third countries. However, skin tests 
perform poorly in SACs and bovine TB has been difficult to diagnose in live animals 
until recently. New serological tests have been validated by APHA, and are now 
approved for use in the UK in conjunction with the skin tests and, in some cases, as 
standalone tests.  
7.11. Deer are susceptible to bovine TB and low levels of infection have been detected in 
farmed deer in the UK (see Table 7.2), mainly in the HRA and the EA.  Deer are 
moved from parks and farms to provide breeding stock for new or existing herds or 
for finishing, or from farms to specialist slaughterhouses, though in much smaller 
numbers compared with cattle. Deer must be moved under licence with animals 
identified using an ear tag. Surveillance entails compulsory notification of suspect 
clinical cases and passive surveillance at slaughterhouses.  Cases of bovine TB 
transmission between deer herds through infected animal movements have been 
recorded in the UK, and experimental studies have shown that the disease can be 
transmitted from deer to cattle, with free-ranging and captive deer implicated in the 
spread of bovine TB in cattle in the USA, Canada, RoI and New Zealand (EFSA 
2008)84. The SICCT is used to test for bovine TB in deer with a minimum between-
test interval of 120 days. 
7.12. Data suggest that the prevalence of bovine TB in goats is low (Table 7.2). There are 
some large commercial milking herds but many goats are kept on hobby farms or 
as pets. Goats are longer-lived than cattle, increasing the risk of disease 
progression and transmission within herds. This has led to a small number of 
serious (‘explosive’) bovine TB incidents involving large commercial dairy goat 
herds in the HRA.  Movements of goats to or from farms must be recorded. 
Surveillance relies on compulsory notification when disease is suspected in 
carcases, post mortem reports, passive surveillance at slaughterhouses and 
targeted skin testing of goats adjoining or co-located with cattle herds affected by 
lesion- or culture-positive bovine TB breakdowns. Goats kept as pets or in petting 
zoos pose a potential route of transmission to humans. 
Table 7.2: Non-Bovine Reactors slaughtered (England)85 
                                            
84 EFSA, 2008. Scientific report on „Tuberculosis testing in deer‟. Panel on Animal Health and 671 Animal 
Welfare, Question No. EFSA-Q-2006-179, Adopted on 30 January 2008. Annex to the 672 EFSA 
Journal 645, 1-34. 
85 https://www.gov.uk/government/statistical-data-sets/other-tb-statistics  
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 Species 2011 2012 2013 2014 2015 2016 2017 
South American Camelids 79 393 75 55 201 37 297 
Sheep 2 62 22 0 0 1 5 
Goats 2 2 165 431 1 755 4 
Pigs 3 5 8 3 0 16 0 
Deer 44 3 16 3 5  6 0 
Other (mainly pets [cats and dogs] and 
the occasional sample from exotic 
mammals kept in zoos, safari parks). 
0 0 0 0 0 0 2 
7.13. The reported incidence of bovine TB in sheep is very low (Table 7.2). There are no 
reports of sheep infecting other species of farmed animals and no evidence of 
disease spread from sheep to wildlife in the UK. Evidence suggests that sheep are 
only likely to become infected when the level of challenge is relatively high, and 
infection within the flock is unlikely to be sustained without contact with a local cattle 
or wildlife reservoir86,87. Clinical signs of disease are very rare in live sheep and 
surveillance relies on statutory post mortem reporting, isolation of M. bovis and 
slaughterhouse surveillance.  The SICCT test is used to test for bovine TB in sheep.  
7.14. The incidence of bovine TB in pigs caused by M. bovis infections has increased 
slightly in recent years in GB, but overall remains very low (Table 7.2). There is no 
evidence of spread of M. bovis from pigs to cattle. The majority of cases in pigs in 
recent years have been detected in areas of endemic bovine TB, caused by the 
same genotype of M. bovis as local cattle infections. With direct contact between 
pigs and cattle rarely reported, this suggests pigs are mainly infected by wildlife88.  
7.15. The number of tuberculous pigs found on the same infected unit is generally very 
low, which suggests limited within-herd transmission. The risk of disease entering 
the pig population is greatest for pigs raised in outdoor systems where there is 
greater opportunity for contact with M. bovis in wildlife, or on farms with limited 
biosecurity. However, pigs are susceptible to a number of highly contagious 
diseases, which has led the industry to adopt relatively strong biosecurity standards 
which will help mitigate risks from bovine TB.  
7.16. There is a statutory requirement to identify, register and report movements of pigs. 
These movements often occur as part of all-in-all-out (AIAO) management systems 
that keep animals together in groups closely matched by age, weight, production 
stage and condition. Animals from different groups are not mixed during their stay 
on the farm. AIAO systems are thought to reduce disease risks from other animals 
and the environment as individual barns or pens can be emptied and sanitized 
                                            
86 Cousins et al. 2001 Rev. sci. tech. Off. int. Epiz., 20, 71-8 
87 Marianelli et al. 2010 https://doi.org/10.1177/104063871002200319   
88 Bailey et al, 2013 https://doi.org/10.1016/j.tvjl.2013.08.035 
76 
between groups. The SICCT test can be used to test for bovine TB in pigs, though 
there is no legal requirement for testing in the context of international trade except 
for the export of germinal products to some third countries such as China.   
7.17. Sporadic incidents of bovine TB in non-bovine farmed animals have been 
documented in other countries; for example, goats and alpacas in Spain and RoI, 
and sheep in North-western Spain.  The OIE Terrestrial Code outlines the 
requirements for trade in non-bovine animals.  For countries without bovine TB-free 
status, a surveillance system must be in place as part of the regulation of live deer 
export.  For other species, a mandatory system of disease notification must be in 
place and exports should only be from bovine TB-free herds.  
7.18. Limited authorisation has been granted in the UK to use an inactivated MAP 
(Mycobacterium avium spp. paratuberculosis) vaccine (Gudair) in sheep and goats 
to help control Johne’s disease.  The vaccine may interfere with the interpretation of 
the SICCT and SICT tests for bovine TB as it tends to elicit a cross-reaction to M. 
bovis and M. avium tuberculins.  The vaccination status of the animal must be noted 
when testing sheep and goats for bovine TB; in the event of a bovine TB 
breakdown, decisions are taken on a case-by-case basis to account for this (for 
example, removing the animals as direct contacts, switching to more severe 
interpretation of SICCT results, or opting to use SICT tests).   
7.19. Only a very small number of M. bovis infections in pets, mostly cats, are recorded 
each year. Public Health England (PHE) has assessed the risk of cats spreading 
bovine TB to humans as very low.  
Current policy 
7.20. There are about 20 million non-bovine farm animals in England, the vast majority 
pigs and sheep. In 2017, 308 non-bovine animals were slaughtered as TB reactors 
or direct contacts.  High numbers of goats slaughtered in 2013, 2014 and 2016 are 
the result of APHA’s decision to undertake whole herd slaughter on individual large 
commercial milking goat herds with persistent and widespread bovine TB problems.  
7.21. There is no statutory surveillance programme for bovine TB in farmed non-bovine 
species equivalent to that in cattle and so there is uncertainty around the true 
prevalence of M. bovis infection in non-bovine farmed animals.  A voluntary 
surveillance scheme is in operation for SACs, mainly for individual animals moved 
between holdings.  There are no active bovine TB testing programmes for deer, 
pigs, goats or sheep though Defra and APHA have discussed with the pig and 
farmed deer sectors possible trials for the validation of bovine TB blood tests in 
those species. Validated blood tests could speed up the resolution of bovine TB 
incidents in species where skin testing is impractical or unreliable.  Testing (at 
government expense) is normally carried out in SACs, goats and captive deer co-
located with, or in close vicinity to, infected cattle; or which have been moved from 
premises where M. bovis infection has been confirmed by culture. 
7.22. There is a statutory duty immediately to notify to APHA the suspicion of disease in 
non-bovine carcases, in live deer, or when M. bovis is identified by laboratory 
examination of a sample from a live animal or carcase. Cases are usually identified, 
post mortem, through meat inspection or laboratory examination.  APHA places the 
remaining animals in the herd of origin under movement restrictions pending 
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bacteriological culture results. If those results are positive for M. bovis the affected 
herd is tested for bovine TB at government’s expense until testing or slaughter 
surveillance has demonstrated the absence of infection. Contiguous or radial 
targeted bovine TB testing takes place around such herds, directed by APHA.  
7.23. Since 2017 non-bovine animals removed by APHA for bovine TB control purposes 
in England attract statutory compensation payments at fixed rates, depending on 
the species and category of the animal89.  
7.24. Government works with various sectors groups to raise awareness among farmers 
of the risks of M. bovis infections in non-bovine species and measures that can be 
taken to reduce them. In 2016, Defra consulted on the need for more stringent 
interventions against the disease in non-bovines; for example, measures to 
enhance reporting and surveillance, and to require veterinary inspectors to 
investigate where there is suspicion of bovine TB in live animals or carcases.   
7.25. The consultation proposed additional steps to enhance disease control for non-
bovines through: (i) isolating animals and restricting movements, (ii) requiring 
operators of markets, shows etc. to manage risks posed by animals exposed to 
bovine TB, (iii) requirements for bovine TB testing at specified intervals, and (iv) 
applying rules and requirements for testing, treatment and vaccination to all non-
bovines.  Responses to the consultation raised concerns about the protection of 
rare breeds, and the efficacy of TB testing in pigs.  No changes in current policy 
have so far resulted from this consultation, except for the introduction of new 
statutory compensation rates for slaughtered non-bovine animals.   
7.26. In England, any live testing of domestic pets for bovine TB is voluntary and done at 
the owner’s expense. Tuberculin skin tests are unreliable in cats and dogs and 
there are no official validated blood tests for bovine TB in these species (an 
experimental IFNγ release assay for cats and dogs is offered on a commercial basis 
by an Edinburgh-based private diagnostic laboratory).  Defra and APHA strongly 
recommend the destruction of pets with confirmed M. bovis infections due to the 
lack of licensed drugs to treat infected animals and the protracted courses of 
antibiotics that would be required.  
7.27. APHA and PHE provide guidance on minimising the risk of human infection to 
keepers of non-bovine animals with confirmed M. bovis infections.  This review has 
not considered the issue of bovine TB in companion animals.  
Options for the future 
Continue with the current regime  
7.28. The incidence of bovine TB (M. bovis infections) in non-bovine farmed animals is 
considered relatively low based on the number of reactors slaughtered through 
passive surveillance (see Table 7.2).  Because there is no statutory surveillance 
system in place there is considerable uncertainty around the true prevalence of M. 
bovis infection in these species, but at present they appear to play an insignificant 
                                            
89 The Tuberculosis (Non-bovine animals) Slaughter and Compensation (England) Order 2017. 
(see: http://www.legislation.gov.uk/uksi/2017/1254/contents/made) 
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role in the transmission of M. bovis infection to cattle and badgers. This suggests 
that the costly interventions introduced for cattle, including routine surveillance 
testing, would be disproportionate.  Incidence remains fairly static in most species, 
but a number of premises have been subject to long-term restrictions. This places a 
burden on individual businesses.   
7.29. There is concern that because of the absence of regular testing there may be more 
infections in non-bovines than is currently appreciated though the number of 
observed cases from passive surveillance at slaughterhouse and veterinary 
laboratories does not appear to be going up.  Further, legislation for the control of 
bovine TB in non-bovine species has developed in piecemeal fashion, remains 
unconsolidated, and can be unclear to industry and challenging to enforce.  
Consolidation of legal provisions 
7.30. Consolidation of current rules, as suggested in the consultation on non-bovines in 
2016, to make a more coherent and transparent regulatory regime would make it 
simpler for businesses to comply and regulators to police and enforce. A unified 
bovine TB Order for non-bovines would set out rules and duties around (i) reporting 
suspicion of the disease; (ii) veterinary enquiry; (iii) government mandated and 
private testing; (iv) vaccination and therapeutic treatment; (v) biosecurity; (vi) 
movement and risk-based trading (vii) compensation, and (viii) financial 
responsibilities. 
Targeted measures where there is a risk of human infection 
7.31. Dairy sheep flocks and goat herds kept to produce unpasteurised milk and dairy 
products for human consumption, or non-bovine animals to which the public are 
exposed on petting farms, zoos or similar establishments, pose an infection risk to 
humans.  This could be reduced by annual testing of animals on such premises. 
7.32. Though the risk to humans is currently understood to be very low, the reputational 
risk both to the farming and recreational sectors involved are great and may justify 
such intervention.  Research and development of appropriate tests would be 
needed for species where a sensitive and specific validated test is not currently 
available. 
Introduce stricter controls on movements of non-bovines 
7.33. The introduction of the Livestock Information Service (Chapter 5) would facilitate the 
introduction of control measures for non-bovine species.  The inclusion of SACs 
would facilitate surveillance, tracing of contact animals and monitoring of movement 
testing. There have been some cases of secondary bovine TB incidents (including 
in the LRA) caused by movements of infected alpacas, goats and farmed deer from 
the HRA. Mandatory pre- and post-movement testing would reduce the risks of 
translocating bovine TB between herds via movements of infected SACs, managed 
deer and goats. Validated tests for bovine TB are available for these species. Such 
testing could be funded by the respective industries, as is presently the case for the 
movement testing of cattle.  
79 
Introduce stricter measures for bovine TB breakdowns in non-bovines  
7.34. In Chapter 3 we discuss means of ridding infections more quickly from cattle herds 
after a breakdown.  These measures could be applied, suitably modified, to non-
bovines, subject to cost-benefit analysis.  As with cattle this could help the farmer 
and reduce the risk of onward transmission of M. bovis infection.  Implementing this 
strategy would require the development of suitable validated tests for different 
species, where these do not currently exist (see also Research Priorities ¶ 7.37).  
Applying to non-bovine species the full range of bovine TB controls that currently 
apply to cattle 
7.35. Such interventions would clearly reduce the risk of bovine TB in species other than 
cattle.  However, the costs of introducing current cattle controls across all species 
would be very great for Government and place a substantial burden on the different 
industry sectors.   
7.36. Selective species could be subject to measures similar to those that currently apply 
to cattle if the incidence of the disease was thought to warrant it in future. Such an 
option would form a part of an adaptive management approach to bovine TB 
control. 
Research priorities  
7.37. Development of better (blood-based) tests for some non-bovine species (chiefly 
pigs and deer) is a research priority.  Given the poor performance of skin tests 
(SICCT, SICT) in some non-bovines, research into the development of alternatives 
would be valuable.  Better tests for pigs are particularly important because a rise in 
prevalence in this species could have significant effects on exports of British pig 
meat to some key international markets such as China and India. 
7.38. Development of rapid molecular diagnostics based on PCR would speed up the 
identification of M. bovis in pathology samples from suspicious lesions discovered 
at slaughterhouse inspection or during post mortem surveillance of non-bovine 
farmed animals.  This would minimise the interval between detection of the index 
case and testing of the herd of origin (or withdrawal of precautionary movement 
restrictions, if the sample proved PCR or culture negative). 
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Chapter 8: Biosecurity, compensation and insurance 
Introduction 
8.1. This chapter discusses several issues that involve the farmer.  These include the 
implementation of biosecurity measures to lessen the risk of transmission amongst 
cattle or from wildlife to cattle, and how farmers are protected from the risks of herd 
breakdown and loss of cattle to slaughter through compensation or insurance.  It 
also explores some issues of how the structure of the farming industry may affect 
disease transmission.  
8.2. Taking biosecurity measures on farms to limit the spread of bovine TB represents 
an important element of management practices that can be implemented by farmers 
through sanitation, surveillance and organisational integration90. 
8.3. An incidence of bovine TB on a farm has substantial economic (and other) 
consequences for the farmer.  Currently part of the economic loss is met through 
compensation paid for by the state. There are alternative models of helping farmers 
cope with the disease, including insurance schemes with state support. 
Rationale for action 
Biosecurity  
8.4. Quantitative information on transmission pathways is difficult to obtain which makes 
it hard to judge the most important routes of infection to address through biosecurity 
interventions.  There have not been large-scale, replicated and controlled trials of 
biosecurity interventions, and the information that does exist is largely correlative 
and based on investigation of individual bovine TB breakdowns.  In 1999 the TB99 
questionnaire was introduced to be used by the then State Veterinary Service 
Veterinary in interviews with farmers and herd managers after every breakdown91. 
The information today is gathered through a similar process using the Disease 
Report Form (DRF), which replaced the TB99 in 2004.  
8.5. Because of the inadequacies of the readily available data, the rationale behind 
many biosecurity measures is thus precautionary or, when relatively cheap to 
implement, a ‘no regret’ option.  In many cases, biosecurity measures 
recommended for Bovine TB overlap with recommendations for the control of other 
diseases such as Johne’s Disease.     
8.6. Herd size is the single most common risk factor for bovine TB in Britain92. However, 
it is probably not size, per se, that determines the greater susceptibility of larger 
                                            
90 Hinchliffe et al. 2012 https://doi.org/10.1111/j.1475-5661.2012.00538.x 
91 The TB99 process is described in some detail in: Independent Scientific Group on Cattle TB (2007)   
Bovine TB: The Scientific Evidence, A Science Base for a Sustainable Policy to Control TB in Cattle 
 
92 Brooks-Pollock, E., & Keeling, M. (2009) https://doi.org/10.1016/j.prevetmed.2007.11.001  Carrique-Mas, 
J. J., Medley G. F., & L. E. Green (2008) https://doi.org/10.1016/j.prevetmed.2007.11.001 
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herds, but practices that tend to be more associated with larger herds such as 
purchasing activity, farm size, number of premises and neighbouring herds93. 
8.7. Transmission between cattle may occur through direct contact, through close 
contact and the inhalation of bacteria in aerosol droplets, or through feed or grazing 
contaminated by infected faeces or slurry.  Calves may contract bovine TB from 
infected colostrum or milk. 
8.8. Transmission to and from badgers and other wildlife is thought most likely to occur 
through environmental contamination rather than from direct contact94.  Infected 
badgers can shed bacteria, and badger presence on cattle grazing, drinking from 
water troughs, and entering cattle sheds to forage for food, are all considered 
possible routes of transmission. 
8.9. The feasibility of implementing different biosecurity measures depends on the 
farming system being operated.  For example, it is easier to insulate indoor-housed 
dairy cows from badgers than those that graze on grassland, but cattle-to-cattle 
transmission is likely to be more frequent in the close confines of cattle sheds.  
Feeding pasteurised colostrum to calves is more practical in intensive dairy systems 
than in single-suckle beef herds. 
8.10. Because of the challenges in identifying routes of transmission, demonstrating the 
efficacy of biosecurity to the farming community has been difficult.  There is 
evidence that farmers are unconvinced of the need for biosecurity measures, or do 
not feel empowered and hence are fatalistic about the risk of bovine TB infection95. 
A similar issue also affects private veterinarians, who play an important role in 
recommending biosecurity measures to farmers, as they are less inclined to advise 
on biosecurity take-up if the demonstrable efficacy of such measures is lacking96. 
There is evidence that implementation of badger but not cattle biosecurity measures 
is more likely on farms that have experienced bovine TB97, an indication that many 
farmers view badger-cattle transmission as more important than cattle-cattle98. 
Structure of the farming industry 
8.11. Investment in biosecurity and other types of capital improvement are influenced by 
ownership models.  For example, there are a range of tenancy agreements from 
Full Agricultural Tenancies (FAT) with long-term security, through Farm Business 
Tenancies (FBT) with an average occupancy of around four years99, to short-term 
contract farming arrangements which typically last less than two years (and grazing 
arrangements that are even shorter).  Responsibility for investment to reduce 
disease risk may be complicated; for example, tenants are typically responsible for 
                                            
93 Broughan, J. M., Maye, et al (2016) https://doi.org/10.1016/j.prevetmed.2016.05.007  
94 Woodroffe, R., et al (2016) https://doi.org/10.1111/ele.12654  
95 Maye, D., Enticott, G., Naylor, R., Illbery, B., & Kirwan, J., (2014) 
https://doi.org/10.1016/j.jrurstud.2014.07.001 
96 Gunn, G.J., Heffernan, C., Hall, M., McLeod, A., & Hovi, M. (2008) 
https://doi.org/10.1016/j.prevetmed.2007.12.003 
97 Farmers were asked about measures taken in the previous twelve months: Brougham et al; op.cit.   
98 Ibid. 
99 CAAV (2018) The Annual Agricultural Land Occupation Surveys for Great Britain. It should be noted that 
the survey is based on the evidence from local associations of the CAAV and therefore many 
informal local arrangements are not covered        
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fences that can prevent contact with neighbouring herds or badger setts, while 
landlords are responsible for buildings that should be badger-proof.  Tenants on 
short-term leases will have limited incentives to invest in biosecurity capital.  Rents 
are usually lower in FATs than shorter-term FBTs100, which reduces the incentive to 
landlords to make expensive capital investments given the low return on capital. 
8.12. There has been a recent increase in the extent to which individual farms are 
fragmented into non-contiguous holdings.   These satellite holdings may have been 
purchased from other landowners or they may be farmed through a tenancy or 
other agreement such as a grazing licence or Temporary Land Association (TLA).  
For example, in England and Wales, since the scheme began in 2016, 13,109 TLAs 
have been approved on CPHs which have an active cattle unit out of a total of 
16,019 TLAs approved for all species101. One driver of this trend has been an 
increase in farm purchase by people only wanting to live in the farm house or who 
carry out restricted ‘hobby farming’ on a subset of the land.   
8.13. Another driver has been the way that the CAP’s Basic Payment Scheme (BPS) and 
UK tax law have encouraged landowners that no longer wish to farm (or who have 
bought the farm for an investment) to retain ownership of land but let others use it 
for grazing or cropping on a range of short-term tenancies or share/contract farming 
arrangements102.  Farmers entering into these arrangements are thought to be 
exploiting local economies of scale though one of the few studies of fragmentation 
(in Brittany) found an association of fragmentation with lower profitability103.  The 
significance of fragmentation for bovine TB is largely as a result of the increased 
opportunity it provides for contacts with cattle from contiguous herds, which has 
been associated with an increased risk of disease transmission104.  In another 
study, the distance of the furthest fragment rather than fragmentation alone 
increased the likelihood of a recent bovine TB incident on beef farms; there was 
less evidence of the significance of fragmentation on dairy farms105. 
8.14. Both beef and milk can be produced under a range of different systems. Beef cattle 
may derive from unwanted calves from the dairy industry or from pure beef suckler 
cow herds. In broad terms, beef cattle are fattened (finished) in one of three 
different systems: ‘intensive’, usually indoors and reliant on concentrates and 
conserved forage (12-15 month finishing time); ‘semi-intensive’, where the animals 
are outdoors in the summer and indoors in winter utilising grass, conserved forage, 
cereals and concentrates (15-20 months); and ‘extensive’ based on forage and 
grass (more than 20 months).  Many beef systems are straw-based so that farm-
yard manure rather than slurry is produced though some of the larger modern 
intensive finishing units will be slurry-based.   
                                            
100 The legal arrangements for rent review are governed by two separate pieces of legislation. The 
Agricultural Holdings Act 1986 provides for statutory rent arbitration for FATs. The Agricultural 
Tenancies Act 1995 for FBTs allows greater contractual freedom including opt-out of statutory 
arbitration. FBS data show FAT rents in 2016 averaged £181 per hectare as against £219 under 
FBTs, a £38 per hectare or 17% difference.   
101 Source: APHA data.  
102 Winter, M. and Lobley, M. (2016) http://www.princescountrysidefund.org.uk/downloads/research/is-there-
a-future-for-the-small-family-farm-in-the-uk-report.pdf 
103 Latruffe, L., & Piet, L. (2014) https://doi.org/10.1016/j.agsy.2014.05.005 
104 Johnston, W. T., et al (2011) https://doi.org/10.1016/j.ijid.2011.08.004; Karolemeas, K., et al (2011) 
https://doi.org/10.1016/j.prevetmed.2011.06.004 
105 Broughan et al (2011) op.cit. 
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8.15. In dairying, there is a continuum from systems that produce milk primarily from 
grass, some using the New Zealand system of intensive paddock grazing for up to 
10 months of the year, through to indoor systems based on conserved forage 
(maize or grass) and concentrates (the vast majority slurry-based).  There are now 
relatively few extensive small dairy herds as part of a mixed farm system though 
there has been a growth of interest in organic micro dairies. Also, the once common 
straw-based dairy herds on arable farms are fewer in number. Dairy systems can 
also be differentiated by whether they calve at one time or continuously. 
8.16. The implications of different systems for bovine TB are complex.   On the one hand 
intensive systems facilitate a reduction in the risk from wildlife and can reduce 
cattle-to-cattle transmission through, for example, pasteurising colostrum. On the 
other hand, grass-based extensive systems can reduce close cattle-to-cattle 
contact. For example, one study has associated lack of outside shelter for cattle at 
pasture with a reduced risk of a breakdown, interpreted to be because of the 
reduction of opportunities for cattle to be in sustained close direct contact106.  
8.17. The proportion of farms using cattle farmyard manure as opposed to cattle slurry 
has remained roughly constant over the last five years, and in 2017 47% of 
surveyed farms used manure and 16% slurry107.  They are not, of course, mutually 
exclusive categories as some farms will use both. 
8.18. The importance of farm contractors as a source of both labour input and specialist 
machinery has increased in recent decades and many livestock farmers use 
contractors who move from farm to farm for tasks such as slurry spreading, silage 
making and hedge cutting. In a survey of over 1,000 farmers in the south-west, over 
90% of dairy farmers and 85% of livestock farmers used contractors108.  The 
movement of slurry tankers without being washed or cleansed within and between 
farms was identified as a potential risk factor in an outbreak of bovine TB in 
Cornwall nearly 45 years ago109. A recent study in Northern Ireland found an 
association between increased risk of bovine TB and the use of contractors for 
spreading slurry110 . 
8.19. Common grazing lands are areas, typically moorland, where multiple livestock 
holders have the right to graze.  There clearly is an opportunity for herds to mix and 
bovine TB transmission to occur on commons.  Rates of herd breakdown amongst 
Dartmoor graziers are slightly higher than for the rest of Devon111 though this could 
be due to a correlation with a third factor.  Grazing of commons can be important in 
the management of habitats, including those important for biodiversity, and the 
                                            
106 Johnston et al 2011 op. cit 
107 https://www.gov.uk/government/statistics/british-survey-of-fertiliser-practice-2017 
108 Nye, C. (2018). https://ore.exeter.ac.uk/repository/handle/10871/33119  
109 Richards, R. (1972). Inquiry into Bovine Tuberculosis in West Cornwall. MAFF, London; cited in McCallan, 
L. McNair, J and Skuce, R. (2014)  A Review of the Potential Role of Cattle Slurry in the Spread of 
Bovine Tuberculosis, Agri-food and Biosciences Institute, Belfast. https://www.daera-
ni.gov.uk/sites/default/files/publications/dard/tb-slurry-lit-review.pdf   
110 O’Hagan, M.J.H., Matthews, D.I., Laird, C. & McDowell, S.W.J. (2013) Bovine Tuberculosis Study, County 
Down, Northern Ireland 2010-2011, Department of Agriculture, Environment and Rural Affairs. 
111 APHA data. 
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Open Spaces Society has raised concern about the imposition of restrictions on 
common grazing112.   
8.20. Individual and social barriers to behaviour change including the greater uptake of 
biosecurity measures have been identified in qualitative research with farmers113. 
An important aspect is the lack of perceived behavioural control over disease 
spread. If farmers do not believe they have a degree of control over TB, they are 
less likely to implement recommended measures114. Another individual aspect is 
the tendency to discount the long-term benefits of investing in biosecurity; because 
the benefits of enhanced biosecurity may not be seen immediately and therefore 
receive less weight in decision-making compared to the immediate needs of the 
farm business115. Among the social barriers, two stand out: the lack of a perceived 
social norm for biosecurity and the engrained social practices that shape how 
farmers approach their daily routine116. Farmers do not operate in isolation and if 
neighbouring farms are not seen to be performing biosecurity, the impetus for action 
is reduced. Evidence shows that many farmers take pride in their accumulated 
expertise, so that the implementation of new or under-utilised biosecurity measures 
may require a fundamental shift to traditional approaches.  
8.21. There are some issues that contribute to the difficulty farmers may face in 
complying with biosecurity conditions.  For example, there is the question of the 
cost of biosecurity measures requiring capital expenditure in relation to the low 
profitability of many beef and some dairy enterprises, and the wide range in 
economic performance across the two sectors. Put simply, some farmers have a 
greater capacity to make the necessary capital investments than others.  In 
particular, the level of debt is a critical issue for any business considering an 
investment.   
8.22. A wide range of debt circumstances face farmers and this is captured in the notion 
of ‘gearing’ which is defined as total liabilities as a percentage of net worth. A low 
ratio suggests that the farm business is more likely to be able to meet its investment 
needs from earnings. The average gearing ratio for all farm types in 2016-17 was 
10%.  There are lower average ratios amongst livestock grazing businesses as this 
is not a capital-intensive sector. The dairy sector has relatively high ratios with 10% 
of dairy farms having a gearing ratio value of over 40% (see Figure 8.1).  Tenanted 
farms have an average gearing ratio of 29%, whilst owner occupied farms had an 
average ratio of 7% (Figure 8.2).  
8.23. There is not a straightforward relationship between gearing and the likelihood of 
farmers making biosecurity investments. Much will depend on the attitude of an 
individual famer to both debt and the need for biosecurity investment.  Some with 
low debt may be averse to investment and borrowing in any circumstances. Some 
with high debt will see the necessary investment as merely a modest addition to an 
                                            
112 https://www.oss.org.uk/bovine-tb-control-and-commons/ 
113 Fisher, R. (2012) http://eprints.glos.ac.uk/1178/ 
114 Ibid. 
115 Garforth, C.J. (2015) https://doi.org/10.1111/zph.12189  
116 Escobar, M.P., & Buller, H. (2014). Projecting social science into Defra’s animal welfare evidence base: A 




already high debt burden. However, there will be some for whom any additional 
debt is seen as highly undesirable and therefore the high level of debt in parts of the 
dairy sector is a cause of concern.  
Figure 8.1 Distribution of Gearing Ratio by farm type117 
 
Figure 8.2:  Distribution of Gearing Ratio by farm tenure118 
 
Compensation 
8.24. Several arguments are used to justify the payment of compensation to farmers for 
the losses occurred due to bovine TB.  The first is that for the benefit of the industry 
(and to a lesser degree public health) robust measures are taken to test for bovine 
TB and to slaughter infected animals beyond those that an individual farmer would 
take for the good of his or her business. The second is that the farming industry is 
being asked by society to refrain from doing certain things that otherwise it would 
want to do, in particular engage in more extensive culling.  The continued presence 
                                            





of protected badgers on farmland can be viewed as a minimum standard, akin to 
basic animal welfare, or as a merit good provided by the farming community that 
justifies recompense.  Third, the unusual prevalence of bovine TB in the UK places 
the industry at a competitive disadvantage which compensation helps redress.  
Fourth, government may wish in general to support the dairy and beef industry for 
the direct benefits it brings, as well as the indirect benefits for rural economies. We 
return to issues of industry versus government support for bovine TB control in 
Chapter 9. 
8.25. Setting the right level of compensation is important to avoid generating perverse 
incentives.  If the level is too high then farmers may lack incentives to reduce the 
risk of disease, and in rare cases may fraudulently claim animals are diseased.  
Setting the level too low would, in addition to causing financial stress to the farmer 
(assuming no other mitigating strategies such as insurance are available), 
incentivise poor compliance with disease surveillance. An analysis of Farm 
Business Survey data shows that there is no significant difference in average farm 
business income or the likelihood of having negative income between farms with 
cattle that had a bovine TB compensation payment in 2014-15 to 2016-17 and 
those that did not (whether or not Basic Farm Payments are included). Similarly, 
there is no significant difference in income between cattle farms in each of the three 
bovine TB risk areas (HRA, EA and LRA)119.  These data do not, of course, reveal 
anything about the levels of stress, anxiety and business disruption suffered by 
many farmers due to bovine TB120.   
Insurance  
8.26. An alternative means of providing mitigation of financial loss is through insurance.  
The cost of insurance could be met wholly by the individual business, it could be 
subsidised by a regional or nation-wide levy, or it could be subsidised by the state.  
The insurance programme could be run by the private or public sector, or by some 
hybrid model.  
8.27. Compensation is akin to insurance with a zero premium and one could transition 
from compensation to insurance by introducing a premium.  An advantage of an 
insurance scheme is that variable premiums could be introduced to incentivise 
behaviours likely to reduce disease incidence.  Currently such behaviour is 
incentivised by reducing compensation in some circumstances which is a much 
coarser instrument.  Making variable premiums work effectively requires experience 
and access to relevant information by the insuring body. 
8.28. Successful insurance schemes must avoid ‘adverse selection’ and ‘moral hazard’. 
Adverse selection is the tendency for those most at risk to purchase insurance while 
those less at risk do not.  This is a particular issue with bovine TB because of its 
concentrated geographical distribution.  It is typically countered by Government 
                                            
119 Clothier, L. and Betts, C. (2018) Loss of Direct Payments: Assessment of vulnerability of farms with cattle 
in bTB risk areas and farms that have had bTB compensation payments, Internal Defra paper.  The 
analysis used a subset of data for farms with cattle from the Farm Business Survey for 2014/15 – 
2016/17.  The analysis compares cattle farms that have had a bovine TB compensation payment 
with those that have not and provides a comparison between the 3 bovine TB risk areas (HRA, EA 
and LRA). The risk areas used are those in place from January 2018.  
120 Farm Crisis Network (2009) Stress and Loss:  A report on the impact of bovine TB on farming families, 
Northampton, FCN. http://www.tbfreeengland.co.uk/assets/4200 
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interventions such as making insurance compulsory or subsidised.  Moral hazard is 
the tendency for those insured to take riskier behaviours (as also occurs with 
compensation).  The introduction of behaviour-related premia can help counteract 
this. 
8.29. Evidence provided to us from the Government Actuary’s Department (GAD) 
explains the circumstances when government might usefully intervene in the 
commercial insurance market.  In addition to the above, one of these is when a 
commercial insurance market may exist in the future, but requires initial government 
intervention as insurers may be unable or unwilling to participate due to a lack of 
experience and reliable models, or a relatively small number of risks to be insured. 
The bovine TB case would appear potentially to fit into this category.    
Current policy 
Biosecurity 
8.30. Since 2016 APHA has issued bovine TB farm level reports routinely to farmers in all 
cases of new bovine TB breakdowns121.  The report presents a collated view of 
historical data on the herd held by APHA and the Rural Payments Agency (RPA). It 
is intended to help farmers understand the causes of bovine TB in their herd and 
assess the potential for changes to their husbandry practices to mitigate future risk. 
Farmers are encouraged to share the report with their veterinary surgeon and seek 
support and advice.  
8.31. In addition, in some circumstances APHA visits take place to investigate the 
circumstances of breakdowns and assess the likely risk pathways for infection.  
Data are gathered through DRFs that are typically compiled by veterinarians based 
on observations during visits to gather epidemiological data and using information 
provided by the farmer, sometimes supplemented by existing APHA and CTS data 
for that farm.  Much of the information is gathered in the form of free text which is 
costly to transcribe and store electronically.  
8.32. In the HRA, DRFs are completed in approximately 60% of cases. This is made up 
of two groups: (i) a random sample of one in three new breakdowns and (ii) a 
proportion of the remaining breakdowns based on a triage process to focus on the 
high priority cases that can benefit from a DRF.  In the EA, DRFs were completed 
for all new breakdowns until very recently – now, in Cheshire, due to the number of 
breakdowns, a triage process (similar to the one deployed in the HRA) has been 
introduced to target interventions. In the LRA, DRFs are completed for all new 
breakdowns. Farmers have the option to share some of the content of the DRF with 
their private veterinarians. Data gathered from DRFs and other systems are fed into 
the Farm Level Report provided to all farmers within seven weeks of a new 
breakdown. 
8.33. Extensive information about biosecurity is provided on AHDB’s bovine TB Hub.  The 
component devoted to biosecurity includes a Bovine TB Biosecurity Five-Point 
Plan122 that focuses on (i) restricting contact between badgers and cattle; (ii) 
                                            
121 APHA Briefing Note 14/16 Provision of bTB herd reports to new breakdowns in the High Risk and Edge 
Area of England http://apha.defra.gov.uk/documents/ov/Briefing-Note-1416.pdf 
122 http://www.tbhub.co.uk/biosecurity/protect-your-herd-from-tb  
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managing cattle feed and water; (iii) preventing infected cattle entering the herd; (iv) 
reducing risk from neighbouring herds; and (v) minimising infection from cattle 
manure. The TBAS (see Chapter 9), funded for an initial 3-year period, also 
provides biosecurity advice through farm visits and a telephone advice service.  
8.34. Different accreditation and certification schemes mandate different biosecurity 
measures.  For example, in the case of spreading slurry or farmyard manure, the 
Red Tractor Scheme recommends a minimum of four weeks before grazing 
resumes with ideally eight weeks for adult livestock and six months for young stock. 
By contrast, the Biosecurity Five-Point Plan recommends a two-month no-grazing 
interval for all cattle.  The Five-Point Plan recommends the storage of manure for at 
least six months, before spreading on pasture, but the Red Tractor Scheme, whilst 
noting the importance of storage, does not specify a time period. 
8.35. The most important accreditation scheme by take-up is the Red Tractor Scheme’s 
‘Farm Health Plan’ 123 (75% of livestock farmers participating in 2018 compared to 
65% in 2017124).  Table 8.1 compares the biosecurity measures recommended by 
the different schemes.   
8.36. It is a condition of badger culling licences (see Chapter 6) issued by Natural 
England that “practicable, proportionate and appropriate” biosecurity measures are 
implemented for the duration of any licence125. Natural England assesses 
compliance by reviewing the mechanisms the culling companies put in place to 
ensure their participating farmers implement required biosecurity; for example, the 
extent of the information they provide farmers and engagement with local 
veterinarians.  Natural England also carries out limited inspection.  In the cull areas, 
30-55% of farms receive APHA epidemiological investigations and Natural England 
targets a further ~5% for their inspections which focus in particular on preventing 
badger-to-cattle transmission.  If non-compliance is found, ‘advisory’ or ‘required’ 
improvement notices are issued. 
8.37. Funded through the Rural Development Programme for England, the 2018 
Countryside Productivity Scheme (CPS) provided small capital grants for, among 
other things, badger-proof feed troughs (which cost ~£300 each), badger-proof lick 
holders (~£100), calf-milk pasteuriser/dispensers (~£7,000), and a machine to inject 
slurry into the soil surface (~£22,000). Grants were awarded between £3,000 and 
£12,000, covering up to 40% of eligible costs. 126 The CPS is a competitive scheme 
and the majority of the range of eligible items are not related to biosecurity. The 
new grants announced recently to tackle ammonia pollution may be helpful in terms 
of reducing the risks associated with slurry spreading127.   
                                            
123 See Red Tractor Beef and Lamb Health Plan Template:  
https://assurance.redtractor.org.uk/contentfiles/files/Mocked_up_completed_health_plan.pdf 
124 Defra Farm Practices Survey 2018:  https://www.gov.uk/government/statistics/farm-practices-survey-
february-2018-greenhouse-gas-mitigation-practices  
125 Defra (May 2018) Guidance to Natural England: Licences to kill or take badgers for the purpose of 
preventing the spread of bovine TB under section 10(2)(a) of the Protection of Badgers Act 1992. 
https://www.gov.uk/government/publications/guidance-to-natural-england-preventing-spread-of-
bovine-tb  
126 Prices from Annex 3 of the 2018 Countryside Productivity Small Grant Scheme Handbook. 
127 https://www.gov.uk/government/news/3m-support-scheme-launched-to-reduce-air-pollution-from-farming  
89 
8.38. For the purposes of bovine TB control, a farm is considered to be a unit with a 
single CPH number associated with a permanent registered holding. Land 
permanently acquired within a 10-mile radius (an area of over 300 square miles) of 
the registered holding can be associated with the same CPH number.  Cattle 
movements within parcels of land in the same CPH do not need to be notified to the 
British Cattle Movement Service (BCMS).  If a herd breakdown occurs, the whole 
CPH is placed under restrictions, though movement can still occur within the CPH. 
Farmers can apply to have non-permanently held land within the same area 
associated with the CPH through a TLA arrangement which lasts a year and can be 
renewed128. 











Xlvets  RSPCA - Dairy Morrisons 
   Restricting contact between badgers and cattle: 
Find out if badgers visit 
your farm ✔ 
          
Introduce barriers to 
prevent badgers 
accessing cattle 
✔     ✔   ✔ 
Limit access of cattle to 
badger latrines and setts ✔         ✔ 
Managing cattle feed and water:   
Badger-proof feed stores, 
troughs & mineral licks ✔ ✔ ✔ ✔     
Don’t put feed on the 
ground at pasture and 
clean up spillages 
✔           
Use clean, fresh water 
and badger-proof water 
troughs 
✔           
Only feed waste milk to 
calves if it has been boiled 
or pasteurised 
✔         ✔ 













Xlvets  RSPCA - Dairy Morrisons 
Preventing infected cattle entering the herd: 
Ask for TB history 
information before you buy 
new cattle 
✔     ✔ ✔ ✔ 
Post-movement test cattle 
entering the herd ✔     ✔   ✔ 
Isolate all higher-risk cattle 
before they enter a herd ✔     ✔ ✔ ✔ 
Reducing risk from neighbouring herd:  
Check local TB 
breakdown data online at 
www.ibtb.co.uk 
✔ ✔ ✔       
Put in place effective 
barriers between 
neighbouring herds 
✔     ✔   ✔ 
Avoid sharing equipment 
or vehicles with other 
farms 
✔     ✔     
Avoid sharing cattle 
grazing with other herds ✔           
Reducing risk from neighbouring herd:  
Store manure for a long 
period before spreading 
on your farm 
✔ ✔ ✔       
Only spread manure on 
arable land or pasture that 
is not going to be grazed 
by cattle for at least two 
months 
✔ ✔ ✔ ✔   ✔ 
Minimise aerosols and 
contamination of 
roadways when spreading 












Xlvets  RSPCA - Dairy Morrisons 
Don’t spread manure from 
other farms ✔     ✔     
 
8.39. Since 2014, pre-movement testing also applies for cattle moving from HRA and EA 
holdings to common grazing in any of the three risk areas.  Pre-movement testing is 
also required for all cattle moving from common grazing in the HRA and EA to a 
holding in any of the three risk areas, though exemptions allowing testing back on 
farm, can be made by local Commoners’ Associations or groups of cattle graziers 
that have agreed a TB Control Plan129. Such plans, which may vary between each 
common (for example, to reflect that grazing practices and risks will vary from 
common to common), must be agreed in advance with APHA. All approved Control 
Plans would be expected to include a commitment to record cattle movements to 
and from the common. 
Compensation  
8.40. A large part of the financial risk of a herd breakdown is currently borne by the state 
through its payment of compensation, though this does not cover all the loss of 
income experienced by the farm business.   Compensation for cattle slaughtered for 
bovine TB, is calculated under the Cattle Compensation (England) Order 2012 
(based upon average livestock market prices for the relevant categories) and the 
Individual Ascertainment of Value (England) Order 2012. Compensation rates are 
adjusted monthly based on real market data from the preceding months. Sales data 
for around 1.4 million cattle are collected each year to support valuations. The 2012 
Compensation Order amended an earlier 2006 Order, but both were based on 
compensation at average market value rates. The use of an average rather than an 
actual valuation of the affected stock means that some famers are over 
compensated and others under compensated for their actual losses. Compensation 
is only for the loss from animals slaughtered. It does not take into account the extra 
costs associated with retaining animals under movement restriction or loss of 
income, for example due to lower milk sales. Previously, farmers were paid 75% of 
the average market value of an animal slaughtered.  
8.41. In England, compensation is reduced on a sliding scale where there has been a 
delay of more than 60 days on the part of the keeper in arranging for the TB testing 
of cattle herds. From 1 November 2018, a 50% reduction in compensation will also 
apply to: 
(i) Animals that cannot be processed for human consumption at a slaughterhouse 
because they fail to meet required standards of cleanliness130. 
                                            
129 Exeter AHVLA, Dartmoor Commoners’ Council and the Dartmoor Hill Farm Project (2014) TB Control 
Plan for Dartmoor. 
130 https://www.food.gov.uk/business-guidance/cleaner-cattle-and-sheep    
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(ii) Animals brought into a breakdown herd that are subsequently found to be bovine 
TB reactors or direct contacts (i.e. other animals in the herd which APHA consider 
to be at high risk of being infected with TB) before the herd regains OTF status. 
This reduction will not apply to herds registered to a CHeCS (see Chapter 5) 
accredited bovine TB health scheme.   
Options for the future 
Improving the biosecurity evidence base 
8.42. Current DRFs do not cover all the information that may be valuable in 
understanding disease transmission and helping to improve biosecurity advice.  
APHA has developed a new much more comprehensive version of the DRF in an 
electronic and more usable format though it has not yet been tested in a pilot.  
Testing and rolling out the new form would improve the evidence base underlying 
biosecurity measures. 
8.43. Farmers do not always fully collate and utilise all the evidence available to them. 
One example of how farmers and veterinarians can work together to assemble and 
analyse the necessary data is the online tool, ‘MyHealthyHerd’131,  a web-based 
health management tool to help measure, manage and plan for animal health on-
farm. The infectious disease module helps farmers to develop control measures for 
a range of endemic diseases, including Johne’s disease and bovine TB. The bovine 
TB component requires further development, however, and there has been only 
limited demand from farmers to date.  There is potential for greater use of 
MyHealthyHerd or equivalent products in preventing disease spread, particularly 
where there have been no recent breakdowns and therefore no APHA involvement.   
Measures to reduce risk of transmission from badgers    
8.44. Extensive information about biosecurity is available on the TB Hub and on the 
websites of the different certification and accreditation schemes.  A free advisory 
service (TBAS) with a special focus on biosecurity is also available to some 
farmers.  Hence, farmers have access to the best current advice should they 
choose to look for it.  To improve awareness of this information and service, 
sources of trusted advice to farmers (private veterinarians, representatives of 
certification schemes, and APHA inspectors) could be encouraged or incentivised to 
be more proactive in stating the importance of biosecurity, and the existence of 
some cheap ‘no regrets’ interventions.  This might be done by targeted information 
campaigns and the provision of training courses.     
8.45. Previous government initiatives empowering private veterinarians to produce 
tailored biosecurity advice and monitor its effectiveness have been associated with 
increased take-up of biosecurity, increased farmer satisfaction with biosecurity, and 
reduced risk of introducing disease132.  These initiatives could be extended and the 
provision of bespoke advice facilitated through analysis of information collected by 
APHA in completing the revised DRFs. 
                                            
131 http://www.myhealthyherd.co.uk/  
132 Royal Veterinary College (2013) Assessment of tailored farm-level biosecurity strategies for beef suckler 
farms in England and Wales. Defra commissioned project, SE4007.  
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8.46. Farmers may find their biosecurity measures scrutinised on multiple occasions; for 
example, during the DRF process in the event of a breakdown, from the TBAS if 
advice is taken up, through certification schemes, and from Natural England when it 
undertakes checks on biosecurity compliance as a condition of issuing badger 
culling licences.   
8.47. As illustrated in Table 8.1, current information and advice from multiple sources can 
be somewhat inconsistent. Given some farmers’ and local veterinarians’ lack of 
belief in the efficacy of biosecurity measures, even slight inconsistencies may act 
against efforts to change behaviour through awareness raising. Biosecurity advice 
across government, delivery bodies, and certification and accreditation schemes 
could be coordinated, with greater data-sharing, to reinforce a coherent message 
across sources. In Chapter 9 we discuss the potential for a single body to undertake 
functions currently carried out by APHA, Natural England and other organisations. If 
this idea were adopted it would facilitate a more consistent approach to biosecurity. 
8.48. There is anecdotal evidence of inadequate compliance with biosecurity conditions 
by a minority of farmers within badger culling areas. Where this is the case, 
compliance could be enforced more strongly, with licences withdrawn if this cannot 
be achieved.  It could also be a condition of the cull licence that biosecurity 
measures are maintained for a reasonable specified period after the end of the cull; 
a condition that would be binding on successors if the land changed hands.      
8.49. In discussing risk-based trading (Chapter 5), and compensation and insurance 
below, we explore the possibility of creating farm-level indices of the risk of bovine 
TB infection.  Such indices could include measures of the take-up of biosecurity 
measures.  Farms could be credited for engagement with TBAS and other sources 
of biosecurity advice, as well as the existence of a biosecurity plan that would be 
subject to inspection. 
8.50. The major accreditation and certification schemes, as well as some supermarkets, 
already mandate some measure of farm-level biosecurity. For example, Sainsbury’s 
ensures that all domestic farmers who supply its red meat and dairy products meet 
the relevant Red Tractor Assurance standards at a minimum. The latest standards 
for beef producers require effective on-farm biosecurity measures to prevent the 
spread of disease and protect food safety and animal health, including a 
documented Farm Biosecurity Policy. These measures could be ’levelled-up’ and 
compliance coordinated and simplified. 
Improving inspection 
8.51. Farms are inspected as part of farm assurance schemes, for producer assurance, 
and to assess bovine TB biosecurity measures (including possible new measures 
suggested elsewhere in this Chapter). There are opportunities to join up and 
combine such inspections, not only those relating to bovine TB but also those 
concerned with other aspects of farming. 
Measures to prevent local cattle-to-cattle transmission 
8.52. The emphasis in biosecurity advice could be broadened to encompass more cattle-
to-cattle transmission risk reduction measures, such as reducing the risk of contact 
between contiguous herds through wider buffers between holdings.  We see a 
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particular issue on parcels of land separate from the main holding but sharing the 
same CPH.  Especially when these fragments are short-term FBT or TLAs there 
may be little incentive to invest in biosecurity measures.   
8.53. At present the registration of a TLA requires no evidence of the extent of buffers 
against surrounding land, nor is information required on the category of livestock 
associated with the TLA or other contiguous holdings. Thus, a TLA could be 
authorised for a farmer to graze high-risk, low-value animals adjacent to a farm with 
high-value pedigree or dairy cattle.  Options that could be considered to reduce the 
risk of movement to TLAs spreading the disease include confining TLAs only to 
sheep in the HRA, not allowing cattle on TLAs if they adjoin existing cattle farms, 
and mandating adequate buffers as a condition of a TLA.  We understand the 
potential financial and regulatory implications of these measures and the need for 
further cost-benefit analysis. 
8.54. More generally, cattle farmers could be discouraged from taking on parcels of land 
not contiguous with the main holding, especially on TLAs applying to seasonal 
grazing licences or informal gentleman’s agreements and short term FBTs.  The 
phased reduction of CAP direct payments up until 2027 is likely to reduce the 
current incentive for existing farmers, already beyond retirement age, to ‘sell’ grass 
keep on an annual basis whilst still retaining their subsidy payments.   
8.55. There are a number of other reasons, related to the tax system, why short-term 
letting arrangements remain attractive to some land occupiers.  This includes land 
owned for investment, residential or recreational purposes by non-farmers133. 
Government could consider providing tax breaks on rental income for longer-term 
agricultural lettings, a model that has been used successfully in the Republic of 
Ireland to shift the market away from very short-term lets towards longer-term 
leases. Tenancy legislation could also be amended to de-risk longer-term leases for 
agricultural landlords. Government could encourage industry bodies to be more 
proactive in providing best practice advice to land agents and other professional 
advisors on the benefits of longer-term lets for both landlord and tenants to 
encourage a culture shift away from off the peg short term agreements.  
Increased focus on slurry and manure 
8.56. M. bovis can survive in stored slurry for up to 6 months134.  The risk of spread of 
disease through slurry can be addressed by giving more emphasis to the injection 
of slurry into the soil.  This could become a condition for those (mostly dairy) 
farmers with slurry systems in the HRA.  The extension of schemes providing 
capital grants for slurry injectors would be helpful with such grants made available 
not only to farmers but also to agricultural contractors, who undertake much slurry 
spreading.  In addition to reducing risks of disease, slurry injection has other 
                                            
133 Strutt & Parker’s Farmland Database for 2013-17 shows an average of 43% of farm sales were to non-
farmer buyers, accounting for 55% of the land marketed. These include lifestyle buyers and private 
investors.  Source: www.struttandparker.com/knowledge-and-research/the-rise-of-non-farmers-in-
the-farmland-market. 
134 Scanlon, M.P. & Quinn, P.J. (2000a). The survival of Mycobacterium bovis in sterilised cattle slurry and its 
relevance to the persistence of this pathogen in the environment. Irish Veterinary Journal 53 (8), 
412-415. 
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important advantages such as reducing ammonia pollution135 and the risk of run off 
after heavy rain.  The cleansing of contractor machinery between farm visits could 
be made mandatory in future.  
8.57. Instead of spreading on land, the use of slurry in high temperature (thermophilic) 
types of anaerobic digestion could be incentivised.  The advantages and 
disadvantages of on-farm or local anaerobic digestion are complex because of the 
capital requirements to set them up, the need for a steady supply of feed material 
which has consequences for both farm economics and local infrastructure, and the 
presence of customers for digestate (often the farmer) and biogas.  We do not go 
into these issues beyond noting that the potential disease-control benefits should be 
included in these calculations.          
8.58. If farmyard manure from cattle is spread directly onto the land, there is a risk of 
disease transmission.  Composting for a minimum of 30 days and turning is 
recommended as temperatures of 50o C are needed to destroy M. bovis.  
Composting has other benefits including reduced weed seed and pathogen burden, 
extended range of time and area for spreading, and less risk of water pollution. 
These benefits need to be balanced against the potential for greater gaseous and 
leachate losses during the storage and turning of manures136. Composting farmyard 
manure could be made mandatory or could contribute to biosecurity indices used in 
incentivising good disease control measures.  Capital grants could be made 
available for the infrastructure required for composting. 
Moving from compensation to insurance 
8.59. The compensation scheme for herd breakdowns could be transformed into a 
mandatory insurance scheme.  The premiums would be made up of two parts, one 
determined by geographical zone (either the existing HRA, EA or LRA 
categorisation or something that evolved from it) and the other a variable 
component that is influenced by farmer behaviours such as degree of risk-based 
trading, adoption of biosecurity measures, and engagement in measures to control 
the disease in wildlife (for example culling or vaccination). The two components 
represent risks that the farmer has no control and some control over. 
8.60. The component of the premium that represents the risks that a farmer has no 
control over could be subsidised by government (effectively a re-designation of the 
compensation payment).  Alternatively, the cost of the premium could in total or in 
part be transferred to the industry.  The industry through a levy might equalise the 
premiums paid by farmers in the different geographical risk zones, or businesses in 
high-risk areas may be asked to pay more.  There is an economic argument for risk-
related payments in that it encapsulates the true costs of the disease and might 
discourage beef and dairy farming in areas of greatest bovine TB prevalence.  
Against this is the welfare argument that the higher premiums may make any type 
of farming inviable in certain areas, with knock-on effects on employment and the 
viability of rural economies.   
                                            
135http://www.neiker.net/la-inyeccion-el-mejor-metodo-para-reducir-las-emisiones-de-amoniaco-procedentes-
de-la-aplicacion-de-purines-en-tierras-agricolas/?lang=en 
136 Department of Agriculture and Food Studies University of Plymouth (2000) Enhancing the effective 
utilisation of animal manures on-farm through compost technology, Report to MAFF. 
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8.61. The premiums paid by individual farmers would have a component that incentivises 
disease control behaviour.  In Chapter 5 we discuss the development of a farm-
level index to be used in risk-based trading and this could also be used in 
determining insurance premiums.  The extent of biosecurity measures taken by a 
farmer should also influence the premium.  There are different ways this could be 
implemented – for example the business could declare a level of biosecurity that 
affects premiums and be subject to inspection or be recognised for joining existing 
accreditation schemes that mandate and monitor high levels of biosecurity.   
8.62. It would be important that the differential in premium between businesses that 
implement strong and poor disease avoidance measures are large enough to 
incentivise the former actions.  In principle this differential could be established with 
no net change in Government expenditure on bovine TB were current spending on 
compensation to be reallocated to insurance.  
8.63. The government has a role in providing information to facilitate risk-based trading 
that is essential for the insurance scheme to produce positive outcomes.  The 
scheme itself is likely best to be run by the insurance industry.  A detailed feasibility 
study would need to be done to ascertain the financial viability of the scheme.  
Government has relevant experience in setting partially subsidised insurance 
schemes, for example the ‘Flood Re’ programme that limits home insurance costs 
to households in particularly flood-prone areas. 
Making compensation more dependent on risk-avoidance behaviour 
8.64. The last section described how an insurance premium for losses to bovine TB could 
be made dependent on an index of farmer disease avoidance actions (for example 
related to risk-based trading, biosecurity and wildlife control).  Currently, 
compensation is reduced to 50% of market value in circumstances that penalise 
particularly risky behaviours.  The index could be used to make reduction in 
compensation more graded and more dependent on farmer decisions. 
8.65. Part of the rationale for compensation is to reduce hardship for farmers who are 
already financially challenged.  Directly assisting such farmers through income 
supplements or hardship grants (as happens in the RoI) would be one way to 
address this.  It has advantages in decoupling assistance from incentives to 
improve biosecurity and in allowing assistance to be better targeted.  A 
disadvantage is that it may disincentivise poorly performing farmers from leaving 
the industry.  Assistance could be provided directly by Government or working 
through agricultural charities such as the Farming Community Network (FCN).  
Research and development priorities 
8.66. There is a need for continuing research on M. bovis transmission and how it can be 
reduced by biosecurity measures.  This includes transmission between cattle and to 
and from cattle and wildlife.  Further study of the role of slurry and manure is 
particularly important and will be facilitated by modern molecular technologies.  This 
is difficult research that produces incremental rather than break-through results but 
which can material contribution to disease outcomes. 
8.67. Some groups of farmers actively seek advice on biosecurity and willingly implement 
biosecurity measures on their farmers; others are much less willing.  A wide variety 
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of economic, social and behavioural factors lie behind these differences and social 
science research is needed into how better to encourage behaviour change in 
farmers with a poor track record in biosecurity. 
Chapter 9: Governance 
Introduction 
9.1. Control of bovine TB in England is an epidemiological challenge but one that is 
situated in the broader context of the structure and socio-economics of the farming 
industry and its relationship to the state.  The relative effectiveness of different 
disease control interventions is influenced by these economic and social factors and 
it is a mistake to view the problem as purely scientific and technical.   
9.2. This chapter discusses some of the governance issues concerning bovine TB 
control.  More than any other topic explored in this review, questions concerning 
governance often involve judgements that in a democracy rightfully are made by 
ministers.  We respect this distinction and aim to highlight the advantages and 
disadvantages of different options that decision makers need to take into account. 
9.3. A discussion of governance is particularly pertinent at the present time with the UK 
leaving the EU.  Much of bovine TB governance is currently determined by EU 
legislation and directives, and there will be more freedom of action outside the 
Union.  Of course, the degree to which British actions will need to mirror those of 
the EU will not be known until the departure negotiations are completed. 
9.4. We consider in this chapter a variety of different issues concerned with the 
governance of bovine TB control in England. These include the relative roles and 
responsibilities of the state and the farming industry, and exactly where regulatory 
and control functions should be situated. 
Rationale for different governance models 
State involvement 
9.5. Bovine TB is a notifiable disease under EU and domestic legislation.  The state 
originally became involved in bovine TB control because of the risk of transmission 
to humans (prior to pasteurisation and meat inspections bovine TB caused 
significant mortality and morbidity in people).  While that risk has receded, the 
disease remains a veterinary issue as infected cattle suffer loss of condition, 
welfare status and economic value.  However, an important reason government 
remains involved is because of consequences of the disease for international trade.  
Trade is impacted because other countries protect their national herds from 
infection by import restrictions on live animals and cattle products, and statutory or 
government measures are required to maintain freedom of trade.  
9.6. Of the notifiable endemic diseases of cattle in the UK, bovine TB is the only one 
with a substantial wildlife reservoir (the badger) protected by binding international 
conventions and domestic legislation. Government is thus inescapably involved with 
any measures to control the disease in wildlife. 
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9.7. An important justification for state intervention is that there is a collective benefit of 
coordinated action to control disease that might not happen if responsibility was left 
to individual farmers.  There are short-term advantages of reducing the impact of 
disease, for example by sending suspected infected animals to market, and costs to 
biosecurity and other disease avoidance interventions. Hence, without a set of 
regulations imposed by Government there is a relatively high likelihood of a 
substantial increase in bovine TB prevalence. Indeed, there is clear evidence from 
the suspension of testing during the 2001 outbreak of Foot and Mouth that without 
the current surveillance systems there would be a rapid increase in bovine TB in 
England.   
9.8. Outside the EU it would be possible for the UK Government to remove the 
disease’s notifiable status (with or without relaxing protection of the badger) and 
transfer all responsibility to the industry.  Public health would be protected by 
pasteurisation and meat inspection. However, increased incidence in cattle could 
pose additional risks to farmers and veterinarians and also spill over into other 
animals. Because of the risks of increased disease prevalence just outlined, and 
because of the possibility the disease would spread to other hosts, including 
domestic animals with the possibility of human infections, this is not considered 
further here. 
Payment for bovine TB control 
9.9. Currently about 60% of the total costs of bovine TB control measures are paid for 
by the state and the rest by the industry.  The arguments for state involvement (in 
addition to regulation) on bovine TB control are: (i) that control of the disease is a 
public good in that it reduces the (low) risk of human infection by M. bovis; (ii) 
without this subsidy beef and dairy farming in some parts of England would be 
uneconomic leading to farm closures and harm to the local rural economy that 
would have ramifications beyond farming, (iii) other governments provide state 
support for bovine TB control and so the UK also doing so ensures a ‘level playing 
field’ for our industry and (iv) collecting money from industry to support bovine TB 
control is complicated and might increase the total costs of combatting the disease. 
9.10. There are also arguments that the industry should pay more for bovine TB control: 
(i) absence of the disease benefits beef and dairy farmers providing private benefits 
to the farmer that should be paid for by the groups that gain from it; (ii) implicitly 
subsidising beef and dairy production distorts economic signals and leads to 
resource allocation inefficiencies, for example the continuation of beef or dairy 
farming in locations where it would otherwise be unprofitable; and (iii) government 
payment for control implies government responsibility for the disease and the 
resulting lack of ownership of the disease by the industry can reduce the impetus to 
implement disease control measures. 
9.11. Decisions about the economics of bovine TB control have to be made in the context 
of overall support for farming in England.  Currently, beef and dairy farmers receive 
support from Pillar One of the Common Agricultural Policy through the Basic 
Payment Scheme (BPS) administered by the Rural Payment Agency (RPA).  This is 
an area-related payment that provides 38% of farm business income for the 
average English dairy farmer and more than 90% for the average English beef 
99 
farmer137. Since 1 January 2014, poor compliance with bovine TB testing 
regulations has been penalised by a reduction in Pillar One payments as part of 
“cross compliance” requirements administered by the RPA. 
9.12. Defra has set out in its Agriculture Bill and accompanying policy document, Health 
and Harmony: the future for food, farming and the environment in a Green Brexit138 
(September 2018), a direction of travel for what will replace the BPS after the UK 
leaves the EU.  Increasingly public money will be allocated to payment for public 
goods. Technically, public goods are non-rival and non-excludable (everyone 
enjoys them and use by one person does not preclude that by another) and include 
things such as cherished and biodiversity-rich landscapes, or environmental flood 
control measures.  Food itself, though colloquially a good thing for the public, is in 
the technical sense a private good as farmers receive market rewards for its 
production. 
9.13. It is likely that the provision of animal welfare standards, including the absence of 
disease, beyond that which maximises private economic benefits, will be included 
within a broad categorisation of public goods.  Though technically not a public good 
in the strict economic sense, the provision of high welfare standards to meet public 
demand, as interpreted by government, is a merit good that might fall within a future 
CAP replacement scheme139.   
Ownership of disease control programmes 
9.14. There is a consensus that responsibility for control of bovine TB is shared by 
government and the industry.  But there is also evidence that the major role played 
by government leaves the industry feeling disempowered and engenders a feeling 
of fatalism amongst some farmers which views the disease as an ‘act of nature’ that 
they can do little to prevent.  Most groups we talked to, both inside and outside the 
farming industry, expressed concern and dissatisfaction with bovine TB control 
ownership. 
9.15. This is a particular issue in the UK where there is a wildlife reservoir that is 
responsible for a fraction of herd breakdowns.  Because unrestricted culling of 
badgers has never been permitted it is possible for some stakeholders to 
characterise the problem as unsolvable and attribute responsibility for the 
continuing presence of the disease to government because of the restrictions on 
culling it has imposed.  The strength of debate about badger culling is 
understandable given the strong and profoundly held views of many groups that 
oppose it, but the attacks on the farming industry (by some but by no means all 
opposed to culling) has tended to reinforce a feeling of powerlessness in the 
industry.  
9.16. Other countries have adopted policies to reinforce shared responsibility. The 
country most similar to England and the DAs is the Republic of Ireland where it is 
estimated that farmers pay 38% towards the cost of bovine TB control, with the 
state contributing 50% and EU funding the remaining 12%. The Irish Government, 
                                            
137 Health & Harmony Evidence Compendium, p.35. 
138 The future for food, farming and the environment: policy statement (2018) 
139 Animal welfare, economics and policy. Report on a study undertaken for the Farm & Animal Health 
Economics Division of Defra by Professor John McInerney February 2004. 
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as part of its strategy to eradicate bovine TB by 2030, has established a 
Stakeholder Forum tasked with developing policies to help achieve this goal. It will 
advise on: (i) how best government and industry can work together; (ii) the 
development of new policies and interventions; and (iii) how the programme can be 
appropriately and sustainably funded on the basis of a formal objective evaluation 
of benefits and cost. 
9.17. New Zealand is a country that has made major progress in reducing the incidence 
of bovine TB.  Important to this was setting up TBfree – a research and operational 
bovine TB control programme with a distinct legal status. The programme is jointly 
funded by industry and government (60% and 40% respectively for the 2016-20 
period). Its key functions include disease management, movement controls, wild 
animal control, research, and engagement with farming communities and 
conservation groups. In considering lessons of TBfree for the UK, several major 
differences between New Zealand and the UK need to be taken into account.  First, 
amongst high-income economies, New Zealand (with Australia) has gone furthest 
along the path of removing subsidies and other support for its agricultural industry, 
and farming after tourism is the country’s largest earner of foreign currency.  
Second, the wildlife reservoir in New Zealand is the introduced brush-tailed possum 
which is also a significant threat to the country’s biodiversity.  There is relatively little 
opposition to lethal control of possums.  
Bovine TB and regulatory reform 
9.18. Concurrent with the work of this review, Dame Glenys Stacey is leading a review of 
Farm Inspection and Regulation. Its terms of reference are to identify ways in which 
regulation can be improved and burdens on farmers can be reduced, while 
maintaining and enhancing animal, environmental and plant health standards.  An 
interim report was produced in July 2018 and the final report is expected by the end 
of December 2018.   
9.19. An important interim conclusion is that farm regulation in the UK would benefit from 
the creation of an independent regulator with considerably more flexibility in setting 
standards and assessing compliance, and with a greater range of enforcement 
powers from notices and advice through civil and criminal penalties.  Such a body 
would take over many functions currently carried out by Defra arm’s length bodies 
as well as some Local Authority responsibilities.  
9.20. Approximately 45% of all farm visits are concerned with bovine TB, obviously 
concentrated on beef and dairy farms. For these farmers the large majority of 
interactions with regulators concern this disease.  The interim report does not 
conclude there are too many farm visits but emphasises the importance of well-
designed, flexible regulation that is trusted and accepted as necessary by both the 
industry and other stakeholders.  The report also highlights the importance of 
appropriate penalties for different types of non-compliance, the role of licensing to 
allow innovation and novelty, and the link between standards set by the state and 
farm assurance schemes.  
9.21. The broader questions of holistic farm regulation are beyond our remit and will be 
considered by the Farm Inspection and Regulation review’s final report.  However, 
we have discussed these issues with Dame Glenys and in this chapter explore 
options for changing regulation along the lines the interim report suggests. 
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The veterinary profession  
9.22. The veterinary profession plays a very major role in the control of bovine TB.  
Veterinarians are involved: (i) within Defra and its arm’s length bodies in advising on 
policy and in implementation; (ii) in private practices advising farmers day-to-day on 
diagnosis and disease risk; (iii) in the specialist companies contracted to carry out 
bovine TB testing; (iv) as Official Veterinarians in slaughterhouses reporting 
suspicion of TB in a carcase to APHA; and (v) through their professional bodies 
such as the British Veterinary Association (BVA) and the British Cattle Veterinary 
Association (BCVA) that represent the profession in discussions on disease 
management and control. 
9.23. Farm veterinarians are a trusted source of information to farmers and build 
relationships with their clients which can be hugely important in advising on all 
aspects of animal health and welfare. This close working relationship and detailed 
local knowledge makes them ideally placed to help farmers avoid bovine TB and, 
when herd breakdowns occur, to get rid of the disease as quickly as possible.  
While this relation sometimes works very well, we were often told that some farmers 
do not ask veterinarians for disease control advice, and their veterinarians do not 
proactively offer it.  Instead, there is the belief on both sides that the farmer must 
just follow the statutory procedures laid out by APHA and that there is nothing that 
can be done to affect disease outcomes.  A regulatory rather than a disease-control 
mind-set.  We believe the veterinary profession has a critical role in overcoming this 
fatalism and improving effective bovine TB control.  
9.24. Routine testing for TB was in the past undertaken by farmers’ private veterinarians, 
who were then paid by government.  Now, routine bovine TB testing is contracted 
out to the private sector which often means that testing is not done by farmers’ own 
veterinarians, reducing opportunities for engagement on bovine TB between 
farmers and their veterinarians. The use of para-veterinary professionals as 
Approved Tuberculin Testers (ATTs) to perform tuberculin skin testing of cattle has 
been permitted in Great Britain since 2005. To date this has been restricted to a 
small number of suitably trained APHA staff under the supervision of an APHA 
veterinarian. Defra has recently consulted on extending the use of ATTs in England 
so that private veterinary businesses also have the option of deploying them to 
carry out bovine TB skin tests. ATTs would have to meet qualifying criteria and 
complete specified training.  
9.25. The results of statutory testing for bovine TB are only communicated to farmers and 
not to their private veterinarian; this includes the comprehensive APHA information 
pack. This is in contrast to results from other laboratory investigations conducted by 
APHA laboratories which are communicated to both farmer and veterinarian. 
Farmers often perceive information overload when bovine TB is diagnosed on their 
farms. The formal APHA information pack for their farm often gets lost in this deluge 
and the opportunity for discussion with their private veterinarian regarding best 
disease control and prevention is thus forgone.  
9.26. In England, routine testing is now organised by five Veterinary Delivery Partners 
contracted to work over defined geographical areas.  Quality assurance is the 
responsibility of APHA, who provides training and can also conduct unannounced 
spot checks during testing.  The arrangements in the DAs are different.  In Wales, 
local veterinary practices are contracted to do routine testing, organised by two 
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Veterinary Delivery Partners. This a deliberate strategy to help support the 
profession economically in rural areas and to maintain a link between veterinary 
practices and disease control in client herds.   In Scotland routine bovine TB testing 
is delivered by private veterinary surgeons qualified as “Official Veterinarians”. In 
Northern Ireland, the Department of Agriculture, Environment and Rural Affairs 
(DAERA) contracts private veterinary practices to carry out a minimum of 90% of 
routine bovine TB testing. High risk testing is done by DAERA employed veterinary 
surgeons. 
9.27. In the Republic of Ireland, measures have been put in place to assure the adequacy 
of routine bovine TB testing by private veterinarians through unannounced field 
inspections. The Irish Animal Health Computer System records details of all bovine 
TB testing carried out in the field and summarises the individual performance of 
each veterinarian on a quarterly and annual basis against peers’ performance, 
including local disease detection rates, the number of inconclusive test results, and 
the number of test reports submitted late. A numerical risk-based weighting is used 
for each aspect of performance measured; the bottom 10% of performers are 
selected for special investigation as high risk and are subjected to additional 
practice and field inspections140.   
Current policy 
The economics of bovine TB control 
9.28. Currently (2016-17), Government spends around £70M annually on bovine TB 
control in England. This comprises: compensation (£33M); wildlife control (£9M); TB 
testing (£23M); and research (£4M through Defra with additional funding by the 
Research Councils as discussed at Annex 5). 
9.29. The average cost of a TB breakdown (officially TB-free status withdrawn OTFW) in 
England is around £37,000 of which £22,000 is borne by Government mainly as 
compensation for animals compulsorily slaughtered and the costs of testing. The 
remaining £15,000 represents consequential losses carried by farmers, including 
disruption to business through movement restrictions. Costs vary greatly amongst 
farms depending on their ability to adapt and mitigate. In addition to the direct 
financial costs of herd breakdowns, there is evidence of significant mental stress to 
farmers and their families after herd breakdowns. 
9.30. Farmers currently pay a production levy on dairy and meat products that is 
administered by the Agriculture & Horticulture Development Board (AHDB). The 
current rate for milk is 0.06p per litre and for beef £5.40 per head, of which the 
producer pays £4.05 and the slaughterhouse/exporter the rest (with calves £0.16 
per head).  AHDB owns and provides a “TB Hub”, paid for from the levy, a website 
on which it publishes advice on biosecurity and herd health (¶ 9.34). AHDB Dairy 
also publishes “TB Advantage,” a genetic index aimed at helping dairy farmers 
make informed decisions on selecting breeding stock which may have improved 
resistance to bovine TB (Chapter 4). 
                                            
140 Duignan et al. 2012 Quality control in the national bovine tuberculosis eradication programme in Ireland, 
Rev. sci. tech. Off. Int. Epiz., 31, 845-860  
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9.31. Future costs to industry for each new cull area have been estimated at £0.14m per 
area over four years (Chapter 6). Total government costs for each new cull area 
have been estimated at £0.48m per area over four years – including costs to 
Natural England (£116,000), APHA (£140,000), Defra (£20,000), and for policing 
(£210,000)141.  
Ownership of bovine TB programmes 
9.32. To foster broad ownership of bovine TB control efforts, Defra has set up a number 
of consultative bodies.  It also carries out extensive consultation on proposed new 
interventions prior to their implementation.  
9.33. The Bovine TB Eradication Advisory Group for England (TBEAG) is an expert group 
tasked with helping implement the 25-year strategy to eradicate bovine TB in 
England.  It advises on funding and budgetary issues and on compliance with EU 
legal requirements.  It also takes an active role in communicating and explaining 
any changes in policy to stakeholders as well as engaging regularly with the farming 
industry, the veterinary profession and wider stakeholders.  The Animal Health and 
Welfare Board for England (AHWBE) has strategic oversight of Defra policy and 
delivery in England in relation to animal health. 
9.34. The TB Hub is a joint industry initiative, supported by AHDB, APHA, the BCVA, 
Defra, Landex (a consortium of higher education colleges with interests in farming), 
and the NFU. It provides practical advice for beef and dairy farmers on dealing with 
bovine TB on their farm, covering everything from biosecurity measures to 
understanding trading rules. It provides access to the ibTB service (Chapter 5), 
which has the latest information on local bovine TB outbreaks in England and 
Wales. 
9.35. The TB Advisory Service (TBAS) is a free service in the HRA and the EA that helps 
farmers improve farm biosecurity and reduce risks associated with cattle 
movements.  It has been funded by Defra through the Rural Development 
Programme for England (RDPE) for a three-year period ending in September 2020.  
Eligible farmers in the HRA and the EA of England can receive an advisory visit to 
their farm and there is also a telephone advice line. The service is currently 
provided by the Origin Group. 
9.36. An increasing number of counties have active TB Eradication Groups (TBEG). 
These are unofficial and variable in structure, but frequently build effective alliances 
between interested farmers, private veterinarians, APHA veterinarians and wildlife 
groups. In some cases they have provided useful discussion fora and have been 
effective sources of local information for farmers.  
9.37. Government routinely consults widely before the implementation of new policies.  
Best practice is that consultations should include an assessment of the costs and 
benefits of the options being considered and their impact on particular groups, and 
that government departments should explain how responses have informed policy. 
To reduce the risk of ‘consultation fatigue’ recent guidance emphasises that 




consultations should be well-targeted and informative, and not conducted just for 
the appearance of engagement. 
9.38. Defra regularly consults on different aspects of bovine TB policy, seeking views and 
evidence to inform future decisions. Since December 2016, formal written 
consultation exercises run by Defra have included proposals on: (i) introducing 
licensed badger controls in the LRA, (ii) simplifying testing in the HRA, (iii) plans to 
implement a supplementary form of badger control after an initial four-year period of 
culling, (iv) introducing enhanced bovine TB surveillance and control measures in 
the HRA and the EA, and (v) introducing more effective control measures to reduce 
the risk of bovine TB in non-bovine animals. These consultations typically run for a 
12-week period. It is normal practice for Defra to publish a summary of responses to 
each consultation and explain how these might influence future policy. 
Bovine TB regulation and enforcement 
9.39. As the delivery body for Defra, APHA is the interface between the industry and 
government.  They are primarily responsible for: (i) ensuring that disease control 
measures are implemented in England in line with government policy; (ii) providing 
expert veterinary and scientific advice to industry in relation to bovine TB; and (iii) 
monitoring and promoting compliance. 
9.40. APHA does not have an enforcement section and does not employ investigators or 
enforcement officers.  Under the Animal Health Act 1981, the responsibility to 
enforce all aspects of domestic bovine TB legislation remains with local authorities. 
This includes: 
(i) ensuring compliance in cases of overdue bovine TB tests; 
(ii) investigating and undertaking enforcement action where pre-movement testing 
rules are not complied with; 
(iii) taking appropriate enforcement action in cases where bovine TB testing has 
been required by notice and is not carried out;  
(iv) enforcing the removal of bovine TB reactors where a refusal has occurred; 
(v) enforcing licence conditions, movement restrictions, isolation requirements, etc.; 
and, 
(vi) conducting investigations prompted by suspicion of illegal movements, 
interference with relevant testing, and cattle identification concerns (including 
where the DNA of a slaughtered bovine TB reactor does not match the sample 
taken at the test).  
9.41. The 2014 bovine TB Strategy for England emphasised the importance of 
maintaining high levels of farmer compliance with bovine TB controls.  Because 
compliance is the responsibility of local authorities it is difficult to get overall 
statistics about enforcement.  Our discussions with different stakeholders suggest 
that the resources allocated to compliance vary greatly across different local 
authorities and are affected by the extent of competing pressures on LA budgets. 
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9.42. Natural England has a dual role in providing advice as the Government’s statutory 
adviser on the natural environment and nature conservation, as well as assessing 
and issuing licence applications to cull or vaccinate badgers to prevent the spread 
of bovine TB. Its role as a licensing authority is to help ensure any proposed cull is 
effective, safe and humane. 
Options for the future 
Continuing with current policy. 
9.43. The regulation of bovine TB has to change as we leave the EU and European 
legislation no longer applies in the UK.  The default option is to incorporate 
European legislation into domestic legislation and to mirror future changes in EU 
rules.  Current governance arrangements could continue substantially unchanged. 
9.44. The chief advantage of this option is that it minimises change and disruption to the 
industry.  This is not to be underestimated given the frequency with which new rules 
and regulations have been introduced in recent decades.  Against this must be set 
the reality that efforts to control bovine TB in the UK are currently failing to achieve 
strong progress, and that while the presence or lack of specific interventions is 
clearly partly responsible, blame is also likely to lie with the overall governance of 
disease control measures. 
9.45. TBEAG (¶ 9.33) has played an important role in bringing together different 
stakeholders to coordinate bovine TB advice to Defra under the strong 
chairmanship of John Cross.  An example of its success is the development of the 
Livestock Information Service proposal (see Chapter 5).  TBEAG’s continuing 
involvement in developing England’s bovine TB strategy will be very helpful.  We 
also see an important role at a more local level for TB Eradication Groups to share 
best practice and disseminate information. 
9.46. Relationships between the farming industry and the NGOs opposed to culling are 
clearly difficult, and in the past have been quite confrontational.  We acknowledge 
the recent efforts on both sides to establish dialogue and hope it is possible for this 
to continue. 
Improving provision of bovine TB advice 
9.47. There is extensive information available on bovine TB both on Defra’s website and 
on TB Hub (¶ 9.34).  We find it well-written and accessible.  Farmers who are 
motivated to look for information will find much that they need on these sites. 
9.48. TBAS (¶ 9.35) is a potentially important initiative currently in a trial phase.  Should it 
prove successful there will be a strong argument for its continuation.  The current 
aim is to carry out 2,400 advisory visits to farms over the three-year project but it 
will be important to assess the quality of advice given not just the number of visits. 
TBAS is being delivered by a private sector veterinary practice who also provide 
veterinary services to clients in the region served. Concerns have been expressed 
that this may lead to conflicts of interest (or that other practices may discourage 
their clients from registering).  Such issues should be considered in evaluating the 
success of the programme.  How TBAS visits might best be coordinated with other 
farm advice visits should also be considered. 
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9.49. Efforts could be made to encourage farmers to consult their expert private 
veterinarians more often to plan how to avoid or tackle the disease. Currently, 
APHA disease reports are sent to farmers rather than their private veterinarians.  
These contain a mass of invaluable information, but are difficult to interpret without 
help from veterinarians.  Ensuring the latter received the report would increase the 
likelihood of the disease report findings leading to action on farm and help foster 
farmer-veterinarian collaboration. 
9.50. The DAs and RoI have adopted policies that maintain greater links between the 
implementation of bovine TB control policy and local veterinarian practices than is 
the case in England.  There is a balance to be struck between the economies of 
scale of providing bovine TB testing at regional levels and the risk of 
disengagement of local veterinarians.  Future policy should consider lessons from 
the DAs and RoI, and will benefit from consultation between the veterinary 
profession, farming groups and government.  
Sharing the costs of disease control between industry and government 
9.51. As described above (¶ 9.28), approximately 60% of the costs of disease control are 
currently borne by government and the rest by industry.  There has been a trend for 
the industry to be asked to pay a larger fraction of the burden, for example to 
contribute substantially to the current badger culling programme.  The precise 
allocation of costs between Government and farming is a decision for ministers but 
we discuss here what the consequences and implications for disease control might 
be of more of the costs being borne by industry. 
9.52. In principle the costs of disease control could be spread evenly across the beef and 
dairy industry or concentrated on the most high-risk businesses.  All of the extra 
expense could be borne before the farm gate as a production cost (where most 
likely to incentivise disease-control behaviour) or some could be moved further 
along the value chain.  Different options would have different effects on UK beef 
and dairy competitiveness and on meat and dairy prices.   
9.53. Arrangements that placed greater burdens on high-risk farms would affect the 
viability of beef and dairy farming in areas of high disease risk.  It might be argued 
that stopping cattle farming in areas where it is not financially profitable when all 
costs are accounted is economically sensible, and it would remove centres of 
infection from which the disease could spread to other areas.  Against this is the 
reality that in many of these areas there is no alternative economic model of farming 
so in the absence of other sources of funding (such as payment for public goods) 
the land would likely come out of agriculture.  From a strategic national point of 
view, allowing farms to go out of business due to a disease that might in the future 
be controlled might be seen as suboptimal.  For those farms that stayed in 
business, the extra financial burden of disease responsibility may make them 
unable to afford anything more that the statutory minimum to help control the 
disease. 
9.54. The New Zealand model of asking the industry to assume the major share of 
disease control costs has been accompanied by a significant shift in the 
determination of policy to the independent industry body.  The resultant ownership 
of the problem by industry has been very helpful in forging a consensus amongst 
farmers to adopt useful measures that at least in the short-term are costly to their 
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businesses.  Following that model in the UK, with its undoubted advantages, is 
much harder because of the differences in the wildlife reservoir.  Whereas in New 
Zealand there is a broad consensus that the industry can undertake the type of 
possum control it thinks best, there would no such consensus in the UK; for 
example, one major political party is committed to halt culling.  Whether full industry 
ownership of the disease in cattle is possible when government determines the 
policy on control in wildlife (and this may change over time) is not clear.  
Setting up an independent regulator 
9.55. As discussed above (¶ 9.18), the interim report of the Farm Inspection and 
Regulation review argues that farming could be regulated more effectively and 
efficiently by independent regulatory arrangements that allowed for adaptive 
approaches, tailored to each of government’s aims for farming.  We explore that 
suggestion here within the context of our remit on bovine TB though realise that to 
take this forward a full options appraisal would need to be done comparing this with 
the status quo and perhaps a New Zealand-type industry-led option (¶ 9.54). 
9.56. The regulatory, licensing, inspection and compliance activities concerning bovine 
TB currently associated with APHA, Natural England and local authorities could be 
vested in a new body with greater independence from Defra.  Using the terminology 
in the Farm Inspection and Regulation interim report we refer to this as the 
‘regulator’ though emphasising this body’s important disease control role.  
Responsibility for general policy would remain with Defra (which we believe is 
essential because of the requirement for ministerial judgement about many of the 
decisions that have to be made) which would set the goals for the consolidated 
body to achieve.  The interim report of the Farm Inspection and Regulation review 
envisages all bodies involved in farm regulation being brought together so as to 
capitalise on synergies and economies involving farm visits.  Though much activity 
involving bovine TB involves specialist activities such as testing for the disease, 
there are opportunities for synergies in using inspection visits as opportunities to 
advise on a broad range of issues of importance to the farmer including disease 
control.  
9.57. Current advice on best practice in regulation supports the independence of 
regulators.  In the context of bovine TB there is a belief amongst environmental 
NGOs that government is unduly influenced by lobbying by the farming industry, 
while the industry complains of the reverse.  Though government would still set the 
goals for disease control, its day-to-day implementation by the regulator would be 
immune from this real or perceived interference.  The remit of the regulator would 
be drawn up carefully to encourage it to engage impartially with the industry and 
other stakeholders in shared ownership of the problem and to avoid regulatory 
capture by any of the interested parties.  
9.58. The regulator would carry out the statutory duties around bovine TB control now 
carried out by a number of different bodies.  With the increased freedom possible 
after leaving the EU, the regulator would be empowered to interpret more flexibly 
and adaptively disease control rules.  Working with industry it would develop 
standards for cattle trading and biosecurity, and develop the type of indices of 
farmer behaviour needed for the innovation in risk-based trading (Chapter 5) and 
insurance and compensation (Chapter 8) discussed earlier in this review.  It would 
be responsible for licensing, including for wildlife culling and vaccination (Chapter 
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6), and to allow innovative approaches to disease control using newly developed 
test (Chapter 3). 
9.59. The regulator would have broad powers of enforcing compliance and the flexibility 
to use them in a way that is perceived as fair and impartial and which generates 
confidence in the farming community.  Thus, minor infringements would be dealt 
with by warnings or directives with more serious incidents attracting enforceable 
undertakings, civil penalties or licence withdrawals.  The body would have the ability 
to act through legal power and criminal prosecution as a last resort. 
9.60. The final report of the Farm Inspection and Regulation review is due to be 
submitted in December 2018 and will then be considered by ministers.  Were 
government to decide on a broad-based independent regulator as flagged by the 
interim report, the activities we discuss here would naturally fall within it.  But were 
this suggestion not accepted then a narrower body with a brief to act on livestock 
disease in general or just on bovine TB should be considered. 
More use of licensing 
9.61. As described in Chapter 3, farmers are prohibited from using non-statutory tests for 
bovine TB, either when they are free from the disease, or when they are restricted 
during breakdowns, even when they wish to pay for them. This reduces the 
potential for them taking ownership of the disease and its prevention on their farms. 
Greater flexibility in allowing licensed use of alternative tests in cattle farms to 
improve both prevention and control – and importantly, to enable reductions in 
within-herd transmission – seems to have great merit. We understand the potential 
for non-statutory tests to be misused and envisage farmers have to achieve “earned 
recognition” to be allowed to do so. 
Consultation frequency 
9.62. Consultation with industry and other stakeholders is an important part of bovine TB 
control and of achieving shared ownership of the problem.  At the moment 
consultation is relative frequent which risks “consultation fatigue” and slows the rate 
at which policy can adapt to changing conditions.  Excessive and slow consultation 
was raised with us by many of the stakeholders we spoke to. An alternative is to 
consult less frequently and at a higher level on broad strategy, mechanisms of 
adaptive management and direction of travel.   
9.63. The chief advantage of such a change is that it could enable operational decisions 
to be made more swiftly as circumstances change and new evidence emerges.  It 
would allow disease control to take a more adaptive management approach.  
Speed of action will be particularly valuable in circumstances such as when a new 
focus of bovine TB appears in the LRA and quick action is required to stop 
establishment. 
9.64. On the negative side, it may be harder to achieve consensus amongst stakeholders 
for actions that are not described in detail.  There is also the risk for multiple 
interpretations of more high-level policy that could undermine shared ownership.  
We are aware that changes in the nature of consultation may involve some changes 
to legislation that stipulates types of consultation. 
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Annex 1: Acronyms and definitions 
95% CI: 95% Confidence Interval 
AFU: Approved Finishing Unit, used to channel cattle from bovine TB restricted herds to 
slaughter 
AHDB: Agriculture and Horticulture Development Board 
AHVLA: Animal Health and Veterinary Laboratories Agency, former executive agency of 
Defra (now part of APHA) 
AHWBE: Animal Health and Welfare Board for England 
AIM: Animal Identification and Movement database (in Republic of Ireland) 
APHA: Animal and Plant Health Agency 
ARAMS: Animal Movement and Reporting Service 
ATT: Approved Tuberculin Testers 
BCG: Bacillius Calmette-Guérin, which is used to manufacture tuberculosis vaccines 
BCMS: British Cattle Movement Service 
BCVA: British Cattle Veterinary Association 
BEVS: Badger Edge Vaccination Scheme 
Biosecurity: Procedures or measures designed to reduce the risk of transmission of 
infectious diseases 
Bovine Tuberculosis: An infectious disease in cattle caused by Mycobacterium bovis (M. 
bovis) 
BPS: Basic Payment Scheme (administered by Rural Payments Agency) 
Breakdown: Detection of exposure to M. bovis infection in a herd (e.g detection of a 
bovine TB reactor or signs of possible bovine TB at post mortem). This is followed by 
breakdown control procedures; the duration of a breakdown depends on the 
successfulness of the breakdown measures to clear the infection from the herd 
BVA: British Veterinary Association 
CAP: Common Agricultural Policy 
CFT test: Caudal Fold Tuberculin Test - tuberculin is injected into the flap at the base of 
the tail rather than the neck 
CHeCS: Cattle Health Certification Standards 
CPH: County Parish Holding, a unique number to describe the land and buildings that 
people use for keeping livestock, including livestock kept as pets. 
CPS: Countryside Productivity Scheme - provides funding for projects in England which 
improve productivity in the farming and forestry sectors and help create jobs and growth 
in the rural economy. 
CTS: Cattle Tracing System 
CVO: Chief Veterinary Officer 
DA: Devolved Administration (Wales, Scotland, Northern Ireland) 
Defra: Department for Environment, Food and Rural Affairs 
DIVA: A test used to differentiate infected from vaccinated animals 
DNA: Deoxyribonucleic acid, the hereditary material in humans and almost all other 
organisms. 
DPP: Dual Path Platform, an immunological blood test that can be used for diagnosis of 
TB infection in badgers. 
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DRF: Disease Report Form 
EA: see Edge Area 
Edge Area: The edge of the HRA where the disease is not yet considered to be endemic 
and disease prevalence is lower than in the HRA but there is a great likelihood of further 
geographical spread of bovine TB out of the HRA. 
EFSA: European Food Safety Authority 
EFU: Exempt Finishing Unit, a route for beef producers to finish cattle without the need for 
a pre-movement test 
ELISA: Enzyme-linked immunosorbent assay, a test that can be used to detect either 
antibody (Ab) or antigen such as viral proteins. 
Endemic disease: A disease which is continuously present in a specific population 
Epidemiology: A study of the distribution and dynamics disease in a population 
EU: European Union 
FAT: Full Agricultural Tenancies  
FSA: Food Standards Agency 
FYM: Farm Yard Manure 
Genotype: A genetically distinct strain of a specimen or species 
Herd Prevalence: This statistic can be expressed in different ways but depicts the 
proportion of herds that are affected by a disease/condition in a specific population 
High Risk Area for bovine TB: An area defined geographically in which cattle herds have 
a greater likelihood of experiencing a bovine TB breakdown. It includes geographical areas 
in which there is a relatively high herd prevalence of bovine TB 
Home range: The specific geographic area where a specific animal or pathogen (for 
example, a genotype of M. bovis) is typically detected 
Host: Animals which can routinely become infected with a pathogen (for example, M. 
bovis) if exposed 
HRA: see High Risk Area 
IAA: Intensive Action Area (South West Wales) 
ibTB: Interactive map showing the locations of bovine TB breakdowns 
IDEXX: IDEXX Laboratories 
IFNγ: Interferon Gamma, see Interferon Gamma Assay 
Incidence: This statistic reflects the number of cases of infection or disease in a 
population as a rate per time unit. 
Inconclusive reactor: An animal which gives an inconclusive reaction to the tuberculin 
skin test as defined in Council Directive 64/432/EEC 
Index infection (or case): The first infection (or case) in a herd or area 
Interferon Gamma Assay: A rapid (24-hour) whole blood in-vitro assay to detect immune 
response to M. bovis infection for the diagnosis of bovine TB 
IR: see Inconclusive reactor 
LAA: Livestock Auctioneers Association 
Lesions: Characteristic tubercles or larger abscess-like structures typically found in lymph 
nodes and organs such as the lungs, liver and spleen 
LIS: Livestock Information Service 
Low Risk Area: An area defined geographically in which cattle herds have a lower 
likelihood of experiencing a bovine TB breakdown. It includes geographic areas with very 
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low herd prevalence of bovine TB and where the disease is not believed to be maintained 
by badgers and is primarily caused by cattle movements 
LRA: see Low Risk Area 
Mycobacteria: A family of bacteria which includes Mycobacterium bovis 
Mycobacterium avium (M. avium): A bacteria which causes tuberculosis in birds and 
swine, and is responsible for the mycobacterium avian complex (MAC) in humans. 
Mycobacterium bovis (M. bovis): One of the bacteria which causes tuberculosis in 
cattle. It can also infect other mammals including humans and wildlife. 
Mycobacterium tuberculosis (M. tuberculosis): One of the bacteria which causes 
tuberculosis in humans 
Natural England: An executive non-departmental public body responsible to Defra, which 
administers applications for licences under the Badger Protection Act 1992 
NFU: National Farmers Union 
NGO: Non-governmental Organisations 
NPV: Negative predictive value, the proportion of negative diagnostic test results that are 
true negative results. 
OIE: World Organisation for Animal Health 
OTF: “Officially Bovine Tuberculosis Free” as defined in Council Directive 64/432/EEC. 
OTF status may apply to herds, regions or Member States 
OTFS: “Officially Bovine Tuberculosis Free” status of herd is suspended, as defined in 
Council Directive 64/432/EEC. This status is used for those cattle and herds where the 
infection is not confirmed by culture of M. bovis 
OTFW: “Officially Bovine Tuberculosis Free” status of herd is withdrawn, as defined in 
Council Directive 64/432/EEC. This status is used for those cattle and herds where the 
infection is confirmed by culture of M. bovis or by finding typical lesions in a carcase of an 
animal 
OV: Official Veterinarian, a private veterinarian permitted to undertake official controls 
such as tuberculin skin testing 
PCR: see Polymerase Chain Reaction 
Perturbation: Disruption of badger social organisation or structure which causes badgers 
to range more widely than they would normally and come in contact more often with other 
animals (including both cattle and other badgers). 
PHE: Public Health England 
Polymerase Chain Reaction: Technology to amplify a single or a few copies of a piece of 
DNA in order to allow easier detection of a particular pathogen by its DNA 
Post Movement Test: A tuberculin skin test applied to an animal after it has moved 
between premises 
PPD-A: Purified Protein Derivative, extract of Mycobacterium avium; tuberculin. 
PPD-B: Purified Protein Derivative, extract of Mycobacterium bovis; tuberculin. 
PPV: Positive Predictive Value, the proportion of positive diagnostic test results that are 
true positive results 
Pre Movement Test: A tuberculin skin test applied to an animal before it has moved 
between premises 
Prevalence: see Herd Prevalence 
R&D: Research and Development 
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RBCT: Randomised Badger Culling Trial, a scientific study carried about from 1998 – 
2005 to quantify the impact of two forms of culling badgers on TB incidence in cattle 
RDPE: Rural Development Programme for England 
Reactor: An animal which gives a positive reaction to the tuberculin skin test as defined in 
Council Directive 64/432/EEC 
Reservoir Host Population: A population in which the pathogen is endemic and from 
which infection is transmitted to a particular target population 
RoI: Republic of Ireland 
Routine herd testing: The programme of routine surveillance testing of breeding cattle in 
herds using the tuberculin skin test in line with Council Directive 64/432/EEC. Routine herd 
testing is applied to four-yearly tested herds 
RPA: Rural Payments Agency 
SAC: South American Camelids, for example alpacas and llamas 
SE: Sensitivity (of a test – ability to detect all cases of disease) 
Severe Interpretation: A more rigorous interpretation of the tuberculin skin test (than the 
“standard interpretation”) in line with Council Directive 64/432/EEC 
Short Interval test: The intensive testing of all cattle in breakdown herds using the 
tuberculin skin test in line with Council Directive 64/432/EEC 
SICCT: Single intradermal comparative cervical test. See tuberculin skin test 
SICT: Single intradermal cervical test. See tuberculin skin test 
Single Farm Payment: An agricultural subsidy paid to farmers in the EU 
SP: Specificity (of a test – the accuracy of the test in ruling out disease) 
Spillover Host Population: A population which can become infected with the pathogen but 
from which the infection is not transmitted to a particular target population. 
SRUC: Scotland’s Rural College 
Standard Interpretation: The routine interpretation of the tuberculin skin test in line with 
the Council Directive 64/432/EEC 
Surveillance: The collection of health data to detect disease in a population by using 
diagnostic or clinical methods. For bovine TB in England, formal surveillance is carried out 
with frequent, whole or routine herd testing, by pre-movement testing of all cattle of 42 
days of age, leaving premises in the HRA and by inspecting all cattle carcases slaughtered 
commercially for post mortem signs of bovine TB 
TB: Tuberculosis 
TBAS: Tuberculosis Advisory Service 
TBEAG: Bovine Tuberculosis Eradication Advisory Group for England 
TBEG: Bovine Tuberculosis Eradication Groups, county level local groups 
Test Interval: The period of time between routine or whole-herd tuberculin tests 
Therapeutics: Pharmaceutical agents (drugs) licenced for use in treating human or animal 
diseases 
TLA: Temporary Land Association, associates a permanent County Parish Holding with 
land or a building within 10 miles of the CPH’s main livestock handling area. 
Tuberculin: Mycobacterial proteins used in tests to detect bovine tuberculosis 
Tuberculin skin test: A diagnostic test measuring an animal’s reaction to injection(s) of 
tuberculin carried out in line with Council Directive 64/432/EEC. 
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TVR: A wildlife intervention research study in Northern Ireland, looking at the effects of 
implementing a test and vaccinate or remove intervention on badgers  
UK: United Kingdom, comprising Great Britain and Northern Ireland 
USA: United States of America 
VDP: Regional Veterinary Delivery Partners 
VMD: Veterinary Medicines Directorate, an agency of Defra 
VNTR: Variable Number of Tandem Repeat, a location in a genome where a short 
nucleotide sequence is organized as a tandem repeat 
Whole herd testing: The testing of all cattle in herds using the tuberculin skin test in line 
with Council Directive 64/432/EEC. Whole herd testing is applied routinely to annually 
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Annex 3: Terms of reference 
The Bovine Tuberculosis Strategy review is initiated by, and will report to, the Secretary of 
State for Environment, Food and Rural Affairs. 
1. Purpose 
To reflect on progress being made with implementation of the bTB Strategy and consider 
how to take the Strategy to the next phase. Advise on what further actions might be 
prioritised now to ensure we maintain progress towards our target of achieving Officially 
Free status for England by 2038. 
2. Objectives 
The review will: 
• consider and advise on the opportunities for improved application, enhancement or 
acceleration of the interventions set out in the Strategy, including cattle vaccination, 
oral badger vaccination, improved genetic resistance and improved diagnostic tests, 
or to deploy new tools and/or technologies to fight the disease 
 
• consider how delivery is monitored and how impact of the Strategy is evaluated 
(and what that tells us about progress of the disease and the dynamics of its 
spread), and make recommendations as to whether and how these can be 
improved 
 
• advise on gaps in the available evidence and disease control tools. Recommend 
options to address these (including the application of epidemiology and research) to 
achieve the aims of the Strategy 
In implementing the review, the review team should also take account of: 
• the structure of the farming industry and the rural environment 
 
• the sustainability, scalability, deliverability and cost-benefit trade-offs of 
interventions 
 
• wider work underway in Defra to consider future farming policy and the farming 
regulatory and enforcement landscape, in light of the UK’s exit from the EU 
 
• lessons learnt from the experiences of the Devolved Administrations and from the 
strategies deployed by other countries to tackle and eradicate bovine and human 
TB and other diseases 
3. Scope 
The review will consider all the drivers for disease spread and how they might be 
addressed. The focus will be on the bTB eradication strategy for England only. It will 
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consider this as a system of intervention to control the disease and advise on how this 
could be improved. 
The review will not re-visit the rationale for current interventions in the Strategy. It will take 
a prospective and not a retrospective view. It is not a review of badger culling. 
4. Roles and responsibilities 
The review will be led and overseen by Professor Sir Charles Godfray FRS. He will be 
supported by a small core working group to which Professor Christl Donnelly FRS, 
Professor James Wood, Professor Michael Winter and Professor Glyn Hewinson have 
been appointed. All reviewers have been selected for their skills, competence, expertise, 
and experience of operating at a strategic level and impartially. 
The UK Chief Veterinary Officer, Christine Middlemiss, will work closely with the core 
group to provide her expertise and a government perspective. Whilst the core group will 
consider her views, they will retain ownership of the final report and will not need to secure 
her agreement or align the report to her views. 
5. Ways of working 
The Chair will be responsible for overseeing the strategic direction and progress of the 
review and delivery of the final report. The Chair will work closely with the CVO and the 
Director of Animal and Plant Health who will oversee the review within Defra. Progress 
reviews will be conducted monthly. 
The Chair, with advice taken from the core working group, may seek to access wider 
expertise dependent on need. 
The review will be supported by a Secretariat within Defra, and by staff within Defra and 
the relevant agencies throughout. 
A communications strategy and stakeholder engagement/management plan will be 
developed. All communication with the media will be undertaken through Defra 
Communications Team. 
6. Timing 
The review will commence in March and is due to be completed by end September 2018. 
7. Reporting 
An evidence-based report will be submitted to Defra Ministers for consideration, detailing 




Annex 4: Summary of stakeholder engagement  
We ran a call for evidence from 24 April 2018 to 31 May 2018 to help inform the bovine TB 
Strategy Review work. 
We sought information about evidence-based interventions (including epidemiological and 
regulatory/economic measures) for bovine TB control. In particular: 
 
• research aimed at improving the deployment of existing bovine TB measures; 
 
• potential new approaches and tools/technologies to deal with bovine TB; 
 
• approaches taken to control bovine TB in other countries; and, 
 
• work in the field of human TB that might be relevant to the Review. 
Call for evidence outcome 
We received 39 responses to the call for evidence. These were submitted by a mixture of 
individuals and organisations, including farming and veterinary groups, NGOs and 
academics.  
We carefully considered all the submissions received and used this evidence to inform our 
final report.  
Issues raised 
Key themes raised in response to the call for evidence were:  
Risk-based trading 
Several responses discussed the role of cattle movements in spreading bovine TB and the 
potential for risk-based trading to mitigate this risk.  
Biosecurity  
Some respondents highlighted issues of on-farm biosecurity and whether this could be 
incentivised and improved. 
Vaccines 
Several responses discussed the potential role of cattle and badger vaccines in terms of 
effective disease management. Work is needed to develop these tools and explore how 
best to deploy them.  
Surveillance and diagnostics 
A number of responses called for further work to improve the identification of the disease, 
including support for new/novel diagnostic tests.  
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Using genetic techniques 
Several organisations highlighted the potential to breed for disease resistance, with some 
suggestions for future research.  
Badger Culling 
There was a range of views about the need for badger culling, its humaneness and 
effectiveness, including how Government might develop an exit strategy. 
Environmental factors  
Some responses discussed the role of slurry and soil in terms of disease transmission.  
International experience 
Responses highlighted good practice in Australia, New Zealand and other countries; for 
example, approaches to risk-based trading and governance. 
Human TB 
Several submissions highlighted relevant research in the field of human TB. 
Bovine TB in other farmed species 
Some responses discussed the need for further action to identify and control the disease 
in a wider range of species.  
Information 
A few responses raised the potential of big data, artificial intelligence and better use of 
analysis and statistics. These could help with monitoring and better targeting of efforts to 
control the disease. 
Role of retailers 
Some organisations felt that the large supermarkets could play an important role in 
influencing farmers and consumers and encouraging good practice.  
Other novel suggestions 
Some responses highlighted novel tools and techniques to detect bovine TB and reduce 
disease risks.  
Stakeholder Meetings 
The Review team also met with a number of stakeholders throughout the course of the 
Review process. This included individuals and organisations linked to farming, 
environmental and wildlife protection and the veterinary profession, NGOs, Government 
and academics.  
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Annex 5: Bovine TB Research Spending (2014/15 to 2018/19) 
Defra funds a substantial bovine TB research programme. This includes:- 
• developing vaccines for use in both cattle and badgers; 
• developing improved diagnostic tests for cattle; 
• exploring epidemiological factors influencing the prevalence and persistence of 
bovine TB in cattle and wildlife;  
• investigating risk factors for the development of the disease in cattle; and 
• undertaking economic and epidemiological analyses of bovine TB control strategies 
and the overall impact of the disease. 
Between 2014/15 and 2018/19, Defra funded 45 individual research projects and invested 
approximately £21 million in its bovine TB Research and Development programme. The 
research budget covers England, Wales and Scotland. 
Figure An5.1 provides a breakdown of research expenditure by Defra since 2014 in the 
following areas: 
• epidemiology, economics, modelling and risk assessment; 
• pathogenesis, genomics and immunology; 
• cattle vaccines and related diagnostics; 
• cattle diagnostics; 
• badger vaccines and related diagnostics; 
• badger diagnostics; and 
• general diagnostics (i.e. multi-species projects). 
 
In 2014, Defra collaborated with the National Centre for the Replacement, Refinement and 
Reduction of Animals in Research (NC3Rs) and the Biotechnology and Biological 
Sciences Research Council (BBSRC) on a £7 million programme aimed at improving 
knowledge of bovine TB biology. The programme is focused on addressing knowledge 
gaps, developing new non-animal models to study disease, and developing novel control 
and eradication strategies.  
The live portfolio of BBSRC awards at 1 April 2018 relating to bovine TB covers 18 active 
projects with a total commitment of £10.9 million. Other Research Councils have also 
invested in bovine TB research in recent years. The Natural Environment Research 
Council (NERC) funds research on the occurrence of bovine TB in wild populations and 
transmission to other species. The Medical Research Council (MRC) has made a number 
of strategic investments in long-term bovine TB research programmes which may produce 







Figure An5.1. Defra bovine TB research spend by scientific area, 2014/15 to 2018/19 
 
Further information on Defra-funded research projects is available at 
http://sciencesearch.defra.gov.uk/  
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Annex 6 – Areas of licensed badger control 








* Indicating the county not the precise 
location within the county. The circles 
are approximately the cumulative size 
of all cull areas centred in each county. 
Individual areas are different shapes 
and sizes and several cross county 
borders.  
One cull in the Low Risk Area of 
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Table An6.1. Number of badgers culled per year (2013 - 2017) 
Key: Shading indicates culling did not occur in these areas/years. Highlighting indicates 
culling has occurred under a licence for supplementary badger control. 
 2013 2014 2015 2016 2017 
Area 1 – Gloucestershire 924 274 432 252 172 
Area 2 – Somerset 955 341 279 217 91 
Area 3 – Dorset   756 502 257 
Area 4 – Cornwall    711 213 
Area 5 – Cornwall    851 358 
Area 6 – Devon    2038 727 
Area 7 – Devon    833 246 
Area 8 – Dorset    3000 1166 
Area 9 – Gloucestershire    1858 1012 
Area 10 – Herefordshire    624 394 
Area 11 – Cheshire     736 
Area 12 – Devon     1874 
Area 13 – Devon     1237 
Area 14 – Devon     708 
Area 15 – Devon     763 
Area 16 – Dorset     3450 
Area 17 – Somerset     1123 
Area 18 – Somerset     489 
Area 19 – Wiltshire     2252 
Area 20 – Wiltshire     1040 
Area 21 – Wiltshire     1229 
